1260 genotypes with 1433 annotations displayed
of selected term and subterms
|
Searched Term: abnormal physiological response to xenobiotic
|
1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/0
(involves: FVB/N)
|
decreased physiological sensitivity to xenobiotic
|
J:193548
|
A4galttm1Kfk/A4galttm1Kfk
(involves: C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:108352
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:108352
|
Abcb1amds/Abcb1amds
(involves: CF-1)
|
increased physiological sensitivity to xenobiotic
|
J:40292,
J:64725
|
Abcb1atm1Bor/Abcb1atm1Bor
(involves: 129P2/OlaHsd * FVB)
|
increased physiological sensitivity to xenobiotic
|
J:18554
|
Abcb1atm1Bor/Abcb1atm1Bor
(FVBTac.129P2-Abcb1atm1Bor)
|
increased physiological sensitivity to xenobiotic
|
J:59145
|
increased susceptibility to ototoxicity-induced hearing loss
|
J:59145
|
Abcb6tm1Jsch/Abcb6tm1Jsch
(involves: 129)
|
increased physiological sensitivity to xenobiotic
|
J:184574
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:184574
|
Abcb6tm1Pkr/Abcb6tm1Pkr
(involves: C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:190243
|
Abcc1tm1Acs/Abcc1tm1Acs
(involves: 129S1/Sv * C57BL/6)
|
increased physiological sensitivity to xenobiotic
|
J:44305
|
Abcc1tm1Bor/Abcc1tm1Bor
(involves: 129P2/OlaHsd * FVB)
|
increased physiological sensitivity to xenobiotic
|
J:44110
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:44110
|
Abcc2tm1Ahs/Abcc2tm1Ahs
(B6.129P2(FVB)-Abcc2tm1Ahs)
|
increased physiological sensitivity to xenobiotic
|
J:208127
|
Abcc9em3Nich/Abcc9em3Nich
(B6.Cg-Abcc9em3Nich)
|
abnormal physiological response to xenobiotic
|
J:308986
|
Abcc10tm1Eah/Abcc10tm1Eah
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased physiological sensitivity to xenobiotic
|
J:172648
|
Abcg2tm1Bsor/Abcg2tm1Bsor
(involves: 129P2/OlaHsd * C57BL/6)
|
increased physiological sensitivity to xenobiotic
|
J:98134
|
Abl1tm1.1Gcos/Abl1+
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased physiological sensitivity to xenobiotic
|
J:168843
|
Abl1tm1.1Gcos/Abl1tm1.1Gcos
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased physiological sensitivity to xenobiotic
|
J:168843
|
Abl1tm1Gcos/Abl1+ Myf5tm2Tajb/Myf5tm2Tajb Myf6tm1Tajb/Myf6tm1Tajb Myod1tm2.1(icre)Glh/Myod1+
(involves: 129S * 129X1/SvJ * C57BL/6J)
|
decreased physiological sensitivity to xenobiotic
|
J:168843
|
Acetm5Keb/Acetm5Keb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:163454
|
Achetm1.1Pata/Achetm1.1Pata
(involves: 129X1/SvJ)
|
increased physiological sensitivity to xenobiotic
|
J:147483
|
Achetm1Loc/Achetm1Loc
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal physiological response to xenobiotic
|
J:130048
|
increased physiological sensitivity to xenobiotic
|
J:130048
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:130048
|
Achetm4Pata/Achetm4Pata
(involves: 129X1/SvJ)
|
increased physiological sensitivity to xenobiotic
|
J:147483
|
Acot11tm1Deco/Acot11tm1Deco
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:182660
|
Acot12em1Holi/Acot12em1Holi
(involves: C57BL/6J * C57BL/6N)
|
increased incidence of tumors by chemical induction
|
J:335836
|
Acvrl1tm1Enl/Acvrl1+
(B6.Cg-Acvrl1tm1Enl)
|
abnormal physiological response to xenobiotic
|
J:226550
|
Adam17tm1Imx/Adam17tm1Imx
(B6.129-Adam17tm1Imx)
|
decreased physiological sensitivity to xenobiotic
|
J:174865
|
Adam17tm1Rain/Adam17tm1Rain
(involves: C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:174865
|
Adam26atm1.1(KOMP)Vlcg/Adam26atm1.1(KOMP)Vlcg
(C57BL/6N-Adam26atm1.1(KOMP)Vlcg/MbpMmucd)
|
decreased bronchoconstrictive response
|
J:211773
|
Adamts13tm1Dgi/Adamts13tm1Dgi Vwftm1Wgr/Vwftm1Wgr
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * CASA/Rk)
|
decreased physiological sensitivity to xenobiotic
|
J:133469
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:133469
|
Adamts18tm1.1Wzha/Adamts18tm1.1Wzha
(involves: 129 * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:258487
|
increased physiological sensitivity to xenobiotic
|
J:258487
|
Adcyap1tm1Clw/Adcyap1tm1Clw
(B6.129S4-Adcyap1tm1Clw)
|
increased susceptibility to dopaminergic neuron neurotoxicity
|
J:194151
|
Adh5tm1.1Llli/Adh5tm1.1Llli Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Adh5tm1.1Llli Speer6-ps1Tg(Alb-cre)21Mgn)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:173666
|
Adh5tm1Gdu/Adh5tm1Gdu
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:55555
|
Adh5tm1Stam/Adh5tm1Stam
(B6.129-Adh5tm1Stam)
|
increased physiological sensitivity to xenobiotic
|
J:88337
|
Adh5tm1Stam/Adh5tm1Stam
(involves: 129)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:173666
|
Adora2atm1Jfc/Adora2atm1Jfc
(involves: 129S4/SvJae * 129S6/SvEvTac)
|
decreased physiological sensitivity to xenobiotic
|
J:106215
|
Adora2btm1Till/Adora2btm1Till
(B6.129P2-Adora2btm1Till)
|
decreased physiological sensitivity to xenobiotic
|
J:125297
|
Adrb1tm1Bkk/Adrb1tm1Bkk
(either: (involves: 129/Sv) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA/2))
|
abnormal physiological response to xenobiotic
|
J:34659
|
Adrb1tm1Bkk/Adrb1tm1Bkk Adrb2tm1Bkk/Adrb2tm1Bkk
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * DBA/2 * FVB/N)
|
abnormal physiological response to xenobiotic
|
J:55553
|
Adrb3tm1Lowl/Adrb3tm1Lowl
(FVB/N-Adrb3tm1Lowl)
|
abnormal physiological response to xenobiotic
|
J:30060
|
Afptm1(Cebpa)Ndw/Afp+
(involves: 129S7/SvEvBrd)
|
decreased incidence of tumors by chemical induction
|
J:103404
|
Agtr1atm1Ecl/Agtr1atm1Ecl
(involves: 129S2/SvPas * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:124206
|
Agtr1atm1Unc/Agtr1atm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal physiological response to xenobiotic
|
J:137944
|
Agtr1atm1Unc/Agtr1atm1Unc Agtr1btm1Cof/Agtr1btm1Cof
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal physiological response to xenobiotic
|
J:137944
|
Agtr1atm1Unc/Agtr1atm1Unc Agtr1btm1Cof/Agtr1btm1Cof Agtr2tm1Tin/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal physiological response to xenobiotic
|
J:137944
|
Agtr1atm1Unc/Agtr1atm1Unc Agtr1btm1Cof/Agtr1btm1Cof Agtr2tm1Tin/Agtr2tm1Tin
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal physiological response to xenobiotic
|
J:137944
|
Agtr2tm1Tin/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
increased physiological sensitivity to xenobiotic
|
J:146326
|
Agtr2tm1Tin/Y
(involves: 129P2/OlaHsd)
|
increased physiological sensitivity to xenobiotic
|
J:103144
|
Agtr2tm1Tin/Y
(SWR.129P2-Agtr2tm1Tin)
|
decreased incidence of tumors by chemical induction
|
J:101726
|
Agtr2tm1Tin/Agtr2tm1Tin
(involves: 129P2/OlaHsd * C57BL/6)
|
increased physiological sensitivity to xenobiotic
|
J:146326
|
Agxttm1Ull/Agxttm1Ull
(involves: 129X1/SvJ * C57BL/6)
|
increased physiological sensitivity to xenobiotic
|
J:181969
|
Ahrb-1/Ahrb-1
(C57BL/6J)
|
increased physiological sensitivity to xenobiotic
|
J:113285,
J:26440,
J:132380
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:113285,
J:26440
|
Ahrb-1/Ahrb-1
(C58/J)
|
increased physiological sensitivity to xenobiotic
|
J:26440
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:26440
|
Ahrb-1/Ahrb-1 Aiptm2.1Bra/Aiptm2.1Bra Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn Aiptm2.1Bra)
|
decreased physiological sensitivity to xenobiotic
|
J:166864
|
Ahrb-1/Ahrd
(involves: 129S1/SvImJ * C57BL/6J)
|
increased incidence of tumors by chemical induction
|
J:113356
|
increased physiological sensitivity to xenobiotic
|
J:113356
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:113356
|
Ahrb-1/Ahrd
(involves: C57BL/6 * DBA/2)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:113285
|
Ahrb-2/Ahrb-2
(C3H/He)
|
increased physiological sensitivity to xenobiotic
|
J:26440
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:26440
|
Ahrb-2/Ahrb-2
(A/He)
|
increased physiological sensitivity to xenobiotic
|
J:26440
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:26440
|
Ahrd/Ahrd
(DBA/2J)
|
decreased physiological sensitivity to xenobiotic
|
J:26440,
J:132380
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:26440
|
Ahrd/Ahrd
(AKR)
|
decreased physiological sensitivity to xenobiotic
|
J:26440
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:26440
|
Ahrd/Ahrd
(DBA/2)
|
decreased physiological sensitivity to xenobiotic
|
J:26440
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:26440
|
Ahrd/Ahrd
(involves: 129S1/SvImJ * C57BL/6J)
|
increased incidence of tumors by chemical induction
|
J:113356
|
increased physiological sensitivity to xenobiotic
|
J:113356
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:113356
|
Ahrd/Ahrd
(B6.D2-Ahrd)
|
decreased physiological sensitivity to xenobiotic
|
J:113285
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:113285
|
Ahrtm1(AHR)Mym/Ahrtm1(AHR)Mym
(B6.129P2-Ahrtm1(AHR)Mym)
|
decreased physiological sensitivity to xenobiotic
|
J:132380
|
Ahrtm1Bra/Ahrtm1Bra
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:83597
|
Ahrtm1Bra/Ahrtm1Bra
(B6.129-Ahrtm1Bra/J)
|
increased physiological sensitivity to xenobiotic
|
J:118646
|
Ahrtm1Bra/Ahrtm1Bra
(B6.129-Ahrtm1Bra)
|
decreased physiological sensitivity to xenobiotic
|
J:126176
|
Ahrtm1Gonz/Ahrtm1Gonz
(involves: 129S4/SvJae * C57BL/6N)
|
decreased physiological sensitivity to xenobiotic
|
J:25048
|
Ahrtm1Gonz/Ahrtm1Gonz
(involves: 129S4/SvJae)
|
decreased physiological sensitivity to xenobiotic
|
J:36360
|
Ahrtm1Gonz/Ahrtm1Gonz
(involves: 129S4/SvJae * C57BL/6J)
|
decreased physiological sensitivity to xenobiotic
|
J:113285
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:113285
|
Ahrtm1Yfk/Ahrtm1Yfk
(involves: 129S/SvEv * C57BL/6J)
|
decreased physiological sensitivity to xenobiotic
|
J:46346
|
Ahrtm2Bra/Ahrtm2Bra
(involves: 129/Sv * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:83597
|
Ahrtm3.1Bra/Ahrtm3.1Bra Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Ahrtm3.1Bra Speer6-ps1Tg(Alb-cre)21Mgn)
|
decreased physiological sensitivity to xenobiotic
|
J:104388
|
Ahrtm3Bra/Ahrtm3Bra
(involves: 129/Sv * C57BL/6J * DBA/2)
|
decreased physiological sensitivity to xenobiotic
|
J:94465
|
Ahrtm4.1Bra/Ahrtm4.1Bra
(involves: 129/Sv * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:141978
|
Ahrrtm1Yfk/Ahrrtm1Yfk
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:130214
|
Aifm1Hq/Y
(B6CBACa Aw-J/A-Aifm1Hq/J)
|
decreased susceptibility to neuronal excitotoxicity
|
J:98103
|
Aifm1Hq/Aifm1Hq
(B6CBACa Aw-J/A-Aifm1Hq/J)
|
decreased susceptibility to neuronal excitotoxicity
|
J:98103
|
Akr1b8tm1Dgen/Akr1b8tm1Dgen
(Not Specified)
|
increased incidence of tumors by chemical induction
|
J:301852
|
Akt1tm1Zzy/Akt1tm1Zzy Akt3tm1Hem/Akt3tm1Hem Tg(Myh6-cre)1Xya/0
(involves: 129P2/OlaHsd * FVB)
|
abnormal physiological response to xenobiotic
|
J:206783
|
Akt3tm1Hem/Akt3tm1Hem
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to neuronal excitotoxicity
|
J:98804
|
Aldh2tm1.1Mak/Aldh2+
(involves: 129S6/SvEvTac * C57BL/6J)
|
increased incidence of tumors by chemical induction
|
J:223796
|
Aldh2tm1.1Mak/Aldh2tm1.1Mak
(involves: 129S6/SvEvTac * C57BL/6J)
|
increased incidence of tumors by chemical induction
|
J:223796
|
Aldh2tm1a(EUCOMM)Wtsi/Aldh2tm1a(EUCOMM)Wtsi Fancd2tm1Hou/Fancd2tm1Hou
(involves: 129S4/SvJae * C57BL/6J * C57BL/6N)
|
increased physiological sensitivity to xenobiotic
|
J:188123
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:193232
|
Alg13em1Bayu/Y
(involves: C57BL/6J)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:275180
|
Als2tm1Cai/Als2tm1Cai
(involves: 129X1/SvJ * C57BL/6J)
|
increased physiological sensitivity to xenobiotic
|
J:100336
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:100336
|
AmfrGt(IST12797A11)Tigm/AmfrGt(IST12797A11)Tigm
(C57BL/6-AmfrGt(IST12797A11)Tigm)
|
increased physiological sensitivity to xenobiotic
|
J:221247
|
Angtm1Dats/Angtm1Dats
(Not Specified)
|
increased physiological sensitivity to xenobiotic
|
J:236081
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:236081
|
Ank2tm1Bnt/Ank2+
(involves: 129)
|
abnormal physiological response to xenobiotic
|
J:163867
|
Anp32btm1Mak/Anp32btm1Mak
(C.129P2(B6)-Anp32btm1Mak)
|
increased incidence of tumors by chemical induction
|
J:227403
|
Anxa1tm1Rjf/Anxa1tm1Rjf
(involves: BALB/c)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:142735
|
Apba3tm1.1Ski/Apba3tm1.1Ski Lyz2tm1(cre)Ifo/Lyz2+
(B6.129-Apba3tm1.1Ski Lyz2tm1(cre)Ifo)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:176742
|
Apba3tm1.2Ski/Apba3tm1.2Ski
(B6.129-Apba3tm1.2Ski)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:176742
|
ApcMin/Apc+
((AKR/J x C57BL/6J-ApcMin)F1)
|
increased incidence of tumors by chemical induction
|
J:15101
|
ApcMin/Apc+ Arhgef4tm1Taki/Arhgef4tm1Taki Spata13tm1Taki/Spata13tm1Taki
(B6J.Cg-Arhgef4tm1Taki Spata13tm1Taki ApcMin)
|
decreased physiological sensitivity to xenobiotic
|
J:157023
|
ApcMin/Apc+ Brca2tm1Mbn/Brca2+
(B6.Cg-Brca2tm1Mbn ApcMin)
|
increased incidence of tumors by chemical induction
|
J:67445
|
ApcMin/Apc+ Gt(ROSA)26Sor/Gt(ROSA)26Sor+
(B6.Cg-Gt(ROSA)26Sor ApcMin)
|
decreased incidence of tumors by chemical induction
|
J:66060
|
Apctm1Cip/Apc+ Mki67em1Dfis/Mki67em1Dfis
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J)
|
decreased incidence of tumors by chemical induction
|
J:304800
|
Apctm1Tno/Apctm1Tno
(involves: 129 * 129S4/SvJae * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:156864
|
Apctm2Rak/Apc+ Tg(Car1-cre)5Flt/0
(involves: 129/Sv * C57BL/6J * SJL)
|
increased incidence of tumors by chemical induction
|
J:164247
|
Apodtm1Dsan/Apodtm1Dsan
(either: B6.129X1-Apodtm1Dsan or C.129X1-Apodtm1Dsan)
|
increased physiological sensitivity to xenobiotic
|
J:143809
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:143809
|
Aqp4tm1Gghu/Aqp4tm1Gghu
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased physiological sensitivity to xenobiotic
|
J:111202
|
Aqp5tm1Amn/Aqp5tm1Amn
(involves: 129X1/SvJ * Black Swiss)
|
increased bronchoconstrictive response
|
J:72954
|
Artm1.1Chc/Y
(involves: 129S/SvEv * C57BL/6 * FVB/N)
|
decreased incidence of tumors by chemical induction
|
J:120844
|
Artm1.1Chc/Artm1.1Chc
(involves: 129S/SvEv * C57BL/6 * FVB/N)
|
decreased incidence of tumors by chemical induction
|
J:120844
|
Arfip2tm1d(EUCOMM)Wtsi/Arfip2tm1d(EUCOMM)Wtsi
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N * CBA)
|
increased physiological sensitivity to xenobiotic
|
J:345639
|
Arhgef1tm1Rmt/Arhgef1tm1Rmt X/Tg(Myh11-icre/ERT2)1Soff
(involves: C57BL/6 * FVB/N)
|
decreased physiological sensitivity to xenobiotic
|
J:157074
|
Arl6ip5tm1.2Jwzh/Arl6ip5tm1.2Jwzh
(B6.129X1-Arl6ip5tm1.2Jwzh)
|
decreased incidence of tumors by chemical induction
|
J:187133
|
Armcx3tm1.1Eso/Y Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
(involves: 129S/SvEv * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:345411
|
Arnttm1.1Gonz/Arnttm1.2Gonz Tg(Lck-cre)I57Jxm/0
(involves: 129X1/SvJ * ICR)
|
decreased physiological sensitivity to xenobiotic
|
J:85934
|
Arnttm1Bra/Arnttm1Bra
(B6.129-Arnttm1Bra)
|
decreased physiological sensitivity to xenobiotic
|
J:89470
|
Arnttm1Gonz/Arnttm1Gonz Tg(Mx1-cre)1Cgn/0
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
decreased physiological sensitivity to xenobiotic
|
J:64967
|
Asah1tm1.1Jhkh/Asah1tm1.1Jhkh
(Not Specified)
|
abnormal physiological response to xenobiotic
|
J:199833
|
Asic3tm1Wsh/Asic3tm1Wsh
(B6.129-Asic3tm1Wsh)
|
abnormal physiological response to xenobiotic
|
J:128319
|
Atf6tm1.1Rjk/Atf6tm1.1Rjk
(involves: C57BL/6 * FVB/N)
|
increased physiological sensitivity to xenobiotic
|
J:124971
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:124971
|
Atf6tm1Hota/Atf6tm1Hota Tg(Ins2-cre)25Mgn/0
(B6.Cg-Atf6tm1Hota Tg(Ins2-cre)25Mgn)
|
decreased physiological sensitivity to xenobiotic
|
J:213542
|
Atf6tm1Hota/Atf6tm1Hota Tg(Ins2-cre)25Mgn/0 Tg(Ins2-GP)1Kbuw/0
(involves: C57BL/6 * DBA)
|
decreased physiological sensitivity to xenobiotic
|
J:213542
|
Atg4ctm1Otin/Atg4ctm1Otin
(involves: 129P2/OlaHsd * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:123386
|
Atg5tm1Myok/Atg5tm1Myok Myl2tm1(cre)Krc/Myl2+
(involves: 129S/SvEv * 129S4/SvJae)
|
increased physiological sensitivity to xenobiotic
|
J:121778
|
Atp1a3tm1.1Tmklh/Atp1a3+
(B6JRj.129S1-Atp1a3tm1.1Tmklh)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:254463
|
Atp1b1tm1.1Akra/Atp1b1tm1.1Akra Myl2tm1(cre)Krc/Myl2+
(involves: 129S/SvEv * 129S4/SvJae)
|
decreased physiological sensitivity to xenobiotic
|
J:152596
|
B3gnt6tm1Lx/B3gnt6tm1Lx
(involves: 129S1/Sv * C57BL/6J)
|
increased incidence of tumors by chemical induction
|
J:123826
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:123826
|
Babam1Gt(IST11207B9)Tigm/Babam1Gt(IST11207B9)Tigm
(involves: C57BL/6N)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:223526
|
Bag5em1Asay/Bag5em1Asay
(C57BL/6JJcl-Bag5em1Asay)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:327046
|
Bag6tm1Pmc/Bag6tm1Pmc
(involves: 129S1/Sv * C57BL/6)
|
decreased susceptibility to neuronal excitotoxicity
|
J:119857
|
Bak1tm1Thsn/Bak1tm1Thsn Baxtm1Sjk/Baxtm1Sjk
(involves: 129S1/Sv * 129S1/SvImJ * 129X1/SvJ * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:66872
|
Bap1em1Test/Bap1+
(involves: FVB)
|
increased incidence of tumors by chemical induction
|
J:213725
|
Bap1em2Test/Bap1+
(involves: FVB)
|
increased incidence of tumors by chemical induction
|
J:231692
|
Bap1em3Test/Bap1+
(involves: FVB)
|
increased incidence of tumors by chemical induction
|
J:231692
|
Bchetm1Loc/Bche+
(involves: 129S1/Sv)
|
increased physiological sensitivity to xenobiotic
|
J:130048
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:130048
|
Bchetm1Loc/Bchetm1Loc
(involves: 129S1/Sv)
|
increased physiological sensitivity to xenobiotic
|
J:130048
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:130048
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
(B6.129S1-Bcl2l11tm1.1Ast)
|
decreased physiological sensitivity to xenobiotic
|
J:123409
|
Bcl2l14tm1.1Boui/Bcl2l14tm1.1Boui
(involves: C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:296081
|
Bdkrb1tm2Bdr/Bdkrb1tm2Bdr Bdkrb2tm1Jfh/Bdkrb2tm1Jfh
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:135789
|
Best2tm1Dgen/Best2+
(involves: C57BL/6)
|
abnormal physiological response to xenobiotic
|
J:136137
|
Best2tm1Dgen/Best2tm1Dgen
(involves: C57BL/6)
|
abnormal physiological response to xenobiotic
|
J:136137
|
Bin1tm1Gcp/Bin1tm2Gcp Tg(Wap-cre)11738Mam/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N * SJL)
|
increased incidence of tumors by chemical induction
|
J:117330
|
Bin1tm2Gcp/Bin1+ Tg(Wap-cre)11738Mam/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N * SJL)
|
increased incidence of tumors by chemical induction
|
J:117330
|
Blmhtm1Geh/Blmhtm1Geh
(either: (involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))
|
increased physiological sensitivity to xenobiotic
|
J:54585
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:54585
|
Braftm1Cpri/Braftm1Cpri Cdkn2atm1Rdp/Cdkn2atm1Rdp Tg(Tyr-cre/ERT2)1Lru/0
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6 * DBA/2 * SJL)
|
increased incidence of tumors by chemical induction
|
J:147434
|
Brca1tm2.1Cxd/Brca1tm2.1Cxd Trp53tm1Brd/Trp53+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd)
|
increased incidence of tumors by chemical induction
|
J:122899
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:122899
|
Brca1tm2.1Cxd/Brca1tm2.1Cxd Trp53tm1Brd/Trp53+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * Black Swiss * FVB)
|
increased physiological sensitivity to xenobiotic
|
J:81559
|
Brca1tm2Arge/Brca1tm2Arge
(involves: 129)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:194229
|
Brca2tm1Mhun/Brca2+
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased incidence of tumors by chemical induction
|
J:89083
|
Bsndtm1.1Suc/Bsndtm1.1Suc
(involves: 129S4/SvJae * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:175265
|
Btbd8em1Lych/Btbd8em1Lych
(involves: C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:349252
|
Bts1C57BL/6JShi/?
(involves: C57BL/6JShi * NON/Shi)
|
decreased incidence of tumors by chemical induction
|
J:51984
|
Bts2C57BL/6JShi/?
(involves: C57BL/6JShi * NON/Shi)
|
decreased incidence of tumors by chemical induction
|
J:51984
|
Bub1tm1.1Jvd/Bub1+
(involves: 129/Sv * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:135093
|
Bub1btm1Jvd/Bub1btm3.1Jvd
(involves: 129S6/SvEvTac * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:293084
|
Bub3tm1Jvd/Bub3+
(Not Specified)
|
increased incidence of tumors by chemical induction
|
J:81546
|
Bub3tm1Jvd/Bub3+ Rae1tm1Jvd/Rae1+
(Not Specified)
|
increased incidence of tumors by chemical induction
|
J:81546
|
Cab39ltm1d(EUCOMM)Wtsi/Cab39ltm1d(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6NCr * CBA)
|
increased incidence of tumors by chemical induction
|
J:350956
|
Cacfd1tm1.1Geno/Cacfd1tm1.1Geno
(involves: 129S2/SvPas * C57BL/6J)
|
decreased incidence of tumors by chemical induction
|
J:184968
|
Cacna1atm1Maag/Cacna1a+
(B6.129P2-Cacna1atm1Maag)
|
abnormal physiological response to xenobiotic
|
J:144701
|
Cacna1atm1Maag/Cacna1atm1Maag
(B6.129P2-Cacna1atm1Maag)
|
abnormal physiological response to xenobiotic
|
J:144701
|
Cacna1atm3Maag/Cacna1a+
(B6.129P2-Cacna1atm3Maag)
|
abnormal physiological response to xenobiotic
|
J:144701
|
Cacna1atm3Maag/Cacna1atm3Maag
(B6.129P2-Cacna1atm3Maag)
|
abnormal physiological response to xenobiotic
|
J:144701
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:144701
|
Cacna1etm1.1Tsch/Cacna1etm1.1Tsch
(involves: BALB/cJ * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:101873
|
Cacna1gtm1Hssh/Cacna1gtm1Hssh Gabra1tm1.1Geh/Gabra1tm1.1Geh
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J)
|
decreased physiological sensitivity to xenobiotic
|
J:174980
|
Camk2gtm1.1Irt/Camk2gtm1.1Irt
(involves: C57BL/6J)
|
decreased incidence of tumors by chemical induction
|
J:243363
|
Capn1tm1Dgen/Capn1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:183585
|
Casp1tm1Flv/Casp1tm1Flv Casp4del/Casp4del
(involves: 129S2/SvPas * C57BL/6J)
|
decreased incidence of tumors by chemical induction
|
J:191239
|
Casp1tm1Sesh/Casp1tm1Sesh Casp4del/Casp4del
(B6.129S2(NOD)-Casp1tm1Sesh Casp4del)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:193522
|
Casp3tm1Mak/Casp3tm1Mak
(B6.129P2-Casp3tm1Mak)
|
decreased physiological sensitivity to xenobiotic
|
J:97650
|
Casp3tm1Mak/Casp3tm1Mak Tg(TcrLCMV)327Sdz/0
(B6.Cg-Casp3tm1Mak Tg(TcrLCMV)327Sdz)
|
decreased physiological sensitivity to xenobiotic
|
J:97650
|
Casp4tm1.1Vmd/Casp4tm1.1Vmd
(involves: C57BL/6)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:193522
|
Casp6tm1.2Xen/Casp6+
(FVB.B6NTac-Casp6tm1.2Xen)
|
decreased susceptibility to neuronal excitotoxicity
|
J:181879
|
Casp6tm1.2Xen/Casp6tm1.2Xen
(FVB.B6NTac-Casp6tm1.2Xen)
|
decreased susceptibility to neuronal excitotoxicity
|
J:181879
|
Casp12tm1Yuan/Casp12tm1Yuan
(involves: 129S4/SvJae * C57BL/6J)
|
decreased susceptibility to neuronal excitotoxicity
|
J:59337
|
Casttm1Tcs/Casttm1Tcs
(B6.129-Casttm1Tcs)
|
increased susceptibility to neuronal excitotoxicity
|
J:109976
|
Catb/Catb
(C3.Cg-Catb/Anl)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:5971
|
increased incidence of tumors by chemical induction
|
J:5971
|
Catb/Catb
(B6.Cg-Catb/Anl)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:5971
|
Cav1tm1Mls/Cav1tm1Mls
(involves: 129/Sv * C57BL/6 * SJL)
|
increased incidence of tumors by chemical induction
|
J:83485
|
Ccdc65em11Gpt/Ccdc65+
(C57BL/6J-Ccdc65em11Gpt)
|
increased incidence of tumors by chemical induction
|
J:327251
|
Cckbrtm1Tom/Cckbrtm1Tom
(involves: 129S4/SvJae * C57BL/6)
|
abnormal physiological response to xenobiotic
|
J:107970
|
Ccl2tm1Rol/Ccl2tm1Rol
(involves: 129S4/SvJae * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:56068
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:116878
|
Ccl2tm1Rol/Ccl2tm1Rol
(involves: 129S4/SvJae)
|
decreased physiological sensitivity to xenobiotic
|
J:147697
|
Ccl2tm1Rol/Ccl2tm1Rol
(B6.129S4-Ccl2tm1Rol)
|
decreased physiological sensitivity to xenobiotic
|
J:110695
|
Ccl2tm1Rol/Ccl2tm1Rol
(B6.129S4-Ccl2tm1Rol/J)
|
decreased susceptibility to neuronal excitotoxicity
|
J:141739
|
Ccn2tm1.1Alea/Ccn2tm1.1Alea Tg(Col1a2-cre/ERT,-ALPP)7Cpd/0
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
decreased physiological sensitivity to xenobiotic
|
J:171300
|
Ccr2tm1.1(CCR2)Rodb/Ccr2tm1.1(CCR2)Rodb
(involves: C57BL/6)
|
increased physiological sensitivity to xenobiotic
|
J:203000
|
Ccr2tm1Ifc/Ccr2tm1Ifc
(involves: 129S4/SvJae * C57BL/6)
|
increased physiological sensitivity to xenobiotic
|
J:61542
|
Ccr5tm1(CCR5)Pfi/Ccr5tm1(CCR5)Pfi
(involves: C57BL/6)
|
increased physiological sensitivity to xenobiotic
|
J:227458
|
Ccr7tm1Rfor/Ccr7tm1Rfor
(B6.129P2-Ccr7tm1Rfor)
|
abnormal physiological response to xenobiotic
|
J:110910
|
Cd1d1tm1Luc/Cd1d1tm1Luc
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:93915
|
Cd19tm1Tft/Cd19tm1Tft
(B6.Cg-Cd19tm1Tft)
|
decreased physiological sensitivity to xenobiotic
|
J:136210
|
Cd34tm1Szk/Cd34tm1Szk
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased incidence of tumors by chemical induction
|
J:121305
|
decreased physiological sensitivity to xenobiotic
|
J:121305
|
Cd96tm1.1Mjs/Cd96tm1.1Mjs
(B6.129P2(Cg)-Cd96tm1.1Mjs)
|
decreased incidence of tumors by chemical induction
|
J:209990
|
Cd151tm2Nki/Cd151tm2Nki Itga3tm1Son/Itga3+ Krt14tm1(cre)Wbm/?
(FVB.129P2-Cd151tm2Nki Itga3tm1Son Krt14tm1(cre)Wbm)
|
decreased incidence of tumors by chemical induction
|
J:205736
|
Cd151tm2Nki/Cd151tm2Nki Krt14tm1(cre)Wbm/?
(FVB.129P2-Cd151tm2Nki Krt14tm1(cre)Wbm)
|
decreased incidence of tumors by chemical induction
|
J:205736
|
Cd209atm1.1Cfg/Cd209atm1.1Cfg
(B6.Cg-Cd209atm1.1Cfg/Mmucd)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:194602
|
Cd226tm1Shib/Cd226tm1Shib
(involves: BALB/c)
|
increased incidence of tumors by chemical induction
|
J:165704
|
Cdatm1d(EUCOMM)Wtsi/Cdatm1d(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6J * C57BL/6N)
|
decreased incidence of tumors by chemical induction
|
J:332259
|
Cdh26tm1.1(KOMP)Vlcg/Cdh26tm1.1(KOMP)Vlcg
(C57BL/6N-Cdh26tm1.1(KOMP)Vlcg/MbpMmucd)
|
decreased bronchoconstrictive response
|
J:211773
|
Cdiptosem1Sunb/Cdiptosem1Sunb
(C57BL/6J-Cdiptosem1Sunb)
|
decreased incidence of tumors by chemical induction
|
J:321215
|
Cdk4+/Cdk4+ Tg(Mt1-Hgf)#Lmb/0
(B6.Cg-Cdk4tm1.1Bbd Tg(Mt1-Hgf)#Lmb)
|
increased incidence of tumors by chemical induction
|
J:111992
|
Cdk4tm1.1Bbd/Cdk4+ Tg(Mt1-Hgf)#Lmb/0
(B6.Cg-Cdk4tm1.1Bbd Tg(Mt1-Hgf)#Lmb)
|
increased incidence of tumors by chemical induction
|
J:111992
|
Cdk4tm1.1Bbd/Cdk4tm1.1Bbd Krt14tm1(cre)Wbm/Krt14+ Pard3tm1Shoh/Pard3tm1Shoh Tg(Mt1-Hgf)#Lmb/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J)
|
increased incidence of tumors by chemical induction
|
J:240961
|
Cdk4tm1.1Bbd/Cdk4tm1.1Bbd Tg(Mt1-Hgf)#Lmb/0
(B6.Cg-Cdk4tm1.1Bbd Tg(Mt1-Hgf)#Lmb)
|
increased incidence of tumors by chemical induction
|
J:111992
|
Cdk5r1tm1Lht/Cdk5r1tm1Lht
(involves: 129S4/SvJae)
|
abnormal physiological response to xenobiotic
|
J:204269
|
Cdkn1atm1Tyj/Cdkn1atm1Tyj
(involves: 129S2/SvPas)
|
decreased physiological sensitivity to xenobiotic
|
J:59647
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:60945
|
Cdkn1atm1Tyj/Cdkn1atm1Tyj
(involves: 129S2/SvPas * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:80271
|
Cdkn1btm1Mlf/Cdkn1b+
(involves: 129S4/SvJaeSor)
|
increased incidence of tumors by chemical induction
|
J:103819
|
Cdkn1btm1Mlf/Cdkn1btm1Mlf
(involves: 129S4/SvJaeSor)
|
increased incidence of tumors by chemical induction
|
J:103819
|
Cdkn1btm2Jro/Cdkn1btm2Jro
(involves: 129S4/SvJaeSor * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:103819
|
Cdkn2atm1.1Brn/Cdkn2atm1.1Brn
(involves: 129P2/OlaHsd * FVB/N)
|
decreased incidence of tumors by chemical induction
|
J:125189
|
Cdkn2atm1.1Brn/Cdkn2atm1.1Brn Cdkn2btm2Brn/Cdkn2btm2Brn
(involves: 129P2/OlaHsd * FVB/N)
|
increased incidence of tumors by chemical induction
|
J:125189
|
Cdkn2atm1Cjs/Cdkn2a+
(involves: 129X1/SvJ * C57BL/6 * NIH/OlaHsd)
|
increased incidence of tumors by chemical induction
|
J:93298
|
Cdkn2atm1Cjs/Cdkn2atm1Cjs
(involves: 129X1/SvJ * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:44427
|
Cdkn2atm1Cjs/Cdkn2atm1Cjs
(involves: 129X1/SvJ * C57BL/6 * NIH/OlaHsd)
|
increased incidence of tumors by chemical induction
|
J:93298
|
Cdkn2atm1Nesh/Cdkn2atm1Nesh
(involves: 129S6/SvEvTac * FVB/N)
|
increased incidence of tumors by chemical induction
|
J:88365
|
Cdkn2atm2.1Brn/Cdkn2atm2.1Brn
(involves: 129P2/OlaHsd * FVB/N)
|
increased incidence of tumors by chemical induction
|
J:71393
|
Cdkn2atm2.1Rdp/Cdkn2atm2.1Rdp
(involves: 129S6/SvEvTac * FVB/N)
|
increased incidence of tumors by chemical induction
|
J:71394,
J:88365
|
cdm/cdm
(BXD2/TyJ)
|
decreased physiological sensitivity to xenobiotic
|
J:5362
|
Ceacam1tm2Bcn/Ceacam1tm2Bcn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:115838
|
Cebpatm1Timc/Cebpatm1Timc
(Not Specified)
|
increased incidence of tumors by chemical induction
|
J:163725
|
Cebpbtm1Es/Cebpbtm1Es Tg(KRT5-cre)5132Jlj/?
(involves: 129S1/Sv * C57BL/6J * DBA/2J)
|
decreased incidence of tumors by chemical induction
|
J:107334
|
Cebpbtm1Pfj/Cebpb+
(B6.Cg-Cebpbtm1Pfj)
|
decreased incidence of tumors by chemical induction
|
J:73558
|
Cebpbtm1Pfj/Cebpbtm1Pfj
(B6.Cg-Cebpbtm1Pfj)
|
decreased incidence of tumors by chemical induction
|
J:73558
|
Cebpbtm1Pfj/Cebpbtm1Pfj Tg(Hba-x-v-Ha-ras)TG.ACLed/0
(involves: C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:73558
|
Cebpbtm3Nerl/Cebpbtm3Nerl
(either: B6.129P2-Cebpbtm3Nerl or (involves: 129P2/OlaHsd * C57BL/6))
|
increased physiological sensitivity to xenobiotic
|
J:153686
|
Cep57em1Jvd/Cep57+
(involves: 129 * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:264300
|
Ces1ctm1.1Loc/Ces1ctm1.1Loc
(C57BL/6-Ces1ctm1.1Loc)
|
decreased physiological sensitivity to xenobiotic
|
J:168821
|
increased physiological sensitivity to xenobiotic
|
J:168821
|
Cftrtm1.1Sdw/Cftrtm1.1Sdw
(involves: C57BL/6 * C57BL/6J)
|
decreased physiological sensitivity to xenobiotic
|
J:323560
|
Cftrtm1Eur/Cftrtm1Eur Nherf1tm1Ssl/Nherf1tm1Ssl
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
abnormal physiological response to xenobiotic
|
J:128912
|
Chd1lGt(E305F08)Wrst/Chd1lGt(E305F08)Wrst
(involves: 129 * 129P2/OlaHsd)
|
decreased incidence of tumors by chemical induction
|
J:302849
|
increased physiological sensitivity to xenobiotic
|
J:302849
|
Chek2tm1Mak/Chek2tm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:78491
|
Chfrtm1Jc/Chfr+
(involves: 129S/SvEv * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:97428
|
Chfrtm1Jc/Chfrtm1Jc
(involves: 129S/SvEv * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:97428
|
Chordc1tm1Mbra/Chordc1+
(Not Specified)
|
increased incidence of tumors by chemical induction
|
J:159109
|
Chrm1tm1Jwe/Chrm1tm1Jwe
(involves: 129S6/SvEvTac * CF-1)
|
increased bronchoconstrictive response
|
J:104034
|
Chrm2tm1Jwe/Chrm2+
(involves: 129S4/SvJae * CF-1)
|
decreased physiological sensitivity to xenobiotic
|
J:53061
|
Chrm2tm1Jwe/Chrm2tm1Jwe
(involves: 129S4/SvJae * CF-1)
|
decreased bronchoconstrictive response
|
J:104034
|
decreased physiological sensitivity to xenobiotic
|
J:53061
|
Chrm3tm1Jwe/Chrm3tm1Jwe
(involves: 129S6/SvEvTac * CF-1)
|
decreased bronchoconstrictive response
|
J:104034
|
Chrna2tm1Jbou/Chrna2tm1Jbou
(B6.129X1-Chrna2tm1Jbou)
|
decreased physiological sensitivity to xenobiotic
|
J:126075
|
Clcn1adr-mto2J/Clcn1adr-mto2J
(BALB/cByJ-Clcn1adr-mto2J)
|
decreased physiological sensitivity to xenobiotic
|
J:112178
|
Clcnkbem1Haca/Clcnkbem1Haca
(C57BL/6-Clcnkbem1Haca)
|
decreased physiological sensitivity to xenobiotic
|
J:259681
|
Clcnkbtm1.1Doel/Clcnkbtm1.1Doel
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased physiological sensitivity to xenobiotic
|
J:259639
|
Clec4dtm1.1Shoy/Clec4dtm1.1Shoy
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:203159
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:203159
|
Clec4etm1Tks/Clec4etm1Tks
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased physiological sensitivity to xenobiotic
|
J:203159
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:203159
|
Clockm1Jt/Clockm1Jt
(involves: C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:92343
|
Clockm1Jt/Clockm1Jt
(involves: BALB/c * C57BL/6 * C57BL/6J * Jcl:ICR)
|
decreased physiological sensitivity to xenobiotic
|
J:128504
|
Clspntm1(KOMP)Vlcg/Clspn+
(C57BL/6N-Clspntm1(KOMP)Vlcg)
|
increased incidence of tumors by chemical induction
|
J:332163
|
Cnpy2tm1.2Zhli/Cnpy2tm1.2Zhli
(B6.Cg-Cnpy2tm1.2Zhli)
|
decreased physiological sensitivity to xenobiotic
|
J:277868
|
Cnr1tm1.1Kpm/Cnr1tm1.1Kpm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased physiological sensitivity to xenobiotic
|
J:208116
|
Cnr1tm1.1Ltz/Cnr1tm1.1Ltz
(involves: 129P2/OlaHsd * C57BL/6N)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:89842
|
Cnr1tm1.2Ltz/Cnr1tm1.2Ltz Tg(Camk2a-cre)2Gsc/0
(involves: 129P2/OlaHsd * C57BL/6N)
|
increased susceptibility to neuronal excitotoxicity
|
J:89842
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:89842
|
Cnr1tm1Map/Cnr1tm1Map
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
increased physiological sensitivity to xenobiotic
|
J:172874
|
increased susceptibility to neuronal excitotoxicity
|
J:109213
|
Cnr1tm2Ltz/Cnr1tm2.1Ltz Neurod6tm1(cre)Kan/Neurod6+
(B6.Cg-Cnr1tm2Ltz/Cnr1tm2.1Ltz Neurod6tm1(cre)Kan)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:199647
|
Cnr1tm2Ltz/Cnr1tm2Ltz
(B6.Cg-Cnr1tm2Ltz)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:199647
|
Col1a1tm1(tetO-Fos)Wag/Col1a1+ Tg(KRT5-rtTA)T2D6Sgkd/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
increased incidence of tumors by chemical induction
|
J:201145
|
Col1a1tm1(tetO-URI1)Ndj/Col1a1+ Tg(Cebpb-tTA)#Bjd/0
(B6.Cg-Col1a1tm1(tetO-URI1)Ndj Tg(Cebpb-tTA)#Bjd)
|
increased incidence of tumors by chemical induction
|
J:217463
|
Col5a3tm1Dgr/Col5a3tm1Dgr
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
increased physiological sensitivity to xenobiotic
|
J:171817
|
Cox15tm1.1Zev/Cox15tm1.1Zev Tg(ACTA1-cre)79Jme/0
(involves: 129 * C57BL/6 * C57BL/6J * SJL)
|
increased physiological sensitivity to xenobiotic
|
J:176080
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:176080
|
Cpa3tm1Hrr/Cpa3tm1Hrr
(B6.129P2-Cpa3tm1Hrr)
|
increased physiological sensitivity to xenobiotic
|
J:125964
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:125964
|
Cpa3tm2Hrr/Cpa3tm2Hrr
(involves: 129P2/OlaHsd)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:125964
|
Cpb2tm1Mng/Cpb2tm1Mng
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased physiological sensitivity to xenobiotic
|
J:107340
|
Cpxm2tm1Lex/Cpxm2tm1Lex
(B6;129S5-Cpxm2tm1Lex/Mmucd)
|
decreased physiological sensitivity to xenobiotic
|
J:345349
|
Craddtm1Mak/Craddtm1Mak
(involves: 129 * C57BL/6)
|
increased physiological sensitivity to xenobiotic
|
J:101402
|
Crbntm1.1Ble/Crbntm1.1Ble
(involves: C57BL/6)
|
increased physiological sensitivity to xenobiotic
|
J:267091
|
Crbntm1.1Ble/Crbntm1.1Ble Csnk1a1tm1.1Ybn/Csnk1a1+ Tg(Mx1-cre)1Cgn/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
increased physiological sensitivity to xenobiotic
|
J:267091
|
Creb3l3tm1Ktak/Creb3l3tm1Ktak
(involves: 129S4/SvJae * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:197204
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:197204
|
Crlf2tm1Wjl/Crlf2tm1Wjl
(Not Specified)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:175844
|
Csf1op/Csf1op
(B6;C3Fe a/a-Csf1op/J)
|
decreased physiological sensitivity to xenobiotic
|
J:147697
|
Cthtm1Liwu/Cthtm1Liwu
(involves: 129S/SvEvBrd * C57BL/6J)
|
decreased physiological sensitivity to xenobiotic
|
J:140705
|
increased physiological sensitivity to xenobiotic
|
J:140705
|
Ctnnb1tm1.1Smoc/Ctnnb1tm1.1Smoc Sox9em1(cre/ERT2)Tchn/Sox9+
(involves: C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:322311
|
Ctpr1BALB/cJ/?
(involves: A/J * BALB/cJ)
|
increased physiological sensitivity to xenobiotic
|
J:108843
|
Cuedc2tm1Qxia/Cuedc2tm1Qxia
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)
|
increased incidence of tumors by chemical induction
|
J:211782
|
Cul9tm1.2Yxi/Cul9+
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
increased incidence of tumors by chemical induction
|
J:170976
|
Cul9tm1.2Yxi/Cul9tm1.2Yxi
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
increased incidence of tumors by chemical induction
|
J:170976
|
Cx3cl1tm1Lira/Cx3cl1tm1Lira
(Not Specified)
|
increased susceptibility to dopaminergic neuron neurotoxicity
|
J:110266
|
Cx3cr1tm1Litt/Cx3cr1tm1Litt
(B6.129P2-Cx3cr1tm1Litt)
|
increased susceptibility to dopaminergic neuron neurotoxicity
|
J:110266
|
Cxcl16tm1Syon/Cxcl16tm1Syon
(B6.129P2-Cxcl16tm1Syon)
|
decreased physiological sensitivity to xenobiotic
|
J:155199
|
Cxcr4tm2Yzo/Cxcr4tm2Yzo Tg(Myh6-cre)2182Mds/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
increased physiological sensitivity to xenobiotic
|
J:289614
|
Cyb5r3tm1c(KOMP)Wtsi/Cyb5r3tm1c(KOMP)Wtsi Tg(Myh11-icre/ERT2)1Soff/0
(B6.Cg-Cyb5r3tm1c(KOMP)Wtsi Tg(Myh11-icre/ERT2)1Soff)
|
increased physiological sensitivity to xenobiotic
|
J:280543
|
Cygbtm1Nka/Cygb+
(B6.Cg-Cygbtm1Nka)
|
increased incidence of tumors by chemical induction
|
J:174134
|
Cygbtm1Nka/Cygbtm1Nka
(B6.Cg-Cygbtm1Nka)
|
increased incidence of tumors by chemical induction
|
J:174134
|
increased physiological sensitivity to xenobiotic
|
J:174134
|
Cyldtm1Lex/Cyldtm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:114972
|
Cyp1a1tm1.1Dwn/Cyp1a1tm1.1Dwn
(B6.129P2-Cyp1a1tm1.1Dwn)
|
decreased physiological sensitivity to xenobiotic
|
J:89337
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:89337
|
increased physiological sensitivity to xenobiotic
|
J:163973,
J:147150
|
Cyp1a1tm3.1Dwn/Cyp1a1tm3.1Dwn
(B6.129X1-Cyp1a1tm3.1Dwn)
|
increased physiological sensitivity to xenobiotic
|
J:163973
|
Cyp1a1tm4.1Dwn/Cyp1a1tm4.1Dwn
(B6.129X1-Cyp1a1tm4.1Dwn)
|
increased physiological sensitivity to xenobiotic
|
J:163973
|
Cyp1a2tm1Dwn/Cyp1a2tm1Dwn
(B6.129P2-Cyp1a2tm1Dwn)
|
abnormal physiological response to xenobiotic
|
J:147150
|
decreased incidence of tumors by chemical induction
|
J:97596
|
decreased physiological sensitivity to xenobiotic
|
J:97596,
J:81115
|
Cyp1a2tm1Gonz/Cyp1a2tm1Gonz Cyp2e1tm1Gonz/Cyp2e1tm1Gonz
(involves: 129S4/SvJae)
|
decreased physiological sensitivity to xenobiotic
|
J:81117
|
Cyp1atm1.1Bra/Cyp1atm1.1Bra
(B6.129-Cyp1atm1.1Bra)
|
abnormal physiological response to xenobiotic
|
J:147150
|
Cyp1b1tm1Gonz/Cyp1b1tm1Gonz
(involves: 129X1/SvJ * C57BL/6N)
|
decreased incidence of tumors by chemical induction
|
J:53827
|
Cyp1b1tm1Gonz/Cyp1b1tm1Gonz
(involves: 129X1/SvJ * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:81113
|
Cyp2e1tm1Gonz/Cyp2e1tm1Gonz
(involves: 129S4/SvJae * C57BL/6N)
|
decreased physiological sensitivity to xenobiotic
|
J:48196
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:48196
|
Cyp2e1tm1Gonz/Cyp2e1tm1Gonz
(involves: 129S4/SvJae)
|
abnormal physiological response to xenobiotic
|
J:143909
|
decreased incidence of tumors by chemical induction
|
J:118150
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:143909
|
Cyp2f2tm1Ding/Cyp2f2tm1Ding
(involves: C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:204724
|
Cyp3a13tm1Nki/Cyp3a13tm1Nki Del(5Cyp3a57-Cyp3a59)2Nki/Del(5Cyp3a57-Cyp3a59)2Nki
(involves: 129P2/OlaHsd * FVB/N)
|
increased physiological sensitivity to xenobiotic
|
J:127366
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:127366
|
Cyp4b1tm1e(KOMP)Wtsi/Cyp4b1tm1e(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
decreased physiological sensitivity to xenobiotic
|
J:207585
|
Dab2iptm1.1Wami/Dab2iptm1.1Wami
(involves: 129 * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:136554
|
Dancrem1.1Bcgen/Dancrem1.1Bcgen
(involves: C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:329926
|
Dbptm1Schb/Dbptm1Schb Hlftm1Schb/Hlftm1Schb Teftm1Schb/Teftm1Schb
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
increased physiological sensitivity to xenobiotic
|
J:129710
|
Dclre1atm1Rleg/Dclre1atm1Rleg
(involves: 129S7/SvEvBrd)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:102381
|
Dclre1atm1Roka/Dclre1atm1Roka
(Not Specified)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:62832
|
Dctn1tm2.1Cai/Dctn1tm2.1Cai Tg(Thy1-cre)1Vln/?
(involves: 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * FVB/N)
|
increased susceptibility to neuronal excitotoxicity
|
J:264431
|
Dektm1Siwe/Dektm1Siwe
(involves: 129P2/OlaHsd)
|
decreased incidence of tumors by chemical induction
|
J:146608
|
Del(1Fmo4-Fmo2)1Eshe/Del(1Fmo4-Fmo2)1Eshe
(B6.129P2-Del(1Fmo4-Fmo2)1Eshe)
|
abnormal physiological response to xenobiotic
|
J:196270
|
Del(7Mrgpra1-Mrgprb4)1And/Del(7Mrgpra1-Mrgprb4)1And
(involves: 129S1/Sv * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:157470
|
Del(15Rr357-Rr303293)2Jta/Del(15Rr357-Rr303293)2Jta
(involves: C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:257088
|
Del(XMagea6-Magea1)1Prp/Y
(involves: C57BL/6)
|
increased physiological sensitivity to xenobiotic
|
J:342299
|
Del(XMagea6-Magea1)1PrpMagea10em1PrpMagea4em1Prp/Y
(involves: C57BL/6)
|
increased physiological sensitivity to xenobiotic
|
J:342299
|
Depdc5tm1c(EUCOMM)Hmgu/Depdc5tm1c(EUCOMM)Hmgu Tg(Syn1-cre)671Jxm/0
(involves: C57BL/6N * CBA)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:260943
|
Dexiem1Kslr/Dexiem1Kslr Tg(CMV-GFP,-RNAi:Clec16a)KD3Kslr/0
(NOD-Dexiem1Kslr Tg(CMV-GFP,-RNAi:Clec16a)KD3Kslr)
|
increased physiological sensitivity to xenobiotic
|
J:285312
|
Dffatm1Mxu/Dffatm1Mxu
(involves: 129S4/SvJae * C57BL/6)
|
decreased susceptibility to neuronal excitotoxicity
|
J:114416
|
Dmdmdx/Dmdmdx
(involves: C57BL/10ScSn)
|
decreased physiological sensitivity to xenobiotic
|
J:20768
|
Dnah11iv/Dnah11iv
(SI/Col Tyrp1b Dnah11iv/J)
|
increased physiological sensitivity to xenobiotic
|
J:148465
|
Dnai7Gt(VICTR21)709Lex/Dnai7+
(involves: 129S5/SvEvBrd)
|
increased incidence of tumors by chemical induction
|
J:111629
|
Dnai7Gt(VICTR21)709Lex/Dnai7Gt(VICTR21)709Lex
(involves: 129S5/SvEvBrd)
|
increased incidence of tumors by chemical induction
|
J:111629
|
Dnajc27Gt(OST374030)Lex/Dnajc27Gt(OST374030)Lex
(involves: 129S5/SvEvBrd * C57BL/6N)
|
decreased incidence of tumors by chemical induction
|
J:210622
|
Dnase1tm1Tmo/Dnase1tm1Tmo
(involves: 129P2/OlaHsd * CD-1)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:110060
|
Dock2tm1Tsas/Dock2tm1Tsas
(B6.Cg-Dock2tm1Tsas)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:130919
|
Drd1tm1Jcd/Drd1tm1Jcd
(B6.129S4-Drd1tm1Jcd/J)
|
decreased physiological sensitivity to xenobiotic
|
J:137069
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:137069
|
Drd1tm1Stl/Drd1tm1Stl
(involves: 129P2/OlaHsd)
|
decreased physiological sensitivity to xenobiotic
|
J:112986
|
Drd2tm1.1Mrub/Drd2tm1.1Mrub Slc6a3tm1.1(cre)Bkmn/Slc6a3+
(B6.Cg-Drd2tm1.1Mrub Slc6a3tm1.1(cre)Bkmn)
|
decreased physiological sensitivity to xenobiotic
|
J:176167
|
increased physiological sensitivity to xenobiotic
|
J:176167
|
Drd2tm1.1Mrub/Drd2tm1.1Mrub Tg(Nes-cre)1Kln/?
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
decreased physiological sensitivity to xenobiotic
|
J:194227
|
Drd2tm1.1Mrub/Drd2tm1.1Mrub Tg(Prl-cre)1Mrub/?
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
decreased physiological sensitivity to xenobiotic
|
J:194227
|
Drd2tm1Ebo/Drd2tm1Ebo
(involves: 129S2/SvPas * C57BL/6)
|
increased susceptibility to neuronal excitotoxicity
|
J:65767
|
Drd2tm1Ebo/Drd2tm1Ebo
(B6.129S2-Drd2tm1Ebo)
|
increased susceptibility to neuronal excitotoxicity
|
J:65767
|
Drd2tm1Low/Drd2+
(involves: 129S2/SvPas * C57BL/6J)
|
increased physiological sensitivity to xenobiotic
|
J:47001
|
Drd2tm1Low/Drd2tm1Low
(either: B6.129S2-Drd2tm1Low or (involves: 129S2/SvPas * C57BL/6))
|
decreased physiological sensitivity to xenobiotic
|
J:41858
|
Drd2tm1Low/Drd2tm1Low
(involves: 129S2/SvPas * C57BL/6J)
|
decreased physiological sensitivity to xenobiotic
|
J:47001
|
Drd2tm1Low/Drd2tm1Low
(B6.129S2-Drd2tm1Low)
|
increased physiological sensitivity to xenobiotic
|
J:103181
|
Drd2tm1Low/Drd2tm1Low
(B6.129S2-Drd2tm1Low/J)
|
decreased physiological sensitivity to xenobiotic
|
J:137069
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:137069
|
increased susceptibility to dopaminergic neuron neurotoxicity
|
J:194407
|
Drd2tm3.1Ebo/Drd2tm3.1Ebo En1tm2(cre)Wrst/En1+
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:185643
|
Drd2tm3.1Ebo/Drd2tm3.1Ebo Tg(Drd1a-cre)AGsc/0
(involves: 129S2/SvPas * C57BL/6 * FVB/N)
|
decreased physiological sensitivity to xenobiotic
|
J:185643
|
Drd3tm1Dac/Drd3tm1Dac
(involves: 129S4/SvJae * C57BL/6)
|
abnormal physiological response to xenobiotic
|
J:115136
|
Drd3tm1Dac/Drd3tm1Dac
(B6.129S4-Drd3tm1Dac/J)
|
abnormal physiological response to xenobiotic
|
J:96803
|
Dusp1tm1Brv/Dusp1tm1Brv
(involves: 129S2/SvPas * C57BL/6)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:118833
|
Dusp5tm1.1Skey/Dusp5+
(involves: C57BL/6 * C57BL/6NTac)
|
increased incidence of tumors by chemical induction
|
J:216939
|
Dusp5tm1.1Skey/Dusp5tm1.1Skey
(involves: C57BL/6 * C57BL/6NTac)
|
increased incidence of tumors by chemical induction
|
J:216939
|
Edil3Tg(lacZ)1Tq/Edil3Tg(lacZ)1Tq
(Not Specified)
|
increased physiological sensitivity to xenobiotic
|
J:254384
|
Eef2ktm1Agry/Eef2ktm1Agry
(Not Specified)
|
decreased physiological sensitivity to xenobiotic
|
J:162129
|
Eef2ktm1Agry/Eef2ktm1Agry
(B6.Cg-Eef2ktm1Agry)
|
decreased physiological sensitivity to xenobiotic
|
J:208406
|
Egln3tm1Pjr/Egln3tm1Pjr
(involves: 129S/SvEv * Swiss)
|
abnormal physiological response to xenobiotic
|
J:136034
|
Egr1tm1Jmi/Egr1tm1Jmi
(involves: 129 * C57BL/6)
|
abnormal physiological response to xenobiotic
|
J:105638
|
increased incidence of tumors by chemical induction
|
J:123870
|
Eif2ak3tm1Dron/Eif2ak3tm1Dron
(involves: 129S6/SvEvTac)
|
increased physiological sensitivity to xenobiotic
|
J:124971
|
Eif2b5tm1Itl/Eif2b5tm1Itl
(involves: 129S/SvEv * C57BL * Swiss Webster)
|
abnormal physiological response to xenobiotic
|
J:179801
|
Elanetm1Sds/Elanetm1Sds
(involves: 129X1/SvJ)
|
decreased physiological sensitivity to xenobiotic
|
J:124377
|
Elanetm1Sds/Elanetm1Sds
(B6.129X1-Elanetm1Sds)
|
decreased physiological sensitivity to xenobiotic
|
J:86599
|
Elavl1tm1.1Dkon/Elavl1tm1.1Dkon Lyz2tm1(cre)Ifo/Lyz2+
(B6.129P2-Elavl1tm1.1Dkon Lyz2tm1(cre)Ifo)
|
increased incidence of tumors by chemical induction
|
J:184388
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:184388
|
Elavl1tm1.1Dkon/Elavl1tm1.1Dkon Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:184388
|
En1tm1(Tnf)Fpit/En1tm1(Tnf)Fpit
(involves: C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:170743
|
Endovtm1Ial/Endovtm1Ial
(involves: C57BL/6J * C57BL/6N)
|
decreased incidence of tumors by chemical induction
|
J:293118
|
Epha2Gt(KST085)Byg/Epha2+
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
increased incidence of tumors by chemical induction
|
J:112120
|
Epha2Gt(KST085)Byg/Epha2Gt(KST085)Byg
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
increased incidence of tumors by chemical induction
|
J:112120
|
Ephx1tm1Gonz/Ephx1tm1Gonz
(involves: 129X1/SvJ * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:56886
|
Epn1tm1.1Wami/Epn1tm1.1Wami Epn2tm1Ocr/Epn2tm1Ocr Tg(Cdh5-cre/ERT2)CIVE23Mlia/0
(involves: 129X1/SvJ * C57BL/6J)
|
decreased incidence of tumors by chemical induction
|
J:193966
|
Ercc1tm2Jhjh/Ercc1tm2Jhjh
(involves: 129P2/OlaHsd * C57BL/6)
|
increased physiological sensitivity to xenobiotic
|
J:41161
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:41161
|
Ercc2tm1Jhjh/Ercc2tm2(ERCC2)Jhjh
(involves: 129P2/OlaHsd * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:48256
|
Eregtm1Dwt/Eregtm1Dwt
(129S6/SvEvTac-Eregtm1Dwt)
|
increased physiological sensitivity to xenobiotic
|
J:93327
|
Errfi1tm1Kln/Errfi1tm1Kln
(involves: 129P2/OlaHsd * C57BL/6N)
|
increased incidence of tumors by chemical induction
|
J:109556
|
Esr1tm1Geog/Esr1tm1Geog
(involves: 129X1/SvJ * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:135981
|
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd)
|
abnormal physiological response to xenobiotic
|
J:135833
|
decreased physiological sensitivity to xenobiotic
|
J:72221
|
Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:101968
|
Etv6tm1(RUNX1)Haho/Etv6+ Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
increased incidence of tumors by chemical induction
|
J:151639
|
F2rl1tm1Wrf/F2rl1tm1Wrf
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:81119
|
F2rl1tm1Wrf/F2rl1tm1Wrf
(involves: 129P2/OlaHsd)
|
abnormal physiological response to xenobiotic
|
J:120751,
J:81119
|
Fads1Gt(IST11525H2)Tigm/Fads1Gt(IST11525H2)Tigm
(C57BL/6-Fads1Gt(IST11525H2)Tigm)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:186265
|
Faf1Gt(XK588)Byg/Faf1Gt(XK588)Byg
(B6.129P2-Faf1Gt(XK588)Byg)
|
decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:194987
|
Fahtm1Mgo/Fahtm1Mgo
(involves: 129S7/SvEvBrd)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:105440
|
Faimtm1Kplm/Faimtm1Kplm
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:164184
|
Fam3dem1Wko/Fam3dem1Wko
(C57BL/6-Fam3dem1Wko)
|
increased incidence of tumors by chemical induction
|
J:300819
|
Fan1tm1.1Jrou/Fan1tm1.1Jrou
(involves: 129P2/OlaHsd)
|
increased physiological sensitivity to xenobiotic
|
J:232403
|
Fan1tm1.1Jrou/Fan1tm1.1Jrou Fancd2Gt(OST57859)Lex/Fancd2Gt(OST57859)Lex
(involves: 129P2/OlaHsd * 129S5/SvEvBrd)
|
increased physiological sensitivity to xenobiotic
|
J:232403
|
Fan1tm1.1Jrou/Fan1tm1.1Jrou Slx1btm1.1Jrou/Slx1btm1.1Jrou
(involves: 129P2/OlaHsd)
|
increased physiological sensitivity to xenobiotic
|
J:232403
|
Fan1tm1.1Jrou/Fan1tm1.1Jrou Slx4tm1.2Jrou/Slx4tm1.2Jrou
(involves: 129P2/OlaHsd)
|
increased physiological sensitivity to xenobiotic
|
J:232403
|
Fan1tm1a(KOMP)Wtsi/Fan1tm1a(KOMP)Wtsi
(129S1.B6-Fan1tm1a(KOMP)Wtsi)
|
increased physiological sensitivity to xenobiotic
|
J:242198
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:242198
|
Fan1tm1d(KOMP)Wtsi/Fan1tm1d(KOMP)Wtsi
(involves: C57BL/6N * FVB/N)
|
increased physiological sensitivity to xenobiotic
|
J:232402
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:232402
|
Fan1tm1d(KOMP)Wtsi/Fan1tm1d(KOMP)Wtsi Fancd2tm1Hou/Fancd2tm1Hou
(involves: 129S4/SvJae * C57BL/6N * FVB/N)
|
increased physiological sensitivity to xenobiotic
|
J:232402
|
Fan1tm1d(KOMP)Wtsi/Fan1tm1d(KOMP)Wtsi Mus81tm1Chmg/Mus81tm1Chmg
(involves: 129S5/SvEvBrd * C57BL/6N * FVB/N)
|
increased physiological sensitivity to xenobiotic
|
J:232402
|
Fancatm1a(EUCOMM)Wtsi/Fancatm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
increased physiological sensitivity to xenobiotic
|
J:188123
|
Fancd2tm1Hou/Fancd2tm1Hou
(involves: 129S4/SvJae)
|
increased physiological sensitivity to xenobiotic
|
J:188123
|
Fancftm1Nki/Fancftm1Nki
(involves: 129P2/OlaHsd * FVB)
|
increased physiological sensitivity to xenobiotic
|
J:180025
|
Fastktm1.1Andp/Fastktm1.1Andp
(B6.129S6-Fastktm1.1Andp)
|
decreased physiological sensitivity to xenobiotic
|
J:160443
|
Fcer1gtm1Tks/Fcer1gtm1Tks
(involves: C57BL/6J)
|
decreased physiological sensitivity to xenobiotic
|
J:203159
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:203159
|
Fcer2atm1Max/Fcer2atm1Max Ighg1tm1.1Pyu/Ighg1+
(involves: 129 * BALB/cJ * C57BL/6 * C57BL/6J)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:198154
|
Fcer2atm1Max/Fcer2atm1Max Ighg1tm1.1Pyu/Ighg1tm1.1Pyu
(involves: 129 * BALB/cJ * C57BL/6 * C57BL/6J)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:198154
|
Fcmrtm1.2Khl/Fcmrtm1.2Khl
(involves: C57BL/6)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:174871
|
Ffar2tm1Dgen/Ffar2tm1Dgen
(involves: C57BL/6)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:153951
|
Ffar2tm2Lex/Ffar2tm2Lex
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:157383
|
Ffar3tm1Gzt/Ffar3tm1Gzt
(involves: C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:172798
|
Ffar4tm1(KOMP)Vlcg/Ffar4tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
decreased physiological sensitivity to xenobiotic
|
J:240649
|
Fgf21tm1.1Djm/Fgf21tm1.1Djm
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:150831
|
Fgf21tm1Lex/Fgf21tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6N)
|
decreased physiological sensitivity to xenobiotic
|
J:240649
|
Fgf22tm1Rpgr/Fgf22tm1Rpgr
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:187809
|
Fgfr2tm1Dsn/Fgfr2tm1Dsn Tg(KRT5-cre)5132Jlj/0
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
increased incidence of tumors by chemical induction
|
J:119723
|
Fgfr4tm1Cxd/Fgfr4tm1Cxd Tg(Myl2-FGF19)1Dfre/0
(involves: 129S6/SvEvTac * FVB/N)
|
decreased incidence of tumors by chemical induction
|
J:187236
|
Fhip2bem1Wwan/Fhip2bem1Wwan
(involves: C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:285283
|
Fhittm1Hbn/Fhit+
(involves: 129X1/SvJ * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:61946,
J:71303,
J:110096
|
Fhittm1Hbn/Fhittm1Hbn
(involves: 129X1/SvJ * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:71303
|
FlcnGt(RRX115)Byg/Flcn+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:147582
|
Fmc1em1Aitn/Fmc1+
(C57BL/6JJmsSlc-Fmc1em1Aitn)
|
decreased susceptibility to neuronal excitotoxicity
|
J:257586
|
Fntbtm1Bbd/Fntbtm1.1Bbd Polr2atm1(cre/ERT2)Bbd/Polr2atm1(cre/ERT2)Bbd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1 * SJL)
|
decreased incidence of tumors by chemical induction
|
J:98944
|
Fntbtm1Bbd/Fntbtm1Bbd Polr2atm1(cre/ERT2)Bbd/Polr2atm1(cre/ERT2)Bbd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1 * SJL)
|
decreased incidence of tumors by chemical induction
|
J:98944
|
Folr1tm1Fnn/Folr1+
(involves: 129 * C57BL/6J)
|
increased incidence of tumors by chemical induction
|
J:96380
|
increased physiological sensitivity to xenobiotic
|
J:96380
|
Foxa1tm1Khk/Foxa1tm1Khk Foxa2tm1Khk/Foxa2tm1Khk Tg(Alb1-cre)1Khk/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
decreased incidence of tumors by chemical induction
|
J:181296
|
increased incidence of tumors by chemical induction
|
J:181296
|
Foxm1tm1Rhc/Foxm1tm1Rhc
(involves: 129X1/SvJ)
|
increased incidence of tumors by chemical induction
|
J:89472
|
Foxm1tm1Rhc/Foxm1tm1Rhc Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129X1/SvJ * C57BL/6 * DBA)
|
decreased incidence of tumors by chemical induction
|
J:89472
|
Foxm1tm1Rhc/Foxm1tm1Rhc Tg(Tek-cre)1Ywa/0
(involves: 129X1/SvJ * C57BL/6 * SJL)
|
increased incidence of tumors by chemical induction
|
J:167773
|
Foxn1nu-str/Foxn1nu-str
(AKR/J-Foxn1nu-str/J)
|
decreased incidence of tumors by chemical induction
|
J:43880
|
Foxo3tm1Nmt/Foxo3tm1Nmt
(B6.Cg-Foxo3tm1Nmt)
|
decreased physiological sensitivity to xenobiotic
|
J:123409
|
Foxo3tm1Nmt/Foxo3tm1Nmt
(involves: C57BL/6)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:142870
|
Foxp3tm4(YFP/icre)Ayr/Y Zfp91tm1Smoc/Zfp91tm1Smoc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:306129
|
Fpr2tm1.2Jimw/Fpr2tm1.2Jimw
(involves: 129X1/SvJ)
|
increased incidence of tumors by chemical induction
|
J:197568
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:197568
|
Frmd8em2Smoc/Frmd8em2Smoc Tg(Vil1-cre)997Gum/0
(involves: C57BL/6J * SJL)
|
increased incidence of tumors by chemical induction
|
J:338904
|
Frzbtm1.1Fplu/Frzbtm1.1Fplu
(B6J.Cg-Frzbtm1.1Fplu)
|
increased physiological sensitivity to xenobiotic
|
J:184281
|
Fsttm1Zuk/Fst+
(B6.129S7-Fsttm1Zuk)
|
increased physiological sensitivity to xenobiotic
|
J:182827
|
Fxyd5em1Namje/Fxyd5em1Namje
(C57BL/6J-Fxyd5em1Namje)
|
decreased incidence of tumors by chemical induction
|
J:325989
|
Fyntm1Yik/Fyntm1Yik
(involves: C57BL/6 * CBA)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:101992
|
Fzr1tm1.1Mama/Fzr1+
(involves: BALB/cJ * C57BL/6 * SJL)
|
decreased incidence of tumors by chemical induction
|
J:137456
|
Gabbr1tm1Bet/Gabbr1tm1Bet
(BALB/c-Gabbr1tm1Bet)
|
decreased physiological sensitivity to xenobiotic
|
J:70558
|
Gabbr2tm1Bet/Gabbr2tm1Bet
(BALB/c-Gabbr2tm1Bet)
|
decreased physiological sensitivity to xenobiotic
|
J:103989
|
Gabra1tm1.1Geh/Gabra1tm1.1Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
decreased physiological sensitivity to xenobiotic
|
J:103381
|
Gabra1tm1.1Uru/Gabra1tm1.1Uru
(either: 129X1.129P2-Gabra1tm1.1Uru or B6.129P2-Gabra1tm1.1Uru)
|
abnormal physiological response to xenobiotic
|
J:75895
|
Gabra1tm1Twr/Gabra1tm1Twr
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal physiological response to xenobiotic
|
J:69290
|
Gabra2tm1Uru/Gabra2tm1Uru Tg(Scn10a-cre)1Rkun/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * DBA/2)
|
decreased physiological sensitivity to xenobiotic
|
J:173378
|
Gabra2tm1Uru/Gabra2tm2.1Uru Tg(Scn10a-cre)1Rkun/0
(involves: C57BL/6 * DBA/2 * SJL)
|
decreased physiological sensitivity to xenobiotic
|
J:173378
|
Gabra2tm2.1Uru/Gabra2tm2.1Uru Tg(Scn10a-cre)1Rkun/0
(involves: C57BL/6 * DBA/2 * SJL)
|
decreased physiological sensitivity to xenobiotic
|
J:173378
|
Gabrg2tm1Dc/Gabrg2tm1Dc
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased physiological sensitivity to xenobiotic
|
J:97175
|
Galtm1Wyn/Galtm1Wyn
(129P2-Galtm1Wyn)
|
increased susceptibility to neuronal excitotoxicity
|
J:89287
|
Gasttm1Psi/Gasttm1Psi
(involves: C57BL/6J)
|
increased incidence of tumors by chemical induction
|
J:77985
|
increased physiological sensitivity to xenobiotic
|
J:77985
|
Gata1tm2Sho/Y
(involves: 129S4/SvJae * C57BL/6 * CD-1)
|
abnormal physiological response to xenobiotic
|
J:78540
|
Gata1tm2Sho/Gata1tm2Sho
(involves: 129S4/SvJae * C57BL/6 * CD-1)
|
abnormal physiological response to xenobiotic
|
J:78540
|
Gata6osem1Zfa/Gata6osem1Zfa
(C57BL/6-1010001N08Rikem1Zfa)
|
decreased incidence of tumors by chemical induction
|
J:268724
|
Gatmem1Btlr/Gatmem1Btlr
(C57BL/6J-Gatmem1Btlr)
|
increased physiological sensitivity to xenobiotic
|
J:252049
|
Gatmm1Btlr/Gatm+
(C57BL/6J-Gatmm1Btlr)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:252049
|
Gatmm1Btlr/Gatmm1Btlr
(C57BL/6J-Gatmm1Btlr)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:252049
|
Gclmtm1Tjka/Gclm+
(B6.129-Gclmtm1Tjka)
|
increased physiological sensitivity to xenobiotic
|
J:125009
|
Gclmtm1Tjka/Gclmtm1Tjka
(B6.129-Gclmtm1Tjka)
|
increased physiological sensitivity to xenobiotic
|
J:125009
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:125009
|
Gclmtm1Tjka/Gclmtm1Tjka
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased susceptibility to neuronal excitotoxicity
|
J:129361
|
Gclmtm1Tjka/Gclmtm1Tjka
(involves: 129S1/Sv * 129X1/SvJ)
|
increased susceptibility to neuronal excitotoxicity
|
J:129045
|
Ghsrtm1.1Lex/Ghsrtm1.1Lex
(involves: 129S4/SvJae * 129S5/SvEvBrd * C57BL/6)
|
abnormal physiological response to xenobiotic
|
J:141985
|
Glp2rtm1Ddr/Glp2rtm1Ddr
(involves: C57BL/6)
|
increased physiological sensitivity to xenobiotic
|
J:182545
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:182545
|
Gnai2tm1.1Rneu/Gnai2tm1.1Rneu
(involves: 129S1/Sv * C57BL/6)
|
increased physiological sensitivity to xenobiotic
|
J:121385
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:121385
|
Gnai2tm1Lbi/Gnai2tm1Lbi
(involves: 129S7/SvEvBrd)
|
decreased physiological sensitivity to xenobiotic
|
J:30507
|
increased physiological sensitivity to xenobiotic
|
J:30507
|
Gnai2tm2.1Lbi/Gnai2tm2.1Lbi Tg(Cd4-cre)1Cwi/0
(involves: 129S/SvEv * C57BL/6 * C57BL/6NTac * DBA)
|
increased incidence of tumors by chemical induction
|
J:194587
|
Gnaztm1Iah/Gnaz+
(C57BL/6JAnu-Gnaztm1Iah/AnuApb)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:97148
|
Gnaztm1Iah/Gnaztm1Iah
(C57BL/6JAnu-Gnaztm1Iah/AnuApb)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:97148
|
Gpa33tm1Jkhh/Gpa33tm1Jkhh
(B6.129-Gpa33tm1Jkhh)
|
increased incidence of tumors by chemical induction
|
J:224768
|
Gpbar1em1Gpt/Gpbar1em1Gpt Tg(Adipoq-cre)1Evdr/0
(involves: C57BL/6JGpt * FVB/NJ)
|
decreased physiological sensitivity to xenobiotic
|
J:325395
|
Gpbar1tm1.2Auw/Gpbar1tm1.2Auw
(involves: 129 * C57BL/6J)
|
decreased physiological sensitivity to xenobiotic
|
J:152388
|
Gpr26tm1Yugs/Gpr26tm1Yugs
(involves: C57BL/6)
|
increased physiological sensitivity to xenobiotic
|
J:189617
|
Gpr37tm1.1Ryot/Gpr37tm1.1Ryot
(involves: C57BL/6)
|
decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:128745
|
Gpr55tm1.1Mijr/Gpr55tm1.1Mijr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal physiological response to xenobiotic
|
J:153225
|
Gpsm1tm2b(KOMP)Wtsi/Gpsm1tm2b(KOMP)Wtsi
(C57BL/6N-Gpsm1tm2b(KOMP)Wtsi/MbpMmucd)
|
decreased bronchoconstrictive response
|
J:211773
|
Grhl3tm1Jane/Grhl3tm3.1Jane Tg(KRT14-cre)8Brn/0
(involves: 129S1/Sv * C57BL/6 * FVB/N)
|
increased incidence of tumors by chemical induction
|
J:178952
|
GrhprGt(OST383093)Lex/GrhprGt(OST383093)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased physiological sensitivity to xenobiotic
|
J:181969
|
GrhprGt(OST383093)Lex/GrhprGt(OST383093)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased physiological sensitivity to xenobiotic
|
J:283585
|
GrhprGt(OST383093)Lex/GrhprGt(OST383093)Lex Prodh2em1Jkni/Prodh2em1Jkni
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased physiological sensitivity to xenobiotic
|
J:283585
|
Gria2tm1Rod/Gria2+
(B6.129-Gria2tm1Rod/J)
|
increased susceptibility to neuronal excitotoxicity
|
J:104951
|
Gria2tm1Rod/Gria2tm1Rod
(B6.129-Gria2tm1Rod/J)
|
increased susceptibility to neuronal excitotoxicity
|
J:104951
|
Gria4tm1Yfkk/Gria4tm1Yfkk
(B6.129S-Gria4tm1Yfkk)
|
increased physiological sensitivity to xenobiotic
|
J:178206
|
Grik4tm1.1Sfh/Grik4tm1.1Sfh
(involves: 129S4/SvJae)
|
decreased physiological sensitivity to xenobiotic
|
J:155003
|
Grik4tm1.1Sfh/Grik4tm1.1Sfh Grik5tm1Cont/Grik5tm1Cont
(involves: 129S/SvEv * 129S4/SvJae)
|
decreased physiological sensitivity to xenobiotic
|
J:155003
|
Grin1Rgsc174/Grin1+
(C57BL/6J-Grin1Rgsc174)
|
abnormal physiological response to xenobiotic
|
J:160947
|
Grin1tm1Nak/Grin1tm1Nak
(involves: 129S/Sv * C57BL/6 * DBA/2)
|
decreased susceptibility to neuronal excitotoxicity
|
J:38582
|
Grin2btm1.1Jlbr/Grin2btm1.1Jlbr Tg(Camk2a-cre)T29-1Stl/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:159387
|
Grk2tm1Gwd/Grk2tm1Gwd Nkx2-5tm1(cre)Rjs/Nkx2-5+
(involves: 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:126501
|
increased physiological sensitivity to xenobiotic
|
J:126501
|
Grm2tm1Nak/Grm2tm1Nak
(B6.129S-Grm2tm1Nak)
|
decreased susceptibility to neuronal excitotoxicity
|
J:202321
|
Grm7tm1Betz/Grm7tm1Betz
(B6.129P2-Grm7tm1Betz)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:138831
|
Grm8tm1En/Grm8tm1En
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:97019
|
Grntm1.1Far/Grntm1.1Far
(involves: 129S4/SvJae * C57BL/6J * FVB/N)
|
increased susceptibility to dopaminergic neuron neurotoxicity
|
J:188324
|
Grntm1Far/Grntm1Far Tg(ITGAM-cre)2781Gkl/0
(involves: 129S4/SvJae * C57BL/6 * CBA * FVB/N)
|
increased susceptibility to dopaminergic neuron neurotoxicity
|
J:188324
|
Gsta3tm1Sell/Gsta3tm1Sell
(C57BL/6-Gsta3tm1Sell)
|
increased physiological sensitivity to xenobiotic
|
J:157029
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:157029
|
Gstm1tm1Gcw/Gstm1tm1Gcw
(involves: 129S/SvEv * C57BL/6)
|
abnormal physiological response to xenobiotic
|
J:159701
|
Gstt2em1Rmah/Gstt2em1Rmah
(Not Specified)
|
abnormal physiological response to xenobiotic
|
J:358834
|
Gt(ROSA)26Sortm1(CAG-CAMK2G*T287D,-EGFP)Whua/Gt(ROSA)26Sor+ Tg(Vil1-cre)997Gum/0
(involves: 129 * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:243363
|
Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sor+ Ptentm1Hwu/Ptentm1Hwu
(involves: 129 * 129S4/SvJae * BALB/c * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:130367
|
Gt(ROSA)26Sortm1(Crh)Jde/Gt(ROSA)26Sortm1(Crh)Jde Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
decreased susceptibility to neuronal excitotoxicity
|
J:140968
|
Gt(ROSA)26Sortm1(RNU6-RNAi:Trpv1)Thch/Gt(ROSA)26Sor+
(Not Specified)
|
abnormal physiological response to xenobiotic
|
J:132700
|
Gt(ROSA)26Sortm1(Trpv1,ECFP)Mde/Gt(ROSA)26Sor+ Tg(Nes-cre)1Wme/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
increased susceptibility to neuronal excitotoxicity
|
J:136582
|
Gt(ROSA)26Sortm1.1(Loxl2)Acan/Gt(ROSA)26Sortm1.1(Loxl2)Acan
(Not Specified)
|
increased incidence of tumors by chemical induction
|
J:220689
|
Gt(ROSA)26Sortm1.1(Otx2)Daac/Gt(ROSA)26Sor+ Slc6a3tm1.1(cre)Bkmn/Slc6a3+
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:166896
|
Gt(ROSA)26Sortm1.1(Otx2)Daac/Gt(ROSA)26Sortm1.1(Otx2)Daac Slc6a3tm1.1(cre)Bkmn/Slc6a3+
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:166896
|
Gt(ROSA)26Sortm1.1(Otx2)Daac/Gt(ROSA)26Sortm1.1(Otx2)Daac Slc6a3tm1.1(cre)Bkmn/Slc6a3+ Tg(CAG-Otx2,-GFP)21Asim/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:166896
|
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sortm1Sor Tg(NPHS2-rtTA2*M2)1Jbk/Tg(NPHS2-rtTA2*M2)1Jbk Tg(tetO-cre)LC1Bjd/Tg(tetO-cre)LC1Bjd
(involves: 129S4/SvJaeSor * BALB/c * C57BL/6 * FVB/N)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:285673
|
Gt(ROSA)26Sortm2(CAG-Lancl1)Pfw/Gt(ROSA)26Sortm2(CAG-Lancl1)Pfw Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL)
|
decreased susceptibility to neuronal excitotoxicity
|
J:214805
|
Gt(ROSA)26Sortm4(EWSR1/ATF1)Mrc/Gt(ROSA)26Sor+
(involves: C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:194308
|
Gt(ROSA)26Sortm9(cre/ESR1)Arte/? Tnfaip3tm1Homy/Tnfaip3tm1Homy
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:212681
|
H2b/H2b
(NOD.B10SnJ-H2b)
|
decreased physiological sensitivity to xenobiotic
|
J:14178
|
H2h2/H2h2
(NOD.Cg-H2h2)
|
decreased physiological sensitivity to xenobiotic
|
J:14178
|
H2h4/H2h4
(NOD.Cg-H2h4)
|
decreased physiological sensitivity to xenobiotic
|
J:14178
|
H2i5/H2i5
(NOD.Cg-H2i5)
|
decreased physiological sensitivity to xenobiotic
|
J:14178
|
H2i7/H2i7
(NOD.Cg-H2i7)
|
decreased physiological sensitivity to xenobiotic
|
J:14178
|
H2k/H2k
(NOD.Cg-H2k)
|
increased physiological sensitivity to xenobiotic
|
J:14178
|
Habp4em1Jkob/Habp4em1Jkob
(involves: C57BL/6J)
|
increased incidence of tumors by chemical induction
|
J:310581
|
Hcsttm1.1Dnax/Hcsttm1.1Dnax
(involves: C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:148086
|
Hgfactm1Hk/Hgfactm1Hk
(involves: C57BL/6 * CBA)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:93428
|
Hif1atm3Rsjo/Hif1atm3Rsjo Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:148597
|
Hif1atm3Rsjo/Hif1atm3Rsjo Myl2tm1(cre)Krc/Myl2+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
abnormal physiological response to xenobiotic
|
J:118455
|
Hif1atm3Rsjo/Hif1atm3Rsjo Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1Tg(Alb-cre)21Mgn
(B6.Cg-Hif1atm3Rsjo Speer6-ps1Tg(Alb-cre)21Mgn)
|
decreased physiological sensitivity to xenobiotic
|
J:211093
|
Hif1atm3Rsjo/Hif1atm3Rsjo Tg(Camk2a-cre)1Szi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal physiological response to xenobiotic
|
J:121971
|
Hif1atm3Rsjo/Hif1atm3Rsjo Tg(Camk2a-cre)2Szi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal physiological response to xenobiotic
|
J:121971
|
Hint1tm1Ibw/Hint1tm1Ibw
(involves: 129 * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:84504
|
Hip1tm4Tsr/Hip1+ Tg(Mx1-cre)1Cgn/0
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:151974
|
Hipk1tm1Mak/Hipk1tm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:99823
|
HnrnpabGt(AV0462)Wtsi/HnrnpabGt(AV0462)Wtsi
(involves: 129P2/OlaHsd)
|
increased susceptibility to neuronal excitotoxicity
|
J:227973
|
Homer1tm2Mhd/Homer1tm2Mhd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:174500
|
Hptm1Skl/Hptm1Skl
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:49888
|
Hptm1Skl/Hptm1Skl Hpxtm1Altr/Hpxtm1Altr
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6J)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:80539
|
Hpcatm1Toho/Hpcatm1Toho
(involves: 129S/SvEv * C57BL/6)
|
increased susceptibility to neuronal excitotoxicity
|
J:97752
|
Hpcal1em1Ylzg/Hpcal1em1Ylzg
(C57BL/6J-Hpcal1em1Ylzg)
|
increased incidence of tumors by chemical induction
|
J:331711
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:331711
|
Hpcr1C57BL/6J/Hpcr1DBA/2J
(involves: C57BL/6J * DBA/2J)
|
decreased incidence of tumors by chemical induction
|
J:22501
|
Hpcr1C57BL/6J/Hpcr1DBA/2J Hpcr2C57BL/6J/Hpcr2DBA/2J
(involves: C57BL/6J * DBA/2J)
|
decreased incidence of tumors by chemical induction
|
J:22501
|
Hpcr1DBA/2J/Hpcr1DBA/2J
(involves: C57BL/6J * DBA/2J)
|
decreased incidence of tumors by chemical induction
|
J:22501
|
Hpcr2C57BL/6J/Hpcr2DBA/2J
(involves: C57BL/6J * DBA/2J)
|
decreased incidence of tumors by chemical induction
|
J:22501
|
Hpcr2DBA/2J/Hpcr2DBA/2J
(involves: C57BL/6J * DBA/2J)
|
decreased incidence of tumors by chemical induction
|
J:22501
|
Hprt1tm1.1(CAG-Smpd1)Jhkh/Hprt1+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal physiological response to xenobiotic
|
J:199833
|
Hrastm1Mok/Hrastm1Mok
(involves: 129S/SvEv * C57BL/6 * DBA/2)
|
decreased incidence of tumors by chemical induction
|
J:62962
|
Hrh3tm1.1Jhwa/Hrh3tm1.1Jhwa
(involves: C57BL/6 * C57BL/6NTac)
|
decreased physiological sensitivity to xenobiotic
|
J:174155
|
Htr2ctm1Knk/Y
(B6.Cg-Htr2ctm1Knk)
|
increased physiological sensitivity to xenobiotic
|
J:142503
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:142503
|
Htr4tm1Comp/Htr4tm1Comp
(129/Sv-Htr4tm1Comp)
|
decreased physiological sensitivity to xenobiotic
|
J:125754
|
Htr7tm1Wtkn/Htr7tm1Wtkn
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:124549
|
Htra2tm1Jdo/Htra2tm1Jdo
(involves: 129P/Ola * C57BL/6)
|
increased susceptibility to neuronal excitotoxicity
|
J:94227
|
Htttm6Mem/Htttm8Mem
(involves: 129S1/Sv * 129X1/SvJ * Swiss Webster)
|
increased susceptibility to malignant hyperthermia
|
J:72915
|
Hyou1tm1Oga/Hyou1+
(involves: 129S1/Sv * C57BL/6)
|
increased susceptibility to neuronal excitotoxicity
|
J:91396
|
Ido1tm1Alm/Ido1tm1Alm
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal physiological response to xenobiotic
|
J:282516
|
Ier3tm1Mxw/Ier3tm1Mxw
(involves: C57BL/6)
|
abnormal physiological response to xenobiotic
|
J:194587
|
decreased incidence of tumors by chemical induction
|
J:194587
|
If1l/If1l
(involves: BALB/c)
|
abnormal physiological response to xenobiotic
|
J:38004
|
Ifnar1tm1Pjh/Ifnar1tm1Pjh
(B6.129S2-Ifnar1tm1Pjh)
|
increased incidence of tumors by chemical induction
|
J:125812
|
Ifnar2tm1Pjh/Ifnar2tm1Pjh
(B6.Cg-Ifnar2tm1Pjh)
|
increased incidence of tumors by chemical induction
|
J:125812
|
Ifnar2tm1Pjh/Ifnar2tm1Pjh Il6sttm1Ern/Il6sttm1Ern
(involves: 129S1/Sv)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:168781
|
Ifngtm1Ts/Ifngtm1Ts
(B6.129S7-Ifngtm1Ts/J)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:91927
|
Ifngtm1Ts/Ifngtm1Ts
(involves: 129S7/SvEvBrd * A/WySn * C57BL/10SnSg * Swiss)
|
decreased physiological sensitivity to xenobiotic
|
J:119207
|
Ifngr1tm1Agt/Ifngr1tm1Agt
(B6.129S7-Ifngr1tm1Agt)
|
decreased physiological sensitivity to xenobiotic
|
J:108669
|
Ighg1tm1.1Pyu/Ighg1tm1.1Pyu
(B6.C(Cg)-Ighg1tm1.1Pyu)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:198154
|
Ighg2cem1Wliu/Ighg2cem1Wliu
(C57BL/6J-Ighg2cem1Wliu)
|
decreased incidence of tumors by chemical induction
|
J:322180
|
Igs2em1(Alb-Golm1)Jdon/Igs2+
(involves: C57BL/6N)
|
increased incidence of tumors by chemical induction
|
J:306528
|
Ikbkgtm1.1Chtr/Y Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N * SJL)
|
decreased physiological sensitivity to xenobiotic
|
J:151485
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:151485
|
Ikbkgtm1.1Chtr/Ikbkgtm1.1Chtr Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N * SJL)
|
increased physiological sensitivity to xenobiotic
|
J:151485
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:151485
|
Il1r1tm1Roml/Il1r1tm1Roml
(involves: 129S1/Sv * BALB/c)
|
decreased incidence of tumors by chemical induction
|
J:191239
|
Il1r1tm1Roml/Il1r1tm1Roml Nlrp1aNeut1/Nlrp1aNeut1
(involves: 129S1/Sv * C57BL/6)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:191055
|
Il1rl2tm1Hblu/Il1rl2tm1Hblu
(involves: 129)
|
decreased physiological sensitivity to xenobiotic
|
J:193548
|
Il4tm1Cgn/Il4tm1Cgn
(involves: 129P2/OlaHsd * A/WySn * C57BL/10SnSg * Swiss)
|
abnormal physiological response to xenobiotic
|
J:119207
|
Il6tm1Kopf/Il6tm1Kopf
(involves: 129S2/SvPas * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:122816
|
Il6tm1Mur/Il6tm1Mur
(B6.129P2(B6)-Il6tm1Mur)
|
increased susceptibility to dopaminergic neuron neurotoxicity
|
J:86039
|
Il6ratm1.2Jcbr/Il6ratm1.2Jcbr
(involves: C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:202764
|
Il6sttm1Ard/Il6sttm1Ard
(involves: 129S1/Sv * C57BL/6)
|
increased physiological sensitivity to xenobiotic
|
J:79073
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:79073
|
Il6sttm1Ern/Il6sttm1Ern
(involves: 129S1/Sv * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:79073
|
Il6sttm1Ern/Il6sttm1Ern
(involves: 129S1/Sv)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:168781
|
Il10tm1Cgn/Il10tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:115459
|
Il10tm1Cgn/Il10tm1Cgn
(B6.129P2-Il10tm1Cgn/J)
|
increased susceptibility to neuronal excitotoxicity
|
J:108086
|
Il12atm1Jm/Il12atm1Jm
(B6.129S1-Il12atm1Jm/J)
|
increased incidence of tumors by chemical induction
|
J:111568
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:91927
|
Il12btm1Jm/Il12btm1Jm
(B6.129S1-Il12btm1Jm/J)
|
decreased incidence of tumors by chemical induction
|
J:111568
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:91927
|
Il17atm1Yiw/Il17atm1Yiw
(involves: 129P2/OlaHsd)
|
decreased physiological sensitivity to xenobiotic
|
J:193548
|
Il17atm1Yiw/Il17atm1Yiw Il22tm1Flv/Il22tm1Flv
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
increased physiological sensitivity to xenobiotic
|
J:126103
|
Il17ctm1Lex/Il17ctm1Lex
(B6.129S5-Il17ctm1Lex)
|
decreased physiological sensitivity to xenobiotic
|
J:178967
|
Il22tm1.1Lex/Il22tm1.1Lex Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129S5/SvEvBrd * C57BL/6N * C57BL/10 * CBA/Ca)
|
decreased physiological sensitivity to xenobiotic
|
J:305794
|
Il22tm1.1Lex/Il22tm1.1Lex Riok2tm1c(KOMP)Wtsi/Riok2+ Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129S5/SvEvBrd * C57BL/6N * C57BL/10 * CBA/Ca)
|
decreased physiological sensitivity to xenobiotic
|
J:305794
|
Il22tm1Flv/Il22+
(B6.Cg-Il22tm1Flv)
|
increased physiological sensitivity to xenobiotic
|
J:126103
|
Il22tm1Flv/Il22tm1Flv
(B6.Cg-Il22tm1Flv)
|
increased physiological sensitivity to xenobiotic
|
J:126103
|
Il22tm1Flv/Il22tm1Flv
(involves: 129/Sv * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:189217
|
Il22tm1Flv/Il22tm1Flv Il22ra2tm2Vlcg/Il22ra2tm2Vlcg
(involves: 129 * 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)
|
increased incidence of tumors by chemical induction
|
J:189217
|
Il22tm1Jcrd/Il22tm1Jcrd
(Not Specified)
|
decreased physiological sensitivity to xenobiotic
|
J:193548
|
Il22ra1tm1.1Koll/Il22ra1tm1.1Koll Eportm1.1(EGFP/icre)Uk/Epor+
(involves: BALB/cJ * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:305794
|
Il22ra2tm2Vlcg/Il22ra2tm2Vlcg
(B6.Cg-Il22ra2tm2Vlcg)
|
increased incidence of tumors by chemical induction
|
J:189217
|
Il23atm1Dnax/Il23atm1Dnax
(B6.Cg-Il23atm1Dnax)
|
decreased incidence of tumors by chemical induction
|
J:111568
|
Il23atm1Dnax/Il23atm1Dnax
(Not Specified)
|
decreased physiological sensitivity to xenobiotic
|
J:193548
|
Il23atm1Gdy/Il23atm1Gdy
(B6.Cg-Il23atm1Gdy)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:139557
|
Il23atm1Ngh/Il23atm1Ngh
(involves: 129 * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:216867
|
Il23rtm1.1Ngh/Il23rtm1.1Ngh
(involves: C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:216867
|
Il27ratm1Mak/Il27ratm1Mak
(B6.129P2-Il27ratm1Mak)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:88618
|
Il33tm1Snak/Il33tm1Snak
(involves: C57BL/6 * CBA)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:165513
|
Il36atm1Yiw/Il36atm1Yiw
(B6.129P2-Il36atm1Yiw)
|
decreased physiological sensitivity to xenobiotic
|
J:263315
|
Il36rntm1Kopf/Il36rntm1Kopf
(B6.129S5-Il36rntm1Kopf)
|
increased physiological sensitivity to xenobiotic
|
J:193548
|
ImacqC57BL/6J/?
(involves: C57BL/6J * LP/J)
|
increased physiological sensitivity to xenobiotic
|
J:123468
|
ImacqLP/J/?
(involves: C57BL/6J * LP/J)
|
decreased physiological sensitivity to xenobiotic
|
J:123468
|
Ing4Gt(XG370)Byg/Ing4Gt(XG370)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:161381
|
Insrtm1Shs/Insr+
(involves: C57BL/6CrSlc)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:98723
|
Ip6k2tm1Dlin/Ip6k2tm1Dlin
(involves: 129X1/SvJ * Black Swiss * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:151345
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:151345
|
Irf1tm1Mak/Irf1tm1Mak
(B6.129S2-Irf1tm1Mak/J)
|
increased incidence of tumors by chemical induction
|
J:91927
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:91927
|
Itgb1tm11.1Ref/Itgb1tm11.1Ref
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased incidence of tumors by chemical induction
|
J:176453
|
Ivns1abptm1Htno/Ivns1abptm1Htno
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased physiological sensitivity to xenobiotic
|
J:162743
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:162743
|
Jam2tm1.2Rha/Jam2tm1.2Rha
(B6.Cg-Jam2tm1.2Rha)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:178387
|
Juntm2.1Wag/Juntm2.1Wag
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
decreased susceptibility to neuronal excitotoxicity
|
J:53481
|
Kalrntm1Ppen/Kalrntm1Ppen
(Not Specified)
|
decreased physiological sensitivity to xenobiotic
|
J:152011
|
Kcna5tm1(Kcna1)Lndn/Kcna5tm1(Kcna1)Lndn
(involves: C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:78122
|
Kcne3tm1.1Tjj/Kcne3tm1.1Tjj
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6J)
|
abnormal physiological response to xenobiotic
|
J:160721
|
Kcnk2tm1Lzd/Kcnk2tm1Lzd
(involves: 129 * C57BL/6J)
|
decreased physiological sensitivity to xenobiotic
|
J:91531
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:91531
|
Kcnn2fri/Kcnn2fri
(129S2.C3Pas-Kcnn2fri)
|
decreased physiological sensitivity to xenobiotic
|
J:177761
|
Kcnq3tm1Dgen/Kcnq3tm1Dgen
(Not Specified)
|
abnormal physiological response to xenobiotic
|
J:142688
|
Kdm1atm1Ebg/Kdm1atm1Ebg
(B6.129-Kdm1atm1Ebg)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:235553
|
Kdm4cGt(897)Tgen/Kdm4c+
(B6.Cg-Kdm4cGt(897)Tgen)
|
decreased incidence of tumors by chemical induction
|
J:227280
|
Keap1tm1Mym/Keap1tm2Mym Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
decreased physiological sensitivity to xenobiotic
|
J:103791
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:103791
|
Kif4em1Noh/Y
(C57BL/6J-Kif4em1Noh)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:336792
|
Kif13atm1.1Noh/Kif13atm1.1Noh
(involves: C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:196383
|
Kif26atm1.1Noh/Kif26atm1.1Noh
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J)
|
decreased physiological sensitivity to xenobiotic
|
J:154859
|
Kittm3.1Bsm/Kittm3.1Bsm
(B6.129S1-Kittm3.1Bsm)
|
increased physiological sensitivity to xenobiotic
|
J:146561
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:146561
|
Kittm4.1Bsm/Kit+
(involves: 129S1/Sv * C57BL/6J * FVB/N)
|
decreased physiological sensitivity to xenobiotic
|
J:188434
|
KitW/KitW-v
(involves: C57BL * C57BL/6 * WB)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:125964
|
Klf4tm1Khk/Klf4tm1Khk Tg(Klf4-cre/ERT)1Wai/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
increased incidence of tumors by chemical induction
|
J:189337
|
Klf5tm2.1Rng/Klf5tm2.1Rng Tg(Postn-cre)1Sjc/0
(involves: C57BL/6)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:156696
|
Klf10tm1Wkle/Klf10tm1Wkle
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:182595
|
Klf14em1Cgw/Klf14em1Cgw
(C57BL/6J-Klf14em1Cgw)
|
increased incidence of tumors by chemical induction
|
J:227200
|
Klhl3tm1.1Slin/Klhl3+
(Not Specified)
|
abnormal physiological response to xenobiotic
|
J:284284
|
Klhl3tm1.1Slin/Klhl3tm1.1Slin
(Not Specified)
|
abnormal physiological response to xenobiotic
|
J:284284
|
Klk6tm1Gsot/Klk6+
(involves: C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:270051
|
Klk6tm1Gsot/Klk6tm1Gsot
(involves: C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:270051
|
Klk8tm1Lth/Klk8tm1Lth
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:71533
|
Krastm4Tyj/Kras+ Trp53tm1Brn/Trp53tm1Brn Tg(KRT5-cre/PGR)1Der/?
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6 * FVB * ICR)
|
decreased incidence of tumors by chemical induction
|
J:124222
|
Krastm4Tyj/Kras+ Trp53tm1Brn/Trp53tm3Glo Tg(KRT5-cre/PGR)1Der/?
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6 * FVB * ICR)
|
increased incidence of tumors by chemical induction
|
J:124222
|
Krastm4Tyj/Kras+ Trp53tm3Glo/Trp53+ Tg(KRT5-cre/PGR)1Der/?
(involves: 129/Sv * C57BL/6 * FVB * ICR)
|
increased incidence of tumors by chemical induction
|
J:124222
|
Krt14tm1(cre)Wbm/Krt14+ Pard3tm1Shoh/Pard3tm1Shoh
(either: FVB.129-Pard3tm1Shoh Krt14tm1(cre)Wbm or (involves: 129P2/OlaHsd * 129S4/SvJae))
|
decreased incidence of tumors by chemical induction
|
J:192905
|
increased incidence of tumors by chemical induction
|
J:192905
|
Krt14tm1(cre)Wbm/Krt14+ Pard3tm1Shoh/Pard3tm1Shoh
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J)
|
increased incidence of tumors by chemical induction
|
J:240961
|
Ksr1tm1Kole/Ksr1tm1Kole Tg(Hba-x-v-Ha-ras)TG.ACLed/0
(involves: 129S1/Sv * C57BL/6 * FVB/N)
|
decreased incidence of tumors by chemical induction
|
J:84644
|
Lancl1tm1.1Pfw/Lancl1tm1.1Pfw
(involves: 129 * C57BL/6)
|
increased susceptibility to neuronal excitotoxicity
|
J:214805
|
Lat2tm1Wz/Lat2tm1Wz
(Not Specified)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:181866
|
Lcn2tm1Mrgr/Lcn2tm1Mrgr
(129(B6)-Lcn2tm1Mrgr)
|
decreased physiological sensitivity to xenobiotic
|
J:173490
|
Ldlrtm1Her/Ldlrtm1Her Nr1h3tm1.1Djm/Nr1h3tm1.1Djm Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6 * DBA)
|
decreased physiological sensitivity to xenobiotic
|
J:184536
|
Lemd2em1Eno/Lemd2em1Eno
(involves: C3H * C57BL/6 * C57BL/6N)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:331716
|
Lepob/Lepob
(B6.Cg-Lepob/J)
|
decreased physiological sensitivity to xenobiotic
|
J:344866
|
Leprtm1Rck/Leprtm1Rck Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
(involves: 129 * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:344866
|
Letmd1em1Mbp/Letmd1em1Mbp
(C57BL/6J-Letmd1em1Mbp)
|
decreased susceptibility to xenobiotic induced hyperthermia
|
J:321533
|
Lonp1tm1Otin/Lonp1+
(Not Specified)
|
decreased incidence of tumors by chemical induction
|
J:221992
|
Loxtm1.1Khki/Loxtm1.1Khki
(involves: C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:264295
|
Loxl2tm1.2Acan/Loxl2tm1.2Acan
(Not Specified)
|
decreased incidence of tumors by chemical induction
|
J:220689
|
Lpar6tm1.1Bcz/Lpar6tm1.1Bcz
(involves: 129 * BALB/cJ * C57BL/6J * C57BL/6NCr)
|
increased incidence of tumors by chemical induction
|
J:350956
|
Lrrk2tm1.1Shn/Lrrk2tm1.1Shn
(involves: 129 * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:151944
|
Ltatm1.1(KOMP)Vlcg/Ltatm1.1(KOMP)Vlcg
(C57BL/6N-Ltatm1.1(KOMP)Vlcg/MbpMmucd)
|
increased bronchoconstrictive response
|
J:211773
|
Ltbtm1Flv/Ltbtm1Flv
(involves: 129S1/Sv * C57BL/6J)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:91927
|
Ltftm1.2Smoc/Ltftm1.2Smoc
(involves: 129 * C57BL/6J)
|
increased incidence of tumors by chemical induction
|
J:219007
|
Lynx1tm1Htz/Lynx1tm1Htz
(involves: 129X1/SvJ * C57BL/6J)
|
increased physiological sensitivity to xenobiotic
|
J:122965
|
increased susceptibility to neuronal excitotoxicity
|
J:122965
|
Lypd3tm1(KOMP)Vlcg/Lypd3tm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac)
|
decreased incidence of tumors by chemical induction
|
J:235771
|
Maobtm1Shih/Maobtm1Shih
(either: (involves: 129S/SvEv) or (involves: 129S4/SvJae))
|
decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:43648
|
Map3k5tm1Hijo/Map3k5tm1Hijo
(B6.129S4-Map3k5tm1Hijo)
|
decreased physiological sensitivity to xenobiotic
|
J:148044
|
Map3k5tm1Hijo/Map3k5tm1Hijo Map3k6tm1Hijo/Map3k6tm1Hijo
(B6.129-Map3k6tm1Hijo Map3k5tm1Hijo)
|
decreased physiological sensitivity to xenobiotic
|
J:148044
|
Map3k6tm1Hijo/Map3k6+
(B6.129P2-Map3k6tm1Hijo)
|
increased incidence of tumors by chemical induction
|
J:148044
|
Map3k6tm1Hijo/Map3k6tm1Hijo
(B6.129P2-Map3k6tm1Hijo)
|
decreased physiological sensitivity to xenobiotic
|
J:148044
|
increased incidence of tumors by chemical induction
|
J:148044
|
Map3k8tm1.1Gkl/Map3k8tm1.1Gkl Tg(Col6a1-cre)1Gkl/0
(involves: C57BL/6 * CBA * FVB/N)
|
increased incidence of tumors by chemical induction
|
J:193546
|
Map3k8tm1.2Gkl/Map3k8tm1.2Gkl
(involves: 129 * C57BL/6J * FVB/N)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:193546
|
increased incidence of tumors by chemical induction
|
J:193546
|
increased physiological sensitivity to xenobiotic
|
J:193546
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:193546
|
Map9tm1.1Bcgen/Map9+ Tg(CDX2-cre/ERT2)752Erf/0
(involves: 129S4/SvJaeSor * C57BL/6J * SJL/J)
|
increased incidence of tumors by chemical induction
|
J:299895
|
Map9tm1.1Bcgen/Map9tm1.1Bcgen Tg(CDX2-cre/ERT2)752Erf/0
(involves: 129S4/SvJaeSor * C57BL/6J * SJL/J)
|
increased incidence of tumors by chemical induction
|
J:299895
|
Mapk8tm1Flv/Mapk8tm1Flv
(involves: 129S1/Sv)
|
increased incidence of tumors by chemical induction
|
J:75228
|
Mapk8tm1Wag/Mapk8tm1Wag Mapk9tm1Mka/Mapk9tm1Mka
(involves: 129 * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:103476
|
Mapk8ip1tm1Rjd/Mapk8ip1tm1Rjd
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased susceptibility to neuronal excitotoxicity
|
J:77616
|
Mapk9tm1Mka/Mapk9tm1Mka
(B6.129-Mapk9tm1Mka)
|
abnormal physiological response to xenobiotic
|
J:103476
|
Mapk10tm1Flv/Mapk10tm1Flv
(involves: 129S1/Sv)
|
decreased susceptibility to neuronal excitotoxicity
|
J:43658
|
Mapk10tm1Flv/Mapk10tm1Flv
(B6.129S1-Mapk10tm1Flv)
|
decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:87428
|
Mapk10tm1Flv/Mapk10tm1Flv Mapk9tm1Flv/Mapk9tm1Flv
(B6.129S-Mapk9tm1Flv Mapk10tm1Flv)
|
decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:87428
|
Mapk14tm1Okee/Mapk14tm1Okee
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:128965
|
Mapkapk2tm1.1Gkl/Mapkapk2tm1.1Gkl Tg(Tie1-cre)9Ref/0
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6J)
|
decreased incidence of tumors by chemical induction
|
J:262876
|
Mapkapk2tm1.1Gkl/Mapkapk2tm1.1Gkl Twist2tm1.1(cre)Dor/Twist2+
(involves: 129X1/SvJ * BALB/cJ * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:262876
|
Mapkapk2tm1.2Gkl/Mapkapk2tm1.2Gkl
(involves: BALB/cJ * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:262876
|
Matn1tm1Ref/Matn1tm1Ref Matn2tm1Asz/Matn2tm1Asz Matn3tm1Asz/Matn3tm1Asz Matn4tm1.1Asz/Matn4tm1.1Asz
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal physiological response to xenobiotic
|
J:237230
|
Mbd3tm2Bh/Mbd3tm2Bh Tg(Vil1-cre)20Syr/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
increased incidence of tumors by chemical induction
|
J:167984
|
Mbd4/Ift122tm1Abc/Mbd4/Ift122tm1Abc
(either: (involves: 129S1/Sv * C57BL/6) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
decreased physiological sensitivity to xenobiotic
|
J:86981
|
Mbd4/Ift122tm1Abc/Mbd4/Ift122tm1Abc
(either: (involves: 129S1/Sv * C57BL/6) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
decreased physiological sensitivity to xenobiotic
|
J:86981
|
Mbd4tm2Abc/Mbd4tm2Abc
(involves: 129/Sv * 129X1/SvJ * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:86981
|
Mbpshi/Mbpshi Tg(Thy1-YFP)HJrs/0
(involves: C3HeB/Fe * C57BL/6 * CBA * SWV)
|
increased susceptibility to neuronal excitotoxicity
|
J:158545
|
Mbtps1wrt/Mbtps1wrt
(C57BL/6J-Mbtps1wrt)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:146454
|
Mecomtm1Aspe/Mecomtm1Aspe
(involves: 129S6/SvEvTac * C57BL/6)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:178429
|
Mgat3tm1Pst/Mgat3tm1Pst
(involves: 129/Sv * C57BL/6 * CD-1 * SJL)
|
decreased incidence of tumors by chemical induction
|
J:48441,
J:86643
|
MgllGt(OST113734)Lex/MgllGt(OST113734)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased physiological sensitivity to xenobiotic
|
J:165274
|
Mglltm1.1Rzim/Mglltm1.1Rzim
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:172679
|
Mgmttm1Mse/Mgmttm1Mse
(involves: 129S/SvEv)
|
increased physiological sensitivity to xenobiotic
|
J:47642
|
Mgst2Gt(OST22210)Lex/Mgst2Gt(OST22210)Lex
(involves: 129S5/SvEvBrd)
|
decreased physiological sensitivity to xenobiotic
|
J:228296
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:228296
|
Miftm1Dvd/Miftm1Dvd
(B6.129S4-Miftm1Dvd)
|
decreased incidence of tumors by chemical induction
|
J:126543
|
Miftm1Gfr/Miftm1Gfr
(C57BL/6-Miftm1Gfr)
|
increased incidence of tumors by chemical induction
|
J:147772
|
Miftm2Gfr/Miftm2Gfr
(C57BL/6-Miftm2Gfr)
|
increased incidence of tumors by chemical induction
|
J:147772
|
Mir21atm1Yoli/Mir21atm1Yoli
(involves: 129S6/SvEvTac * C57BL/6N)
|
decreased incidence of tumors by chemical induction
|
J:173464
|
decreased physiological sensitivity to xenobiotic
|
J:173464
|
Mir22tm1.1Arod/Mir22tm1.1Arod
(involves: 129S1/SvImJ * 129S7/SvEvBrd)
|
increased physiological sensitivity to xenobiotic
|
J:183005
|
Mir34atm1Hher/Mir34atm1Hher
(involves: 129 * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:209587
|
Mir139em1Jwli/Mir139em1Jwli
(C57BL/6J-Mir139em1Jwli)
|
increased incidence of tumors by chemical induction
|
J:280467,
J:248779
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:280467
|
Mir144/Mir451atm1.1Mjwe/Mir144/Mir451atm1.1Mjwe
(Not Specified)
|
abnormal physiological response to xenobiotic
|
J:163250
|
Mir144/Mir451atm1.1Mjwe/Mir144/Mir451atm1.1Mjwe
(Not Specified)
|
abnormal physiological response to xenobiotic
|
J:163250
|
Mir144/Mir451atm1.2Doca/Mir144/Mir451atm1.2Doca
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * BALB/cJ)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:163418
|
Mir144/Mir451atm1.2Doca/Mir144/Mir451atm1.2Doca
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * BALB/cJ)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:163418
|
Mir192tm1.1Rnat/Mir192tm1.1Rnat
(involves: 129)
|
decreased physiological sensitivity to xenobiotic
|
J:208963
|
Mir203tm1.2Yir/Mir203tm1.2Yir
(B6(Cg)-Mir203tm1.2Yir)
|
increased incidence of tumors by chemical induction
|
J:226044
|
Mir301tm1Yoli/Mir301tm1Yoli
(involves: C57BL/6J)
|
decreased incidence of tumors by chemical induction
|
J:237900
|
Mir379em1Rnat/Mir379em1Rnat
(C57BL/6J-Mir379em1Rnat)
|
abnormal physiological response to xenobiotic
|
J:333117
|
Mir425em1Nju/Mir425+
(involves: C57BL/6)
|
increased susceptibility to dopaminergic neuron neurotoxicity
|
J:280159
|
Mir451atm1Eno/Mir451atm1Eno
(involves: C57BL/6)
|
increased physiological sensitivity to xenobiotic
|
J:163251
|
Mirc13tm1Biat/Mirc13+ Mirc4tm1.1Biat/Mirc4tm1.1Biat Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * C57BL/6N * CBA/J)
|
decreased physiological sensitivity to xenobiotic
|
J:314874
|
Mirc13tm1Biat/Mirc13tm1Biat
(involves: C57BL/6J * C57BL/6N)
|
decreased physiological sensitivity to xenobiotic
|
J:314874
|
Mirc13tm1Biat/Mirc13tm1Biat Mirc4tm1.1Biat/Mirc4tm1.1Biat Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * C57BL/6N * CBA/J)
|
decreased physiological sensitivity to xenobiotic
|
J:314874
|
Mki67em1Dfis/Mki67em1Dfis
(involves: C57BL/6J)
|
decreased incidence of tumors by chemical induction
|
J:304800
|
Mlh1tm1Rak/Mlh1tm1Rak
(involves: 129P2/OlaHsd)
|
decreased physiological sensitivity to xenobiotic
|
J:133352
|
Mmp1atm1Otin/Mmp1atm1Otin
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased incidence of tumors by chemical induction
|
J:198586
|
Mmp7tm1Lmm/Mmp7tm1Lmm
(B6.129-Mmp7tm1Lmm)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:149388
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129S6/SvEvTac)
|
decreased physiological sensitivity to xenobiotic
|
J:84293
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(FVB.129S6-Mmp9tm1Tvu)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:104644
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129S6/SvEvTac * CD-1)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:149957
|
Mmp11tm1Mrio/Mmp11tm1Mrio
(either: (involves: 129S2/SvPas * 129X1/SvJ) or (involves: 129S2/SvPas * 129X1/SvJ * BALB/c) or (involves: 129S2/SvPas * 129X1/SvJ * C57BL/6J))
|
decreased incidence of tumors by chemical induction
|
J:79012
|
Mmp12tm1Sds/Mmp12tm1Sds
(B6.129X1-Mmp12tm1Sds)
|
decreased physiological sensitivity to xenobiotic
|
J:86599
|
Mmp19tm1Amp/Mmp19tm1Amp
(Not Specified)
|
decreased incidence of tumors by chemical induction
|
J:90802
|
Modc2BALB/cJ/Modc2BALB/cJ
(involves: BALB/cJ * C57BL/6J)
|
decreased incidence of tumors by chemical induction
|
J:101472
|
Modc2BALB/cJ/Modc2C57BL/6J
(involves: BALB/cJ * C57BL/6J)
|
decreased incidence of tumors by chemical induction
|
J:101472
|
Mpgtm1Rhe/Mpgtm1Rhe
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal physiological response to xenobiotic
|
J:70603
|
increased physiological sensitivity to xenobiotic
|
J:50033
|
Mpgtm1Rhe/Mpgtm1Rhe
(B6.129P2-Mpgtm1Rhe)
|
decreased incidence of tumors by chemical induction
|
J:86644
|
increased physiological sensitivity to xenobiotic
|
J:86644
|
Mpig6btm1.1(KOMP)Vlcg/Mpig6btm1.1(KOMP)Vlcg
(C57BL/6N-Mpig6btm1.1(KOMP)Vlcg/MbpMmucd)
|
decreased bronchoconstrictive response
|
J:211773
|
Mpotm1Lus/Mpotm1Lus
(involves: 129X1/SvJ * C57BL/6J)
|
increased physiological sensitivity to xenobiotic
|
J:102688
|
Msh2tm1Htr/Msh2tm1Htr
(involves: 129P2/OlaHsd * FVB)
|
increased incidence of tumors by chemical induction
|
J:45433
|
Msh2tm1Rak/Msh2tm2.1Rak Tg(Vil1-cre)20Syr/0
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6 * DBA/2 * SJL)
|
abnormal physiological response to xenobiotic
|
J:161577
|
Msh2tm2.1Rak/Msh2tm3.1Rak Tg(Vil1-cre)20Syr/0
(involves: 129/Sv * C57BL/6 * DBA/2 * SJL)
|
abnormal physiological response to xenobiotic
|
J:161577
|
Mst1rtm2(Mst1r*)Sew/Mst1rtm2(Mst1r*)Sew
(FVB.129P2(Cg)-Mst1rtm2(Mst1r*)Sew)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:215969
|
Mt1tm1Bri/Mt1tm1Bri Mt2tm1Bri/Mt2tm1Bri
(involves: 129S7/SvEvBrd)
|
increased physiological sensitivity to xenobiotic
|
J:120459
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:120459
|
Mt1tm1Bri/Mt1tm1Bri Mt2tm1Bri/Mt2tm1Bri
(129S7/SvEvBrd-Mt1tm1Bri Mt2tm1Bri/J)
|
abnormal physiological response to xenobiotic
|
J:56770,
J:126620
|
increased incidence of tumors by chemical induction
|
J:56770
|
increased physiological sensitivity to xenobiotic
|
J:126620,
J:126420,
J:89429
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:120196
|
Mt1tm1Bri/Mt1tm1Bri Mt2tm1Bri/Mt2tm1Bri
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased physiological sensitivity to xenobiotic
|
J:116275
|
Mt1tm1Rch/Mt1tm1Rch Mt2tm1Rch/Mt2tm1Rch
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased incidence of tumors by chemical induction
|
J:120459
|
increased physiological sensitivity to xenobiotic
|
J:120459
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:120459
|
MtdhGt(XB780)Byg/MtdhGt(XB780)Byg
(FVB.129P2-MtdhGt(XB780)Byg)
|
decreased incidence of tumors by chemical induction
|
J:214244
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:214244
|
Mtdhtm1.2Dsar/Mtdhtm1.2Dsar
(either: B6.129(FVB)-Mtdhtm1.2Dsar or (129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N))
|
decreased incidence of tumors by chemical induction
|
J:216688
|
Mtf1tm1Wsc/Mtf1tm1Wsc Tg(Mx1-cre)1Cgn/0 Tg(UBC-Mtf1)1Wsc/0
(involves: 129/Sv * C57BL/6 * CBA)
|
increased physiological sensitivity to xenobiotic
|
J:91119
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:91119
|
Mtfp1tm1.2Wait/Mtfp1tm1.2Wait Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6N * FVB/N)
|
increased physiological sensitivity to xenobiotic
|
J:330965
|
Mto1Gt(G019A03)Wrst/Mto1Gt(G019A03)Wrst
(involves: 129S2/SvPas * C57BL/6J)
|
increased physiological sensitivity to xenobiotic
|
J:223246
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:223246
|
Muc2wnn/Muc2wnn
(C57BL/6-Muc2wnn)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:194148
|
Muc4tm1Skb/Muc4tm1Skb
(involves: 129 * C57BL/6J)
|
decreased incidence of tumors by chemical induction
|
J:234205
|
Mus81tm1Chmg/Mus81tm1Chmg
(involves: 129S4/SvJae * 129S5/SvEvBrd * C57BL/6)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:100407
|
Mus81tm1Chmg/Mus81tm1Chmg
(involves: 129S5/SvEvBrd)
|
increased physiological sensitivity to xenobiotic
|
J:232402
|
Mus81tm1Raz/Mus81tm1Raz
(involves: 129P2/OlaHsd)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:91570
|
Mutyhtm1Yun/Mutyhtm1Yun
(involves: 129 * C57BL/6JJcl)
|
decreased susceptibility to neuronal excitotoxicity
|
J:193978
|
Mutyhtm1Yun/Mutyhtm1Yun Ogg1tm1Yun/Ogg1tm1Yun
(involves: 129S/SvEv * C57BL/6JJcl)
|
decreased susceptibility to neuronal excitotoxicity
|
J:193978
|
Mxi1tm1Rdp/Mxi1tm1Rdp
(involves: 129/Sv * C57BL/6J * SJL)
|
increased incidence of tumors by chemical induction
|
J:48236
|
Myd88tm1Aki/Myd88tm1Aki
(B6.129P2-Myd88tm1Aki)
|
increased physiological sensitivity to xenobiotic
|
J:102879
|
Myd88tm1Aki/Myd88tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:162097
|
Myh6tm1.1Jpsc/Myh6+
(involves: 129)
|
increased physiological sensitivity to xenobiotic
|
J:247162
|
Myh6tm1Jse/Myh6+ Postntm1Jmol/Postntm1Jmol
(involves: 129S/SvEv * 129X1/SvJ)
|
decreased physiological sensitivity to xenobiotic
|
J:165269
|
Myh6tm3.1Jse/Myh6+
(involves: 129X1/SvJ)
|
increased physiological sensitivity to xenobiotic
|
J:165269
|
Myh11tm1Peri/Myh11tm1Peri
(Not Specified)
|
decreased bronchoconstrictive response
|
J:97298
|
Myh11tm2Peri/Myh11tm2Peri
(involves: 129 * C57BL/6)
|
increased physiological sensitivity to xenobiotic
|
J:142230
|
Myod1tm1Jae/Myod1tm1Jae
(involves: 129S4/SvJae)
|
decreased physiological sensitivity to xenobiotic
|
J:168843
|
N4bp1tm1.2Vmd/N4bp1tm1.2Vmd
(involves: C57BL/6)
|
increased physiological sensitivity to xenobiotic
|
J:297419
|
Nacc1tm1Jabl/Nacc1tm1Jabl
(involves: 129S6/SvEvTac)
|
increased physiological sensitivity to xenobiotic
|
J:128447
|
Naip1tm1Aem/Naip1tm1Aem
(129X1/SvJ-Naip1tm1Aem)
|
increased susceptibility to neuronal excitotoxicity
|
J:60925
|
Naipctm1.1Kmma/Naipctm1.1Kmma
(involves: BALB/cJ * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:222114
|
Naipctm1Kmma/Naipctm1Kmma Tg(Vil1-cre)997Gum/0
(B6.Cg-Naipctm1Kmma Tg(Vil1-cre)997Gum)
|
increased incidence of tumors by chemical induction
|
J:222114
|
Nalcntm1.1Dren/Nalcntm1.1Dren
(involves: C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:141581
|
Ncapd2em1Cya/Ncapd2+
(C57BL/6N-Ncapd2em1Cya)
|
decreased incidence of tumors by chemical induction
|
J:310248
|
Ncoa3tm1.1Bwo/Ncoa3tm1.1Bwo
(involves: 129S/SvEv * C57BL/6J)
|
increased incidence of tumors by chemical induction
|
J:161276
|
Ncor2tm1Rev/Ncor2tm1Rev
(involves: 129/Sv * C57BL/6)
|
abnormal physiological response to xenobiotic
|
J:142665
|
Ndfip1tm1.1Sest/Ndfip1tm1.1Sest
(involves: C57BL/6)
|
increased susceptibility to dopaminergic neuron neurotoxicity
|
J:212711
|
Ndnfem1Nou/Ndnfem1Nou
(C57BL/6J-Ndnfem1Nou)
|
increased physiological sensitivity to xenobiotic
|
J:322617
|
Neu3tm1Yamk/Neu3tm1Yamk
(B6.129-Neu3tm1Yamk)
|
decreased incidence of tumors by chemical induction
|
J:189604
|
Nfe2l2tm1Mym/Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * ICR)
|
abnormal physiological response to xenobiotic
|
J:68072,
J:118068
|
increased incidence of tumors by chemical induction
|
J:68072
|
Nfe2l2tm1Mym/Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal physiological response to xenobiotic
|
J:136120
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:136120
|
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk
(involves: 129X1/SvJ * C57BL)
|
increased physiological sensitivity to xenobiotic
|
J:112943
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:112943
|
Nherf1tm1Ssl/Nherf1tm1Ssl
(FVB.129-Nherf1tm1Ssl)
|
abnormal physiological response to xenobiotic
|
J:128912
|
Nherf1tm1Ssl/Nherf1tm1Ssl Nherf2Gt(OST2298)Lex/Nherf2Gt(OST2298)Lex
(involves: 129S1/Sv * 129S5/SvEvBrd * 129X1/SvJ * FVB/N)
|
abnormal physiological response to xenobiotic
|
J:128912
|
Nipsnap1tm1Eoa/Nipsnap1tm1Eoa
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
decreased physiological sensitivity to xenobiotic
|
J:183272
|
Nit1tm1.1Hbn/Nit1tm1.1Hbn
(involves: 129X1/SvJ * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:115052
|
Nit1tm1Hbn/Nit1tm1.1Hbn
(involves: 129X1/SvJ * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:115052
|
Nlrp6tm1Flv/Nlrp6tm1Flv
(B6.Cg-Nlrp6tm1Flv)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:173245
|
Nlrp6tm1Macha/Nlrp6tm1Macha
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased incidence of tumors by chemical induction
|
J:173352
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:173352
|
Nlrp12tm1Tdk/Nlrp12tm1Tdk
(B6.Cg-Nlrp12tm1Tdk)
|
increased incidence of tumors by chemical induction
|
J:178951
|
Nmitm1.1Geno/Nmitm1.1Geno Tg(KRT14-cre)1Amc/0
(B6.Cg-Nmitm1.1Geno Tg(KRT14-cre)1Amc)
|
increased incidence of tumors by chemical induction
|
J:261035
|
Nmral1tm1.1(KOMP)Vlcg/Nmral1tm1.1(KOMP)Vlcg
(C57BL/6N-Nmral1tm1.1(KOMP)Vlcg/MbpMmucd)
|
decreased bronchoconstrictive response
|
J:211773
|
Nod2tm1Mka/Nod2tm1Mka
(involves: C57BL/6)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:96128
|
Nos1tm1Plh/Nos1+
(B6.129S4-Nos1tm1Plh)
|
abnormal physiological response to xenobiotic
|
J:105579
|
Nos1tm1Plh/Nos1tm1Plh
(involves: 129S4/SvJae * C57BL/6)
|
increased physiological sensitivity to xenobiotic
|
J:106328
|
Nos1tm1Plh/Nos1tm1Plh
(involves: 129S4/SvJae)
|
decreased susceptibility to neuronal excitotoxicity
|
J:111644
|
Nos1tm1Plh/Nos1tm1Plh
(B6.129S4-Nos1tm1Plh)
|
decreased susceptibility to neuronal excitotoxicity
|
J:150557
|
Nos1aptm1Tsso/Nos1aptm1Tsso
(involves: C57BL/6JJcl)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:268528
|
Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae)
|
increased susceptibility to neuronal excitotoxicity
|
J:111644
|
Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:108540
|
Nos3tm1Plh/Nos3tm1Plh Ptgs1tm1Unc/Ptgs1tm1Unc
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:108540
|
Nox4tm1Kkr/Nox4tm1Kkr
(B6.129-Nox4tm1Kkr)
|
decreased physiological sensitivity to xenobiotic
|
J:199354
|
Npas4tm1Ooe/Npas4tm1Ooe
(involves: 129/Sv * C57BL/6)
|
increased susceptibility to neuronal excitotoxicity
|
J:145569
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:145569
|
Nppctm1.1Fgr/Nppctm1.1Fgr
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased physiological sensitivity to xenobiotic
|
J:153212
|
Npsr1tm1Bhk/Npsr1tm1Bhk
(129S/SvEv-Npsr1tm1Bhk)
|
abnormal physiological response to xenobiotic
|
J:144688
|
Npy1rtm1.1Wpg/Npy1rtm1.1Wpg
(involves: 129X1/SvJ * C57BL/6)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:124729
|
Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
(involves: 129X1/SvJ * C57BL/6)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:124729
|
Nr1h3tm1.1Djm/Nr1h3tm1.1Djm Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S/SvEv * C57BL/6 * DBA)
|
decreased physiological sensitivity to xenobiotic
|
J:184536
|
Nr1i2tm1(NR1I2)Arte/Nr1i2tm1(NR1I2)Arte
(involves: C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:140975
|
increased physiological sensitivity to xenobiotic
|
J:140975
|
Nr1i2tm1(NR1I2)Arte/Nr1i2tm1(NR1I2)Arte Nr1i3tm1.1Arte/Nr1i3tm1.1Arte
(involves: C57BL/6NTac)
|
decreased physiological sensitivity to xenobiotic
|
J:140975
|
Nr1i2tm1Rev/Nr1i2tm1Rev
(involves: 129S4/SvJae * C57BL/6J)
|
decreased physiological sensitivity to xenobiotic
|
J:63639
|
Nr1i2tm1Sakl/Nr1i2tm1Sakl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal physiological response to xenobiotic
|
J:103505
|
decreased physiological sensitivity to xenobiotic
|
J:103235
|
Nr1i2tm3Arte/Nr1i2tm3Arte
(involves: C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:140975
|
Nr1i2tm3Arte/Nr1i2tm3Arte Nr1i3tm1.1Arte/Nr1i3tm1.1Arte
(involves: C57BL/6NTac)
|
decreased physiological sensitivity to xenobiotic
|
J:140975
|
Nr1i3tm1(NR1I3)Arte/Nr1i3tm1(NR1I3)Arte
(involves: C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:140975
|
increased physiological sensitivity to xenobiotic
|
J:140975
|
Nr1i3tm1.1Arte/Nr1i3tm1.1Arte
(involves: C57BL/6NTac)
|
decreased physiological sensitivity to xenobiotic
|
J:140975
|
Nr1i3tm1Ddm/Nr1i3tm1Ddm
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:65416,
J:82748,
J:83102
|
Nr1i3tm1Ddm/Nr1i3tm1Ddm Tg(Alb1-NR1I3)1Ddm/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased physiological sensitivity to xenobiotic
|
J:83102
|
Nr1i3tm1Dgen/Nr1i3tm1Dgen
(involves: 129)
|
decreased physiological sensitivity to xenobiotic
|
J:89824
|
Nr3c1tm1Dage/Nr3c1+
(involves: 129P1/ReJ * C57BL/6 * C57BL/6J * SJL)
|
abnormal physiological response to xenobiotic
|
J:147914
|
Nr3c1tm1Dage/Nr3c1tm1Dage
(involves: 129P1/ReJ * C57BL/6 * C57BL/6J * SJL)
|
abnormal physiological response to xenobiotic
|
J:147914
|
Nr3c1tm2.1Ljm/Nr3c1tm2.1Ljm Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
decreased susceptibility to neuronal excitotoxicity
|
J:197150
|
Nr3c1tm2Gsc/Nr3c1tm2Gsc Tg(Lck-cre)I57Jxm/0
(B6.Cg-Nr3c1tm2Gsc Tg(Lck-cre)I57Jxm)
|
decreased physiological sensitivity to xenobiotic
|
J:137157
|
Nr4a2tm1Tpe/Nr4a2+ Nr4a3tm1Dgen/Nr4a3tm1Dgen
(involves: 129P2/OlaHsd)
|
increased susceptibility to neuronal excitotoxicity
|
J:162076
|
Nrastm1Tyj/Nras+ Tg(Vil1-cre)20Syr/0
(involves: C57BL/6 * DBA/2)
|
decreased physiological sensitivity to xenobiotic
|
J:132357
|
Nrg1tm1Cbm/Nrg1+
(involves: 129P2/OlaHsd)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:100313
|
Ntrk2tm1Bxu/Ntrk2tm1Bxu
(involves: 129 * C57BL/6)
|
increased susceptibility to dopaminergic neuron neurotoxicity
|
J:170724
|
Ntstm1Dob/Ntstm1Dob
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal physiological response to xenobiotic
|
J:80590
|
Nudt1tm1Tts/Nudt1tm1Tts Ogg1tm1Yun/Ogg1tm1Yun
(involves: 129S/SvEv * C57BL/6JJcl)
|
increased susceptibility to neuronal excitotoxicity
|
J:193978
|
Ociad1tm1.1Msin/Ociad1tm1.1Msin
(involves: BALB/cJ * C57BL/6NCrlj * CBA/JNCrlj)
|
increased physiological sensitivity to xenobiotic
|
J:279239
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:279239
|
Ogg1tm1Yun/Ogg1tm1Yun
(involves: 129S/SvEv * C57BL/6JJcl)
|
increased susceptibility to neuronal excitotoxicity
|
J:193978
|
Oprd1tm1.1Cgrf/Oprd1tm1.1Cgrf Scn10atm2(cre)Jwo/Scn10a+
(involves: 129 * C57BL/6J)
|
decreased physiological sensitivity to xenobiotic
|
J:208176
|
Oprd1tm1.2Cgrf/Oprd1tm1.2Cgrf
(involves: 129 * C57BL/6J)
|
decreased physiological sensitivity to xenobiotic
|
J:208176
|
Oprd1tm1Jep/Oprd1tm1Jep Oprm1tm1Jep/Oprm1tm1Jep Oprm1tm1Jep/Oprm1tm1Jep
(involves: 129S/SvEv * 129S2/SvPas)
|
abnormal physiological response to xenobiotic
|
J:124042
|
Oprm1tm1.2Cgrf/Oprm1tm1.2Cgrf
(involves: 129 * C57BL/6 * C57BL/6J * SJL)
|
decreased physiological sensitivity to xenobiotic
|
J:207536
|
Oprm1tm1Lex/Oprm1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6NTac)
|
decreased physiological sensitivity to xenobiotic
|
J:170718
|
Oprm1tm1Loh/Oprm1+
(involves: 129P2/OlaHsd)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:47187
|
Oprm1tm1Loh/Oprm1tm1Loh
(involves: 129P2/OlaHsd)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:47187
|
Oprm1tm1Uhl/Oprm1+
(either: B6.129S7-Oprm1tm1Uhl or (involves: 129S7/SvEvBrd))
|
decreased physiological sensitivity to xenobiotic
|
J:106256
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:106256
|
Oprm1tm1Uhl/Oprm1tm1Uhl
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:106256
|
Or55b4em1Lsj/Or55b4em1Lsj
(involves: C57BL/6J)
|
decreased physiological sensitivity to xenobiotic
|
J:252600
|
Osbpl3tm1c(EUCOMM)Wtsi/Osbpl3tm1c(EUCOMM)Wtsi Tg(KRT14-cre)1Amc/0
(involves: C57BL/6 * C57BL/6N * CBA)
|
increased incidence of tumors by chemical induction
|
J:341532
|
Otub2tm1.1Gpt/Otub2+
(involves: C57BL/6JGpt)
|
increased incidence of tumors by chemical induction
|
J:330595
|
Otub2tm1.1Gpt/Otub2tm1.1Gpt
(involves: C57BL/6JGpt)
|
increased incidence of tumors by chemical induction
|
J:330595
|
Otud5tm1Vmd/Otud5tm1Vmd Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:219495
|
Otx2tm6Asim/Otx2tm11Asim Slc6a3tm1.1(cre)Bkmn/Slc6a3+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
increased susceptibility to dopaminergic neuron neurotoxicity
|
J:166896
|
P2ry13tm1Loma/P2ry13tm1Loma
(B6.129-P2ry13tm1Loma)
|
decreased physiological sensitivity to xenobiotic
|
J:166205
|
Paqr3tm1Ychn/Paqr3+
(involves: 129 * C57BL/6J)
|
increased incidence of tumors by chemical induction
|
J:139058
|
Paqr3tm1Ychn/Paqr3tm1Ychn
(involves: 129 * C57BL/6J)
|
increased incidence of tumors by chemical induction
|
J:139058
|
Par1M. spretus/Par1M. spretus
(involves: A/J * M. spretus)
|
decreased incidence of tumors by chemical induction
|
J:120319
|
Par2A/J/? Politm1.1Lgh/Poli+
(involves: A/J * C57BL/6J)
|
increased incidence of tumors by chemical induction
|
J:212610
|
Par2BALB/c/?
(involves: A/J * BALB/c)
|
decreased incidence of tumors by chemical induction
|
J:36219
|
Par3A/J/Par3SM/J
(involves: A/J * SM/J)
|
decreased incidence of tumors by chemical induction
|
J:67468
|
Par3SM/J/Par3SM/J
(involves: A/J * SM/J)
|
decreased incidence of tumors by chemical induction
|
J:67468
|
Pargtm1Zqw/Pargtm1Zqw
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:92244
|
Park7Gt(XE726)Byg/Park7Gt(XE726)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to dopaminergic neuron neurotoxicity
|
J:134826
|
Park7tm1Dsp/Park7tm1Dsp
(B6.129P2-Park7tm1Dsp)
|
abnormal physiological response to xenobiotic
|
J:97366
|
Parp1tm1Hsmm/Parp1tm1Hsmm
(involves: 129S4/SvJae)
|
decreased physiological sensitivity to xenobiotic
|
J:53360
|
Parp1tm1Zqw/Parp1tm1Zqw
(involves: 129S2/SvPas * C57BL/6)
|
decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:23942
|
Parp1tm1Zqw/Parp1tm1Zqw
(129S-Parp1tm1Zqw/J)
|
decreased physiological sensitivity to xenobiotic
|
J:96548
|
Parp12tm1.1(KOMP)Vlcg/Parp12tm1.1(KOMP)Vlcg
(C57BL/6N-Parp12tm1.1(KOMP)Vlcg/MbpMmucd)
|
decreased bronchoconstrictive response
|
J:211773
|
Pas1cBALB/cOlaHsd/Pas1cBALB/cOlaHsd
(involves: A/JOlaHsd * BALB/cOlaHsd)
|
increased incidence of tumors by chemical induction
|
J:50533
|
Pas5bA/JOlaHsd/Pas5bA/JOlaHsd
(involves: A/JOlaHsd * BALB/cOlaHsd)
|
increased incidence of tumors by chemical induction
|
J:50533
|
Pas7A/JOlaHsd/Pas7A/JOlaHsd
(involves: A/JOlaHsd * BALB/cOlaHsd)
|
increased incidence of tumors by chemical induction
|
J:50533
|
Pas8A/JOlaHsd/Pas8A/JOlaHsd
(involves: A/JOlaHsd * BALB/cOlaHsd)
|
increased incidence of tumors by chemical induction
|
J:50533
|
Pas8A/JOlaHsd/Pas8BALB/cOlaHsd
(involves: A/JOlaHsd * BALB/cOlaHsd)
|
increased incidence of tumors by chemical induction
|
J:50533
|
Pas9A/JOlaHsd/Pas9A/JOlaHsd
(involves: A/JOlaHsd * BALB/cOlaHsd)
|
decreased incidence of tumors by chemical induction
|
J:50533
|
Pas17C57BL/6JBy/Pas17C57BL/6JBy Politm1.1Lgh/Poli+
(involves: C57BL/6J)
|
increased incidence of tumors by chemical induction
|
J:212610
|
Pas17C57BL/6JBy/Pas17C57BL/6JBy Politm1.1Lgh/Politm1.1Lgh
(involves: C57BL/6J)
|
increased incidence of tumors by chemical induction
|
J:212610
|
Pcsk1tm1Dfs/Pcsk1tm1Dfs
(involves: 129 * C57BL/6J)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:184882
|
PctmBALB/cAnPt/PctmBALB/cAnPt
(involves: BALB/cAnPt * DBA/2N)
|
decreased incidence of tumors by chemical induction
|
J:15235
|
PctmBALB/cAnPt/PctmDBA/2N
(involves: BALB/cAnPt * DBA/2N)
|
increased incidence of tumors by chemical induction
|
J:15235
|
PctsBALB/cAnPt/PctsBALB/cAnPt
(involves: BALB/cAnPt * DBA/2N)
|
increased incidence of tumors by chemical induction
|
J:15235
|
Pdctm1Luhe/Pdctm1Luhe
(B6.129P2-Pdctm1Luhe)
|
increased physiological sensitivity to xenobiotic
|
J:155373
|
Pde8atm1Dgen/Pde8atm1Dgen Pde8btm1Dgen/Pde8btm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:203335
|
Pde8btm1Dgen/Pde8btm1Dgen
(B6.129P2-Pde8btm1Dgen)
|
decreased physiological sensitivity to xenobiotic
|
J:203335
|
Pdgfrbtm1Msas/Pdgfrbtm1Msas Tg(Nes-cre)1Nogu/?
(involves: 129 * C57BL/6)
|
increased susceptibility to neuronal excitotoxicity
|
J:110616
|
Peli1tm1Tigm/Peli1tm1Tigm
(involves: 129/Sv * C57BL/6)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:152781
|
Penk-rstm1Pig/Penk-rstm1Pig
(B6.129-Penk-rstm1Pig)
|
decreased physiological sensitivity to xenobiotic
|
J:66732
|
Penk-rstm1Pig/Penk-rstm1Pig
(B6.129-Penk-rstm1Pig/J)
|
decreased physiological sensitivity to xenobiotic
|
J:98226
|
Pfn4tm1b(KOMP)Wtsi/Pfn4tm1b(KOMP)Wtsi
(C57BL/6N-Pfn4tm1b(KOMP)Wtsi/MbpMmucd)
|
decreased bronchoconstrictive response
|
J:211773
|
Pgcem1Hcz/Pgcem1Hcz
(Not Specified)
|
decreased incidence of tumors by chemical induction
|
J:338079
|
Pglyrp1tm1Rdz/Pglyrp1tm1Rdz
(involves: 129S5/SvEvBrd * BALB/c)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:178053
|
Pglyrp2tm1Rdz/Pglyrp2tm1Rdz
(involves: 129S/SvEv * BALB/c)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:178053
|
Pglyrp3tm1Rdz/Pglyrp3tm1Rdz
(involves: 129S6/SvEvTac * BALB/c)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:178053
|
Pglyrp4tm1Rdz/Pglyrp4tm1Rdz
(involves: 129S6/SvEvTac * BALB/c)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:178053
|
Phf24tm1.2(HBEGF)Azmo/Phf24tm1.2(HBEGF)Azmo
(involves: 129 * BALB/cJ * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:218052
|
Pik3catm1Jdo/Pik3catm1Jdo
(B6.129S7(Cg)-Pik3catm1Jdo)
|
decreased incidence of tumors by chemical induction
|
J:122866
|
Pik3cbtm1.1Jdo/Pik3cbtm1.1Jdo
(involves: C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:198414
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:198414
|
Pla2g4atm1Jvb/Pla2g4atm1Jvb
(involves: 129S4/SvJae)
|
decreased physiological sensitivity to xenobiotic
|
J:120035,
J:278285
|
decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:120035
|
Pla2g4atm1Jvb/Pla2g4atm1Jvb
(involves: 129S4/SvJae * C57BL/6J)
|
decreased incidence of tumors by chemical induction
|
J:91526
|
Pla2g5tm1.1Kiku/Pla2g5tm1.1Kiku
(involves: 129 * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:186024
|
Plautm1.1Bug/Plautm1.1Bug
(involves: C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:164542
|
Plce1tm1Tkat/Plce1+
(involves: 129/Sv * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:94952
|
decreased physiological sensitivity to xenobiotic
|
J:94952
|
Plce1tm1Tkat/Plce1tm1Tkat
(involves: 129/Sv * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:94952
|
decreased physiological sensitivity to xenobiotic
|
J:94952
|
Plcl1tm1.1Matk/Plcl1tm1.1Matk
(FVB.Cg-Plcl1tm1.1Matk)
|
increased incidence of tumors by chemical induction
|
J:207384
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:207384
|
Plcl1tm1.1Matk/Plcl1tm1.1Matk
(involves: C57BL/6 * FVB)
|
increased incidence of tumors by chemical induction
|
J:207384
|
Plcl1tm1Mh/Plcl1tm1Mh
(involves: 129/Sv * C57BL/6)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:92956
|
Plcl1tm2.1Matk/Plcl1tm2.1Matk
(FVB.Cg-Plcl1tm2.1Matk)
|
increased incidence of tumors by chemical induction
|
J:207384
|
Plgtm1Jld/Plgtm1Jld
(B6.129P2-Plgtm1Jld/J)
|
decreased susceptibility to neuronal excitotoxicity
|
J:141739
|
Plppr5em2Gpt/Plppr5em2Gpt
(C57BL/6-Plppr5em2Gpt)
|
decreased physiological sensitivity to xenobiotic
|
J:324004
|
plt/plt
(either: B6.DDD-plt or C.DDD-plt)
|
abnormal physiological response to xenobiotic
|
J:110910
|
Pms2tm1Lisk/Pms2+
(involves: 129S2/SvPas)
|
increased incidence of tumors by chemical induction
|
J:61787
|
Pnpla6tm1Blw/Pnpla6+
(involves: 129S6/SvEvTac * C57BL/6J)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:82791
|
Pofut2Gt(RST434)Byg/Pofut2Gt(RST434)Byg
(involves: 129P2/OlaHsd)
|
abnormal physiological response to xenobiotic
|
J:165751
|
Politm1.1Lgh/Politm1.1Lgh Tg(gptdelta)1Nmi/0
(involves: C57BL/6J)
|
increased incidence of tumors by chemical induction
|
J:212610
|
Pomctm1Low/Pomctm1Low
(B6.129S2-Pomctm1Low)
|
increased physiological sensitivity to xenobiotic
|
J:115712
|
Pon1tm1Lus/Pon1tm1Lus
(involves: 129X1/SvJ * C57BL/6J)
|
increased physiological sensitivity to xenobiotic
|
J:63392
|
Ppardtm1Jps/Ppardtm1Jps
(involves: 129/Sv * C57BL/6N)
|
increased incidence of tumors by chemical induction
|
J:90337,
J:90217
|
Ppargtm1.1Gonz/Ppargtm1.1Gonz Tg(Aqp2-cre)1Dek/0
(involves: 129X1/SvJ * C57BL/6 * SJL)
|
abnormal physiological response to xenobiotic
|
J:99873
|
Ppargtm1Tka/Pparg+
(involves: C57BL/6 * CBA)
|
increased incidence of tumors by chemical induction
|
J:98823
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:98823
|
Ppargc1atm1.1Amos/Ppargc1atm1.1Amos
(involves: C57BL/6JOlaHsd)
|
increased incidence of tumors by chemical induction
|
J:171361
|
Ppp1r1btm1Aaf/Ppp1r1btm1Aaf
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased physiological sensitivity to xenobiotic
|
J:78045
|
Ppp1r1btm1Aaf/Ppp1r1btm1Aaf
(Not Specified)
|
decreased physiological sensitivity to xenobiotic
|
J:54156
|
Ppp1r1btm1Pggd/Ppp1r1btm1Pggd
(involves: 129 * C57BL/6)
|
abnormal physiological response to xenobiotic
|
J:106270
|
Ppp1r1btm3Pggd/Ppp1r1btm3Pggd
(involves: 129 * C57BL/6)
|
abnormal physiological response to xenobiotic
|
J:106270
|
Ppp1r9btm1Jfe/Ppp1r9btm1Jfe
(involves: 129X1/SvJ * C57BL/6)
|
decreased susceptibility to neuronal excitotoxicity
|
J:77284
|
Ppp2r1atm1.2Wltr/Ppp2r1a+
(FVB.129S1-Ppp2r1atm1.2Wltr)
|
increased incidence of tumors by chemical induction
|
J:175748
|
Ppp2r1atm1.2Wltr/Ppp2r1atm2.1Wltr
(FVB.129-Ppp2r1atm1.2Wltr/Ppp2r1atm2.1Wltr)
|
increased incidence of tumors by chemical induction
|
J:175748
|
Ppp2r1atm2.1Wltr/Ppp2r1a+
(FVB.129-Ppp2r1atm2.1Wltr)
|
increased incidence of tumors by chemical induction
|
J:175748
|
Ppp2r5aGt(IST13127C10)Tigm/Ppp2r5aGt(IST13127C10)Tigm
(involves: C57BL/6N * FVB/N)
|
increased incidence of tumors by chemical induction
|
J:254808
|
Ppp6ctm1Shma/Ppp6ctm1Shma Tg(KRT14-cre/ERT)20Efu/0
(involves: C57BL/6 * CBA * CD-1)
|
increased incidence of tumors by chemical induction
|
J:231809
|
Prdx1tm1Yu/Prdx1tm1Yu
(Not Specified)
|
decreased incidence of tumors by chemical induction
|
J:306075
|
Prf1tm1Sdz/Prf1tm1Sdz
(NOD.B6-Prf1tm1Sdz)
|
increased physiological sensitivity to xenobiotic
|
J:43468
|
Prima1tm1Vebe/Prima1tm1Vebe
(involves: C57BL/6 * DBA/2)
|
increased physiological sensitivity to xenobiotic
|
J:147425
|
Prkab2tm1.1Grst/Prkab2tm1.1Grst
(involves: C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:167339
|
Prkar1atm1Lsk/Prkar1atm1Lsk Tg(Akr1b7-cre)1Anm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased physiological sensitivity to xenobiotic
|
J:161521
|
Prkchtm1Cda/Prkchtm1Cda
(involves: 129S/SvEv * C57BL/6J)
|
increased incidence of tumors by chemical induction
|
J:83498
|
Prkcqtm1Litt/Prkcqtm1Litt
(B6.129P2-Prkcqtm1Litt)
|
decreased physiological sensitivity to xenobiotic
|
J:94285
|
Prkdcdxnph/Prkdcdxnph
(BALB/cJ)
|
increased physiological sensitivity to xenobiotic
|
J:96632
|
Prkdcdxnph/Prkdcdxnph
(129X1/SvJ)
|
increased physiological sensitivity to xenobiotic
|
J:96632
|
Prodh2em1Jkni/Prodh2em1Jkni
(involves: C57BL/6J)
|
decreased physiological sensitivity to xenobiotic
|
J:283585
|
Psen1tm1Mpm/Psen1tm1Mpm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased susceptibility to neuronal excitotoxicity
|
J:51950
|
Ptentm2Mak/Ptentm2Mak Tg(Fabp1-cre)1Jig/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
increased incidence of tumors by chemical induction
|
J:113388
|
Ptentm2Mak/Ptentm2Mak Tg(SFTPC-rtTA)5Jaw/0 Tg(tetO-cre)1Jaw/0
(involves: 129 * 129P2/OlaHsd * C57BL/6 * C57BL/6J)
|
increased incidence of tumors by chemical induction
|
J:127405
|
Ptger1tm1Sna/Ptger1tm1Sna
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal physiological response to xenobiotic
|
J:103150
|
increased physiological sensitivity to xenobiotic
|
J:103150
|
Ptger1tm1Sna/Ptger1tm1Sna
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased physiological sensitivity to xenobiotic
|
J:59509
|
Ptger1tm1Sna/Ptger1tm1Sna
(involves: 129P2/OlaHsd * C57BL/6Cr)
|
abnormal physiological response to xenobiotic
|
J:95533
|
decreased incidence of tumors by chemical induction
|
J:95533
|
Ptger2tm1.1Kand/Ptger2tm1.1Kand Tg(ITGAM-cre)2781Gkl/0
(involves: C57BL/6 * CBA)
|
decreased physiological sensitivity to xenobiotic
|
J:202677
|
increased physiological sensitivity to xenobiotic
|
J:202677
|
Ptger2tm1Brey/Ptger2tm1Brey
(involves: 129S6/SvEvTac)
|
decreased incidence of tumors by chemical induction
|
J:116015
|
Ptger3tm1Sna/Ptger3tm1Sna
(B6.129P2-Ptger3tm1Sna/Sna)
|
abnormal physiological response to xenobiotic
|
J:105574
|
Ptger4tm1Sna/Ptger4tm1Sna
(involves: 129P2/OlaHsd * C57BL/6Cr)
|
decreased incidence of tumors by chemical induction
|
J:73944
|
Ptgs1tm1Unc/Ptgs1tm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:146321
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:60668
|
Ptgs1tm1Unc/Ptgs1tm1Unc
(B6;129P2-Ptgs1tm1Unc/Tac)
|
decreased physiological sensitivity to xenobiotic
|
J:103642
|
Ptgs1tm1Unc/Ptgs1tm1Unc
(B6.129P2-Ptgs1tm1Unc)
|
decreased physiological sensitivity to xenobiotic
|
J:115589
|
increased bronchoconstrictive response
|
J:141201
|
Ptgs2tm1Jed/Ptgs2tm1Jed
(B6;129S-Ptgs2tm1Jed/J)
|
decreased physiological sensitivity to xenobiotic
|
J:103642
|
Ptgs2tm1Unc/Ptgs2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:158426
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:158426,
J:60668
|
Ptgs2tm1Unc/Ptgs2tm1Unc
(B6.129P2-Ptgs2tm1Unc)
|
decreased susceptibility to neuronal excitotoxicity
|
J:67211
|
Ptgs2tm1Unc/Ptgs2tm1Unc
(B6;129P2-Ptgs2tm1Unc/Tac)
|
increased susceptibility to neuronal excitotoxicity
|
J:141610
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:141610
|
Ptgs2tm1Unc/Ptgs2tm2.1Hahe
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:158426
|
Ptk2tm1.1Jtpa/Ptk2tm1.1Jtpa
(B6.129P2-Ptk2tm1.1Jtpa)
|
increased physiological sensitivity to xenobiotic
|
J:142317
|
Ptk2tm1Gwm/Ptk2tm1Gwm Tg(KRT14-cre/ERT2)1Ipc/0
(involves: 129P2/OlaHsd * FVB)
|
decreased incidence of tumors by chemical induction
|
J:94680
|
Ptp4a3tm1.1Geh/Ptp4a3tm1.1Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased incidence of tumors by chemical induction
|
J:194458
|
Ptpn11tm1Gsf/Ptpn11tm1Gsf Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
increased incidence of tumors by chemical induction
|
J:172422
|
Ptpn11tm1Gsf/Ptpn11tm1Gsf Stat3tm1Vpo/Stat3tm1Vpo Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
increased incidence of tumors by chemical induction
|
J:172422
|
Ptpn22tm1.1Draw/Ptpn22tm1.1Draw
(involves: 129 * C57BL/6)
|
increased physiological sensitivity to xenobiotic
|
J:201448
|
PtprjScc1-r/PtprjScc1-r
(involves: BALB/cHeA * STS/A)
|
decreased incidence of tumors by chemical induction
|
J:31355
|
Ptprttm1Sata/Ptprttm1Sata
(B6.129P2-Ptprttm1Sata)
|
increased incidence of tumors by chemical induction
|
J:157542
|
Ptprvtm1Asmi/Ptprvtm1Asmi
(involves: 129P2/OlaHsd)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:126780
|
Pvrtm1Hfuk/Pvr+
(involves: 129X1/SvJ * C57BL/6 * DBA)
|
decreased incidence of tumors by chemical induction
|
J:143250
|
decreased physiological sensitivity to xenobiotic
|
J:143250
|
Pvrtm1Hfuk/Pvrtm1Hfuk
(involves: 129X1/SvJ * C57BL/6 * DBA)
|
decreased incidence of tumors by chemical induction
|
J:143250
|
decreased physiological sensitivity to xenobiotic
|
J:143250
|
Pycardtm1Ayaz/Pycardtm1Ayaz Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased incidence of tumors by chemical induction
|
J:191239
|
Rab11atm1.1Ngao/Rab11atm1.1Ngao Tg(Vil1-cre)997Gum/0
(involves: 129S4/SvJae * C57BL/6J * SJL)
|
increased incidence of tumors by chemical induction
|
J:278932
|
Rad52tm1Aps/Rad52tm1Aps Rad54ltm1Jhjh/Rad54ltm1Jhjh
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:101697
|
Rad54btm1Roka/Rad54btm1Roka
(involves: 129P2/OlaHsd)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:105544
|
Rad54btm1Roka/Rad54btm1Roka Rad54ltm1Jhjh/Rad54ltm1Jhjh
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:105544
|
Rad54ltm1Jhjh/Rad54ltm1Jhjh
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:101697
|
Rae1tm1Jvd/Rae1+
(Not Specified)
|
increased incidence of tumors by chemical induction
|
J:81546
|
Ralgapa2tm1Hhor/Ralgapa2tm1Hhor
(C57BL/6J-Ralgapa2tm1Hhor)
|
increased incidence of tumors by chemical induction
|
J:193368
|
Ralgdstm1Cjm/Ralgdstm1Cjm
(involves: 129X1/SvJ * MF1)
|
decreased incidence of tumors by chemical induction
|
J:96936
|
Ranbp2tm1Jvd/Ranbp2tm1.1Jvd
(involves: 129/Sv * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:137482
|
Ranbp2tm1Jvd/Ranbp2tm1Jvd
(involves: 129/Sv * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:137482
|
Rangrftm1.1Tke/Rangrftm1.1Tke
(involves: C57BL/6)
|
increased physiological sensitivity to xenobiotic
|
J:325055
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:325055
|
Rargtm1Blt/Rargtm1Blt
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased physiological sensitivity to xenobiotic
|
J:27473
|
Rasd1tm1.1Snyd/Rasd1tm1.1Snyd
(involves: C57BL/6)
|
decreased susceptibility to neuronal excitotoxicity
|
J:195135
|
Rassf1tm1Gpp/Rassf1+
(involves: 129S1/SvImJ * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:95683
|
Rassf1tm1Gpp/Rassf1tm1Gpp
(involves: 129S1/SvImJ * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:95683
|
Rassf5tm1Sblee/Rassf5tm1Sblee
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:166871
|
Rbfox1tm1.1Dblk/Rbfox1+ Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * SJL)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:176189
|
Rbfox1tm1.1Dblk/Rbfox1tm1.1Dblk Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * SJL)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:176189
|
Rbfox3tm1a(EUCOMM)Hmgu/Rbfox3tm1a(EUCOMM)Hmgu
(B6Dnk;B6N-Rbfox3tm1a(EUCOMM)Hmgu/H)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:234043
|
Relatm1Asba/Relatm1Asba Tg(Vil1-cre)997Gum/0
(involves: 129 * C57BL/6J * SJL)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:131977
|
Relatm1Rsch/Relatm1Rsch Ptf1atm1(cre)Hnak/?
(involves: C57BL/6)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:122194
|
Ren1tm1.2Sig/Ren1tm1.2Sig
(involves: C57BL/6J)
|
decreased physiological sensitivity to xenobiotic
|
J:169129
|
Retnlbtm1Lex/Retnlbtm1Lex
(FVB.129S5-Retnlbtm1Lex)
|
increased incidence of tumors by chemical induction
|
J:235058
|
Retnlbtm1Lex/Retnlbtm1Lex
(B6.129S5-Retnlbtm1Lex)
|
decreased incidence of tumors by chemical induction
|
J:235058
|
Rgs4tm1.1Amus/Rgs4tm1.1Amus
(B6.129-Rgs4tm1.1Amus)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:195186
|
Rhbdd1tm1.1Mfm/Rhbdd1tm1.1Mfm
(involves: 129S/SvEv * C57BL/6J)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:346394
|
Rhbdd3tm1Caox/Rhbdd3tm1Caox
(B6.129S6-Rhbdd3tm1Caox)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:197348
|
Rhobtm1Gcp/Rhobtm1Gcp
(involves: 129)
|
increased incidence of tumors by chemical induction
|
J:71577
|
Rhojtm1.2Auem/Rhojtm1.2Auem
(B6.Cg-Rhojtm1.2Auem)
|
increased physiological sensitivity to xenobiotic
|
J:208154
|
Riok2tm1c(KOMP)Wtsi/Riok2+ Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/6N * C57BL/10 * CBA/Ca)
|
increased physiological sensitivity to xenobiotic
|
J:305794
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:305794
|
Riox2tm1Mtsun/Riox2tm1Mtsun
(B6CrSlc.Cg-Riox2tm1Mtsun)
|
decreased physiological sensitivity to xenobiotic
|
J:201871
|
Rnf20Gt(RRJ249)Byg/Rnf20+
(involves: 129P2/OlaHsd)
|
increased incidence of tumors by chemical induction
|
J:268221
|
Rnf186em1Ktak/Rnf186em1Ktak
(involves: C57BL/6 * DBA/2)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:258197
|
Rnf186tm1Ktak/Rnf186tm1Ktak
(involves: 129S4/SvJae * C57BL/6)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:258197
|
Rps6ka5tm1Jsca/Rps6ka5tm1Jsca
(Not Specified)
|
increased susceptibility to neuronal excitotoxicity
|
J:172062
|
Rr250em1Ebres/Rr250em1Ebres
(C57BL/6N-Rr250em1Ebres)
|
increased physiological sensitivity to xenobiotic
|
J:270526
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:270526
|
Runx1tm3Spe/Runx1tm3Spe Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
increased incidence of tumors by chemical induction
|
J:267082
|
Runx1tm3Spe/Runx1tm3Spe U2af1tm1.1Hev/U2af1+ Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * 129S6/SvEvTac * BALB/c * C57BL/6 * CBA/J)
|
increased incidence of tumors by chemical induction
|
J:267082
|
Ryr1em1Tmur/Ryr1+
(Not Specified)
|
increased physiological sensitivity to xenobiotic
|
J:322211
|
increased susceptibility to malignant hyperthermia
|
J:322211
|
Ryr1tm1.1Inp/Ryr1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal physiological response to xenobiotic
|
J:181523
|
increased susceptibility to malignant hyperthermia
|
J:181523
|
Ryr1tm1.1Inp/Ryr1tm1.1Inp
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal physiological response to xenobiotic
|
J:181523
|
increased susceptibility to malignant hyperthermia
|
J:181523
|
Ryr1tm2.1Alle/Ryr1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased susceptibility to malignant hyperthermia
|
J:168222
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:168222
|
Ryr1tm3.1Alle/Ryr1+
(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased physiological sensitivity to xenobiotic
|
J:303297
|
increased susceptibility to malignant hyperthermia
|
J:303297
|
Ryr1tm3.1Alle/Ryr1tm3.1Alle
(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased physiological sensitivity to xenobiotic
|
J:303297
|
increased susceptibility to malignant hyperthermia
|
J:303297
|
Ryr2tm1.1Maya/Ryr2+
(C57BL/6J-Ryr2tm1.1Maya)
|
increased physiological sensitivity to xenobiotic
|
J:159451
|
Ryr2tm1.1Swch/Ryr2+
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
increased physiological sensitivity to xenobiotic
|
J:174541
|
S1pr1tm1.1Thla/S1pr1tm1.1Thla
(B6.Cg-S1pr1tm1.1Thla)
|
decreased physiological sensitivity to xenobiotic
|
J:163389
|
Sdc4tm1Tmu/Sdc4tm1Tmu
(B6.129S2-Sdc4tm1Tmu)
|
increased physiological sensitivity to xenobiotic
|
J:68843,
J:131075
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:68843,
J:131075
|
Sel1ltm1c(KOMP)Wtsi/Sel1ltm1c(KOMP)Wtsi Tg(CAG-cre/Esr1*)5Amc/0
(involves: C57BL/6 * C57BL/6N * CBA * SJL)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:206568
|
Serpine1tm1.1Vlp/Serpine1tm1.1Vlp
(involves: 129 * C57BL/6)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:229191
|
Serpine1tm1Mlg/Serpine1tm1Mlg
(involves: 129S2/SvPas)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:229191
|
Setd7tm1.1Ital/Setd7tm1.1Ital
(involves: C57BL/6 * CBA)
|
decreased physiological sensitivity to xenobiotic
|
J:238299
|
Setd7tm1Frga/Setd7+
(involves: 129 * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:136558
|
Setd7tm1Frga/Setd7tm1Frga
(involves: 129 * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:136558
|
Setxtm1.1Als/Setx+
(involves: 129 * C57BL/6J)
|
increased susceptibility to neuronal excitotoxicity
|
J:320844
|
Sf1Gt(pU17)1Teya/Sf1+
(involves: C57BL/6 * CBA)
|
increased incidence of tumors by chemical induction
|
J:141491
|
Sirt2tm1.1Fwa/Sirt2tm1.1Fwa
(involves: 129S6/SvEvTac * C57BL/6)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:195041
|
Skitm1Cco/Ski+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:73349
|
Skiltm1.1Kluo/Skiltm1.1Kluo
(B6.129P2-Skiltm1.1Kluo)
|
decreased incidence of tumors by chemical induction
|
J:154718
|
Skiltm1Sis/Skil+
(involves: C57BL/6 * CBA)
|
increased incidence of tumors by chemical induction
|
J:62174
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:62174
|
Slc1a3tm1Kta/Slc1a3tm1Kta
(involves: 129P2/OlaHsd)
|
increased susceptibility to ototoxicity-induced hearing loss
|
J:99715
|
Slc3a2tm1.1Merl/Slc3a2+ Tg(Vil1-cre)997Gum/0
(B6.Cg-Slc3a2tm1.1Merl Tg(Vil1-cre)997Gum)
|
decreased incidence of tumors by chemical induction
|
J:173946
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:173946
|
Slc4a1tm1Llp/Slc4a1+
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal physiological response to xenobiotic
|
J:148154
|
Slc4a1tm1Llp/Slc4a1tm1Llp
(involves: 129S4/SvJae * C57BL/6J)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:148154
|
Slc4a8tm1.1Doel/Slc4a8tm1.1Doel
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal physiological response to xenobiotic
|
J:161474
|
Slc5a7tm1Rbl/Slc5a7+
(involves: 129S6/SvEvTac * C57BL/6)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:90846
|
Slc6a2tm1Mca/Slc6a2tm1Mca
(involves: 129S4/SvJaeSor * C57BL/6J)
|
increased physiological sensitivity to xenobiotic
|
J:61825
|
Slc6a2tm1Mca/Slc6a2tm1Mca
(involves: 129S4/SvJaeSor)
|
abnormal physiological response to xenobiotic
|
J:66729
|
Slc6a3tm1.1Jaja/Slc6a3tm1.1Jaja
(B6.129-Slc6a3tm1.1Jaja)
|
decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:180517
|
Slc6a3tm1Rbl/Slc6a3tm1Rbl
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased physiological sensitivity to xenobiotic
|
J:216661
|
Slc6a3tm2Mca/Slc6a3tm2Mca
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal physiological response to xenobiotic
|
J:67549
|
Slc6a4tm1.1Rbl/Slc6a4tm1.1Rbl
(129S6/SvEvTac-Slc6a4tm1.1Rbl)
|
decreased physiological sensitivity to xenobiotic
|
J:170356
|
Slc6a4tm2.1Rbl/Slc6a4tm2.1Rbl
(involves: 129S4/SvJae * 129S6/SvEvTac)
|
increased physiological sensitivity to xenobiotic
|
J:202876
|
Slc7a11m1Mtka/Slc7a11m1Mtka
(C57BL/6-Slc7a11m1Mtka)
|
increased incidence of tumors by chemical induction
|
J:159323
|
Slc10a1tm1Tac/Slc10a1tm1Tac
(either: B6.Cg-Slc10a1tm1Tac or (involves: 129S/SvEv * C57BL/6J))
|
decreased physiological sensitivity to xenobiotic
|
J:274149
|
Slc12a3em3Gpt/Slc12a3em4Gpt
(involves: C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:336073
|
Slc12a3tm1Ges/Slc12a3tm1Ges
(involves: C57BL/6)
|
abnormal physiological response to xenobiotic
|
J:161474
|
Slc17a6tm1Lowl/Slc17a6tm1Lowl Tg(CAG-Bgeo/GFP)21Lbe/0 Tg(Nr5a1-cre)2Lowl/0
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * FVB)
|
decreased physiological sensitivity to xenobiotic
|
J:129860
|
Slc18a2tm1Mca/Slc18a2+
(involves: 129X1/SvJ)
|
decreased physiological sensitivity to xenobiotic
|
J:45184
|
Slc18a2tm1Uhl/Slc18a2+
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased susceptibility to dopaminergic neuron neurotoxicity
|
J:42811
|
Slc18a2tm2Kmo/Slc18a2tm2Kmo
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to dopaminergic neuron neurotoxicity
|
J:70606
|
Slc19a1tm1Rsc/Slc19a1+
(involves: 129P2/OlaHsd * SWV/Fnn)
|
increased physiological sensitivity to xenobiotic
|
J:96380
|
Slc22a1tm1Kmgi/Slc22a1tm1Kmgi
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N)
|
abnormal physiological response to xenobiotic
|
J:122106
|
Slc22a3tm1Dpb/Slc22a3tm1Dpb
(involves: 129P2/OlaHsd)
|
increased susceptibility to dopaminergic neuron neurotoxicity
|
J:180517
|
Slc22a6tm1Dgen/Slc22a6tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased physiological sensitivity to xenobiotic
|
J:108655
|
Slc26a1tm1Mark/Slc26a1tm1Mark
(involves: 129X1/SvJ * CD-1)
|
increased physiological sensitivity to xenobiotic
|
J:158567
|
Slc34a2tm1.1Scc/Slc34a2tm1.1Scc Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: 129 * C57BL/6 * C57BL/6NTac)
|
decreased physiological sensitivity to xenobiotic
|
J:166317
|
Slc35e1em1Cya/Slc35e1em1Cya
(C57BL/6J-Slc35e1em1Cya)
|
decreased physiological sensitivity to xenobiotic
|
J:340684
|
Slc47a1Gt(IST12634F2)Tigm/Slc47a1Gt(IST12634F2)Tigm
(B6.B6N-Slc47a1Gt(IST12634F2)Tigm)
|
increased physiological sensitivity to xenobiotic
|
J:206792
|
Slco1b2tm1Cdk/Slco1b2tm1Cdk
(involves: 129S1/Sv * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:133919
|
Slco1b2tm1Cdk/Slco1b2tm1Cdk
(B6.129S1-Slco1b2tm1Cdk)
|
decreased physiological sensitivity to xenobiotic
|
J:133919
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:133919
|
Slx4tm1a(EUCOMM)Wtsi/Slx4tm1a(EUCOMM)Wtsi
(C57BL/6N-Slx4tm1a(EUCOMM)Wtsi)
|
increased physiological sensitivity to xenobiotic
|
J:188123
|
Smad2tm1.1Epb/Smad2tm1.1Epb Smad3tm1Cxd/Smad3tm1Cxd Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129/Sv * 129S6/SvEvTac * C57BL/6 * DBA * SJL)
|
increased physiological sensitivity to xenobiotic
|
J:119642
|
Smad3tm1Cxd/Smad3tm1Cxd
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal physiological response to xenobiotic
|
J:137529
|
Smad3tm1Sche/Smad3tm1Sche
(B6.129P2-Smad3tm1Sche)
|
abnormal physiological response to xenobiotic
|
J:145114
|
Smarcal1tm1.1Cfbo/Smarcal1tm1.1Cfbo
(either: B6.129-Smarcal1tm1.1Cfbo or (involves: 129 * C57BL/6))
|
increased physiological sensitivity to xenobiotic
|
J:183899
|
Smpd1tm1Esc/Smpd1tm1Esc
(involves: 129S1/Sv)
|
abnormal physiological response to xenobiotic
|
J:199833
|
Sncatm1.1Koks/Snca+
(either: B6.129P2-Sncatm1.1Koks or (involves: 129P2/OlaHsd * C57BL/6))
|
decreased physiological sensitivity to xenobiotic
|
J:201391
|
Sncatm1Rosl/Sncatm1Rosl
(B6.129X1-Sncatm1Rosl)
|
decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:92213
|
Sncatm1Rosl/Sncatm1Rosl Sncgtm1Vlb/Sncgtm1Vlb
(B6.129-Sncatm1Rosl Sncgtm1Vlb)
|
decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:92213
|
Sncatm1Wtd/Sncatm1Wtd
(involves: 129)
|
decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:79993
|
increased physiological sensitivity to xenobiotic
|
J:79993
|
Sncgtm1Vlb/Sncgtm1Vlb
(B6.129P2-Sncgtm1Vlb)
|
decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:92213
|
Socs1tm1Jni/Socs1+
(Not Specified)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:91651
|
Sod1tm1Ysh/Sod1tm1Ysh
(involves: 129X1/SvJ * C57BL/6)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:46672
|
Sod2tm1(tetO-Sod2)Evbo/Sod2+
(involves: 129S4/SvJae * C57BL/6)
|
increased physiological sensitivity to xenobiotic
|
J:162190
|
Sosttm1Dgen/Sosttm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:179873
|
Sostdc1tm1Myan/Sostdc1tm1Myan
(involves: 129X1/SvJ * C57BL/6J)
|
decreased physiological sensitivity to xenobiotic
|
J:105264
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:105264
|
Sox9em1(cre/ERT2)Tchn/Sox9+ Stk26tm2.1Zzh/Stk26tm2.1Zzh
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:322311
|
Sox9em1(cre/ERT2)Tchn/Sox9+ Stk26tm2.1Zzh/Stk26tm2.1Zzh
(involves: C57BL/6 * SJL)
|
increased incidence of tumors by chemical induction
|
J:322311
|
Sphk2Gt(NPX039)Byg/Sphk2Gt(NPX039)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:102911
|
Spint1tm2.1Hk/Spint1tm2.1Hk Tg(Vil1-cre)997Gum/0
(involves: C57BL/6 * C57BL/6J * SJL)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:179937
|
Spp1tm1Blh/Spp1tm1Blh
(involves: 129S6/SvEvTac * Black Swiss)
|
increased physiological sensitivity to xenobiotic
|
J:108144
|
Spp1tm1Blh/Spp1tm1Blh
(B6.129S6-Spp1tm1Blh)
|
decreased physiological sensitivity to xenobiotic
|
J:118432
|
decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:118432
|
Spp1tm1Blh/Spp1tm1Blh
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:119298
|
Spp1tm1Blh/Spp1tm1Blh
(129S6/SvEvTac-Spp1tm1Blh)
|
decreased incidence of tumors by chemical induction
|
J:112122
|
Spp1tm1Rit/Spp1tm1Rit
(B6.129S7-Spp1tm1Rit)
|
decreased physiological sensitivity to xenobiotic
|
J:93915
|
Srrtm1(cre/PGR)Himo/Srrtm1(cre/PGR)Himo
(C57BL/6N-Srrtm1(cre/PGR)Himo)
|
decreased susceptibility to neuronal excitotoxicity
|
J:144030
|
Srxn1tm1Mtol/Srxn1tm1Mtol
(either: B6.129S2-Srxn1tm1Mtol or (involves: 129S2/SvPasCrl * C57BL/6))
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:199277
|
Ssu72tm1Cwl/Ssu72tm1Cwl Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(B6.Cg-Ssu72tm1Cwl Speer6-ps1Tg(Alb-cre)21Mgn)
|
increased physiological sensitivity to xenobiotic
|
J:309624
|
St3gal5tm1Skoz/St3gal5tm1Skoz
(Not Specified)
|
abnormal xenobiotic induced morbidity/mortality
|
J:229230
|
Stag1Gt(P099A04)Wrst/Stag1+
(involves: 129S2/SvPas)
|
decreased incidence of tumors by chemical induction
|
J:184720
|
Stat1tm1Rds/Stat1tm1Rds
(129S6/SvEv-Stat1tm1Rds/Tac)
|
decreased susceptibility to neuronal excitotoxicity
|
J:116659
|
Stat3tm1Vpo/Stat3tm1Vpo Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
increased incidence of tumors by chemical induction
|
J:172422
|
Stat3tm1Xyfu/Stat3tm1.1Xyfu Tg(Myh6-cre)2182Mds/0
(involves: 129S1/Sv * FVB/N)
|
increased physiological sensitivity to xenobiotic
|
J:86400
|
Stat3tm2Aki/Stat3tm2Aki Tg(KRT5-cre/ERT2)AJdg/0
(involves: 129P2/OlaHsd * FVB/N)
|
decreased incidence of tumors by chemical induction
|
J:138529
|
Stk11tm1.2Rdp/Stk11+
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N * SJL)
|
increased incidence of tumors by chemical induction
|
J:131037
|
Stk26tm1.1Zzh/Stk26+ Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
(involves: 129 * 129P2/OlaHsd * C57BL/6 * SJL)
|
increased incidence of tumors by chemical induction
|
J:289548
|
Stk26tm1.1Zzh/Stk26tm1.1Zzh Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
(involves: 129 * 129P2/OlaHsd * C57BL/6 * SJL)
|
increased incidence of tumors by chemical induction
|
J:289548
|
Stk38tm1Hem/Stk38+
(involves: 129P2/Ola * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:185408
|
Stk38tm1Hem/Stk38tm1Hem
(involves: 129P2/Ola * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:185408
|
Strapem1Pkda/Strap+
(involves: C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:245661
|
Surf1tm2.1Zev/Surf1tm2.1Zev
(involves: 129S7/SvEvBrd * C57BL/6 * DBA/2)
|
decreased susceptibility to neuronal excitotoxicity
|
J:117871
|
Taar1m1J/Taar1+
(involves: C57BL/6J * DBA/2J)
|
abnormal physiological response to xenobiotic
|
J:224677
|
Taar1m1J/Taar1m1J
(involves: C57BL/6J * DBA/2J)
|
abnormal physiological response to xenobiotic
|
J:224677
|
Taar1tm1Mmil/Taar1tm1Mmil
(B6.129S2-Taar1tm1Mmil)
|
decreased physiological sensitivity to xenobiotic
|
J:178061
|
increased physiological sensitivity to xenobiotic
|
J:178061
|
Taar1tm1Tdw/Taar1tm1Tdw
(involves: 129S1/Sv * C57BL/6J)
|
increased physiological sensitivity to xenobiotic
|
J:141501
|
Taar6tm1.1(KOMP)Vlcg/Taar6tm1.1(KOMP)Vlcg
(C57BL/6N-Taar6tm1.1(KOMP)Vlcg/MbpMmucd)
|
decreased bronchoconstrictive response
|
J:211773
|
Tacr1tm1Rhn/Tacr1tm1Rhn
(129S/SvEv-Tacr1tm1Rhn)
|
abnormal physiological response to xenobiotic
|
J:77640
|
Taf4tm1Idvd/Taf4tm1Idvd Tg(KRT14-cre/ERT2)1Ipc/0
(involves: C57BL/6 * SJL)
|
increased incidence of tumors by chemical induction
|
J:124111
|
Tcra-Jtm1Tgi/Tcra-Jtm1Tgi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:93915
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:89695
|
Tdp1Gt(XD105)Byg/Tdp1Gt(XD105)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased physiological sensitivity to xenobiotic
|
J:127605
|
Tdp1Gt(XD105)Byg/Tdp1Gt(XD105)Byg
(involves: 129P2/OlaHsd * 129S/SvEv)
|
increased physiological sensitivity to xenobiotic
|
J:127602
|
Tdp2tm1.1Huy/Tdp2tm1.1Huy
(involves: 129P2/OlaHsd * CD-1)
|
increased physiological sensitivity to xenobiotic
|
J:195301
|
Terctm1Rdp/Terctm1Rdp
(involves: 129/Sv * C57BL/6J * SJL)
|
decreased incidence of tumors by chemical induction
|
J:96945
|
Terctm1Rdp/Terctm1Rdp Tg(KRT5-Tert)8043Blas/0
(involves: 129/Sv * C57BL/6 * C57BL/6J * DBA/2 * SJL)
|
decreased incidence of tumors by chemical induction
|
J:96945
|
Terttm1Rdp/Terttm1Rdp
(B6.Cg-Terttm1Rdp)
|
decreased incidence of tumors by chemical induction
|
J:108914
|
Terttm1Rdp/Terttm1Rdp Trp53tm1Tyj/Trp53+
(B6.Cg-Trp53tm1Tyj Terttm1Rdp)
|
increased incidence of tumors by chemical induction
|
J:108914
|
Tfamtm1Lrsn/Tfamtm1Lrsn Tg(Ckmm-cre)1Lrsn/0
(involves: 129S1/Sv * 129X1/SvJ)
|
increased physiological sensitivity to xenobiotic
|
J:51964
|
Tg(Alb1HBV)44Bri/0
(C57BL/6J-Tg(Alb1HBV)44Bri/J)
|
increased incidence of tumors by chemical induction
|
J:223921
|
Tg(Alb-SND1)3aDsar/0
(involves: C57BL/6 * CBA)
|
increased incidence of tumors by chemical induction
|
J:242582
|
Tg(AZIP/F)1Vsn/0
(involves: FVB/N)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:50807
|
Tg(BCL2OVARY)1Ah/0
(involves: FVB)
|
abnormal physiological response to xenobiotic
|
J:55158
|
Tg(CAG-Pgam2)#Hiko/0
(involves: C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:306793
|
Tg(Camk2a-App*,-Apbb1)25Spim/0
(C57BL/6-Tg(Camk2a-App*,-Apbb1)25Spim)
|
increased susceptibility to neuronal excitotoxicity
|
J:153738
|
Tg(CAMK2A-CAST)7Tcs/0
(involves: C57BL/6Cr)
|
decreased susceptibility to neuronal excitotoxicity
|
J:109976,
J:98730
|
Tg(Camk2a-DISC1)10Asaw/0
(C57BL/6-Tg(Camk2a-DISC1)10Asaw)
|
increased physiological sensitivity to xenobiotic
|
J:194985
|
Tg(Camk2a-DISC1)37Asaw/0
(C57BL/6-Tg(Camk2a-DISC1)37Asaw)
|
increased physiological sensitivity to xenobiotic
|
J:194985
|
Tg(Camk2a-tTA)1Mmay/0 Tg(tetO-Csnk1d)#Mfla/0
(involves: 129/Sv * C57BL/6)
|
increased physiological sensitivity to xenobiotic
|
J:158611
|
Tg(Ckm-Chrne*L269F)5Cgz/?
(involves: FVB/NJ)
|
increased physiological sensitivity to xenobiotic
|
J:193524
|
Tg(CMV-GFP,-RNAi:Clec16a)KD3Kslr/0
(NOD-Tg(CMV-GFP,-RNAi:Clec16a)KD3Kslr)
|
increased physiological sensitivity to xenobiotic
|
J:285312
|
Tg(Col1a1-Atf4)1Kry/0
(involves: FVB)
|
increased physiological sensitivity to xenobiotic
|
J:152695
|
Tg(Cyp19)C2-3Rrte/0
(involves: BALB/c * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:69745
|
Tg(DBH-Gal)1923Stei/0
(B6.Cg-Tg(DBH-Gal)1923Stei)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:77625
|
Tg(ED-L2-IL1RN/IL1B)#Tcw/?
(B6.Cg-Tg(ED-L2-IL1RN/IL1B)#Tcw)
|
increased incidence of tumors by chemical induction
|
J:180282
|
Tg(Eno2-PTGS2)32Pasi/0
(involves: C3H/HeNTac * C57BL/6NTac)
|
increased susceptibility to neuronal excitotoxicity
|
J:100973
|
Tg(GAS)2Tcw/0
(involves: FVB/N)
|
increased incidence of tumors by chemical induction
|
J:63579
|
Tg(Gfap-TK)7.1Mvs/0
(involves: C57BL/10 * CBA * CFLP)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:104241
|
increased susceptibility to neuronal excitotoxicity
|
J:113202
|
Tg(Gt(ROSA)26Sor-BCHE*G117H)844Loc/Tg(Gt(ROSA)26Sor-BCHE*G117H)844Loc
(involves: C57BL/6 * SJL)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:89332
|
Tg(Hba-x-v-Ha-ras)TG.ACLed/0 Tg(KRT5-cre)1Tak/Tg(KRT5-cre)1Tak
(involves: C3H * C57BL/6 * FVB/NTac)
|
increased incidence of tumors by chemical induction
|
J:120797
|
Tg(Hba-x-v-Ha-ras)TG.ACLed/0 Wrntm1Led/Wrntm1Led
(involves: 129 * FVB/N * Black Swiss)
|
increased incidence of tumors by chemical induction
|
J:79056
|
Tg(HIV)26Aln/0
(involves: FVB/N)
|
increased physiological sensitivity to xenobiotic
|
J:84552
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:84552
|
Tg(HRAS)2Jic/?
(involves: BALB/c * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:101590,
J:73016
|
Tg(IGF1)1Jdg/0
(involves: FVB * ICR)
|
increased incidence of tumors by chemical induction
|
J:39752
|
Tg(Ins1-Cat,Tyr)25Pne/0
(involves: FVB)
|
abnormal physiological response to xenobiotic
|
J:59275
|
Tg(Ins1-Cat,Tyr)25Pne/0
(NOD.FVB-Tg(Ins1-Cat,Tyr)25Pne)
|
increased physiological sensitivity to xenobiotic
|
J:108415
|
Tg(Ins1-GAS)1Sbr/0
(involves: FVB/NTac)
|
increased incidence of tumors by chemical induction
|
J:63579
|
Tg(INS-MT2A,Tyr)1Pne/0
(FVB-Tg(INS-MT2A,Tyr)1Pne)
|
decreased physiological sensitivity to xenobiotic
|
J:90564
|
Tg(INS-MT2A,Tyr)1Pne/0
(NOD.FVB-Tg(INS-MT2A,Tyr)1Pne)
|
decreased physiological sensitivity to xenobiotic
|
J:108415
|
Tg(K5-Ptgs2)19Kmd/0
(involves: NMRI)
|
increased incidence of tumors by chemical induction
|
J:79071
|
Tg(K5-Ptgs2)667Kmd/0
(involves: NMRI)
|
increased incidence of tumors by chemical induction
|
J:79071
|
Tg(Kap-Ppara/AGT)562Dpo/0
(Not Specified)
|
decreased physiological sensitivity to xenobiotic
|
J:172337
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:172337
|
Tg(KRT5-rtTA)#Glk/0 Tg(tetO/CMV-Dek,-luc)317Siwe/0
(involves: FVB/N)
|
increased incidence of tumors by chemical induction
|
J:261249
|
Tg(KRT5-Tert)8043Blas/0
(involves: C57BL/6 * DBA/2)
|
increased incidence of tumors by chemical induction
|
J:69757,
J:96945
|
Tg(KRT14-Birc5)19Gros/0
(involves: C3H * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:81530
|
Tg(KRT14-Birc5)19Gros/0 Trp53tm1Brd/Trp53+
(involves: 129S7/SvEvBrd * C3H * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:81530
|
Tg(LYZ-rtTA2S*M2,tetO-ELAVL1)632Dkon/0
(B6.Cg-Tg(LYZ-rtTA2S*M2,tetO-ELAVL1)632Dkon)
|
decreased incidence of tumors by chemical induction
|
J:184388
|
Tg(Mbp-SNCA)1Ema/0
(involves: C57BL/6 * DBA/2)
|
abnormal physiological response to xenobiotic
|
J:207162
|
Tg(MGMT)3Bec/Tg(MGMT)3Bec
(involves: NMRI)
|
decreased incidence of tumors by chemical induction
|
J:92925
|
increased incidence of tumors by chemical induction
|
J:92925
|
Tg(MMTV-ERBB3)1Slg/0
(involves: FVB)
|
increased incidence of tumors by chemical induction
|
J:80974
|
Tg(MMTV-ERBB3)1Slg/0 Tg(MMTVneu)202Mul/0
(involves: FVB)
|
increased incidence of tumors by chemical induction
|
J:80974
|
Tg(MMTVTGFB1)46Hlm/0
(involves: C57BL/6 * DBA/2)
|
decreased incidence of tumors by chemical induction
|
J:71696
|
Tg(Mt1)174Bri/0
(B6.Cg-Tg(Mt1)174Bri/J)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:120196
|
Tg(Myh6-ADRB1)4Mjlo/0
(FVB/N-Tg(Myh6-ADRB1)4Mjlo)
|
increased physiological sensitivity to xenobiotic
|
J:55719
|
Tg(Myh6-CACNA1C)M1Aschw/0
(involves: FVB/N)
|
decreased physiological sensitivity to xenobiotic
|
J:129494
|
Tg(Myh6-Cast)1Gwd/0
(involves: FVB/N)
|
decreased physiological sensitivity to xenobiotic
|
J:133797
|
Tg(Myh6-CREB1*S133A)1Jml/0
(involves: CD-1)
|
decreased physiological sensitivity to xenobiotic
|
J:133881
|
Tg(Myh6-EP300)21Csk/0
(C57BL/6-Tg(Myh6-EP300)21Csk)
|
decreased physiological sensitivity to xenobiotic
|
J:110550
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:110550
|
Tg(Myh6-EP300)39Csk/0
(C57BL/6-Tg(Myh6-EP300)39Csk)
|
decreased physiological sensitivity to xenobiotic
|
J:110550
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:110550
|
Tg(Myh6-MT2A)15Pne/?
(involves: FVB)
|
decreased physiological sensitivity to xenobiotic
|
J:100354
|
Tg(Myh6-Myh7)102Rbns/Tg(Myh6-Myh7)102Rbns
(involves: FVB/N)
|
abnormal physiological response to xenobiotic
|
J:166125
|
Tg(Myh6-Myh7)137Rbns/0
(involves: FVB/N)
|
abnormal physiological response to xenobiotic
|
J:166125
|
Tg(Myh6-Tnni3*)1Ammu/0
(involves: A/J * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:59433
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:59433
|
Tg(Myh6-Tpm1*E54K)30Dfw/0
(involves: FVB/N)
|
decreased physiological sensitivity to xenobiotic
|
J:137813
|
Tg(Myh6-Tpm1*E54K)67Dfw/0
(involves: FVB/N)
|
decreased physiological sensitivity to xenobiotic
|
J:137813
|
Tg(Myh6/tetO-Tnnc1*L48Q)2Jmol/0 Tg(Myh6-tTA)55Rbns/0
(involves: FVB)
|
decreased physiological sensitivity to xenobiotic
|
J:234490
|
Tg(Myl1-Trp53inp2)1Azo/0
(involves: C57BL/6J)
|
increased physiological sensitivity to xenobiotic
|
J:212763
|
Tg(Myl2-FGF19)1Dfre/?
(involves: FVB)
|
increased incidence of tumors by chemical induction
|
J:187236
|
Tg(Notch3*R169C)88Bbb/0
(involves: FVB/N)
|
decreased physiological sensitivity to xenobiotic
|
J:156682
|
Tg(OPN1LW-DT)1Mame/0 Tg(OPN1LW-lacZ)1Nat/0
(involves: A/J * C57BL/6 * C57BL/6J)
|
decreased physiological sensitivity to xenobiotic
|
J:128414
|
Tg(PDGFB-Hyou1)#Tam/0
(involves: BALB/c * C57BL/6)
|
decreased susceptibility to neuronal excitotoxicity
|
J:91396
|
Tg(PDGFB-SNCA*A53T)8Ema/0
(Not Specified)
|
decreased physiological sensitivity to xenobiotic
|
J:226922
|
Tg(PDGFB-UCHL1*I93M)LWada/0
(involves: C57BL/6J)
|
increased susceptibility to dopaminergic neuron neurotoxicity
|
J:128045
|
Tg(Pim1-Il9)5Jcrd/0
(involves: FVB/N)
|
increased incidence of tumors by chemical induction
|
J:17848
|
Tg(Plp1-SNCA)1Haa/0
(involves: C57BL/6 * DBA/2)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:96778
|
Tg(Prnp-SETX*R2136H)1920Als/0
(involves: C57BL/6J)
|
increased susceptibility to neuronal excitotoxicity
|
J:320844
|
Tg(Prp-GPR37)1Ryot/0
(involves: C3H * C57BL/6)
|
increased susceptibility to dopaminergic neuron neurotoxicity
|
J:128745
|
Tg(Pten)1Srn/0
(involves: C57BL/6 * CBA)
|
decreased incidence of tumors by chemical induction
|
J:182671
|
Tg(RP11-209M4)AGglo/0
(involves: C57BL/6 * FVB)
|
decreased physiological sensitivity to xenobiotic
|
J:179873
|
Tg(S100a4-TK)M31Egn/0
(involves: BALB/c * C57BL/6 * SJL)
|
abnormal physiological response to xenobiotic
|
J:160213
|
Tg(Scgb1a1-Has2)1Nbl/0
(C57BL/6J-Tg(Scgb1a1-Has2)1Nbl)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:102879
|
Tg(TcraTcrb)1100Mjb/?
(involves: C57BL/6 * MRL/Mp)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:72817
|
Tg(tetO-Plau)1Ths/0 Tg(Scgb1a1-rtTA)1Jaw/0
(involves: C57BL/6 * SJL)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:80184
|
Tg(Th-SNCA)5Eric/0
(involves: C57BL/6 * C57BL/6J)
|
increased physiological sensitivity to xenobiotic
|
J:96494
|
Tg(Th-SNCA*A30P*A53T)39Eric/0
(involves: C57BL/6 * C57BL/6J)
|
increased physiological sensitivity to xenobiotic
|
J:96494
|
Tg(THY1-APOD1)1Era/0
(B6.Cg-Tg(THY1-APOD1)1Era)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:143809
|
Tg(Thy1-APP)3Somm/0
(involves: C57BL/6J * DBA/2)
|
decreased physiological sensitivity to xenobiotic
|
J:129162
|
Tg(Trp53)1Srn/0
(involves: C57BL/6 * CBA)
|
decreased incidence of tumors by chemical induction
|
J:80311
|
Tg(Trp53A135V)L3Ber/0
(involves: C57BL/6 * CD-1)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:73757
|
Tg(Trp53R172H)8512Jmr/0
(involves: FVB)
|
increased incidence of tumors by chemical induction
|
J:46426
|
Tg(Trp53R172L)4491Jmr/0
(involves: FVB/N)
|
decreased incidence of tumors by chemical induction
|
J:101547
|
Tg(Vil1-PPARGC1A)#Amos/0
(involves: FVB/N)
|
decreased incidence of tumors by chemical induction
|
J:171361
|
Tg(Vil-SLC3A2)HEMerl/0
(involves: FVB/N)
|
increased incidence of tumors by chemical induction
|
J:173946
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:173946
|
Tg(YAC18)18Hay/0
(involves: FVB/N)
|
decreased susceptibility to neuronal excitotoxicity
|
J:144917
|
Tg(YAC72)2511Hay/0
(involves: FVB/N)
|
increased susceptibility to neuronal excitotoxicity
|
J:144917
|
Tg(YAC72)2511Hay/Tg(YAC72)2511Hay
(FVB/N-Tg(YAC72)2511Hay)
|
increased susceptibility to neuronal excitotoxicity
|
J:105728
|
Tg(YAC128)53Hay/0
(FVB/N-Tg(YAC128)53Hay)
|
increased susceptibility to neuronal excitotoxicity
|
J:105723
|
Tg(YAC128)55Hay/0
(FVB/N-Tg(YAC128)55Hay)
|
increased susceptibility to neuronal excitotoxicity
|
J:105723
|
Tg(YAC128)55Hay/Tg(YAC128)55Hay
(FVB/N-Tg(YAC128)55Hay)
|
increased susceptibility to neuronal excitotoxicity
|
J:105723,
J:105728
|
Tg(YAC353G6)W7Hay/Tg(YAC353G6)W7Hay
(FVB/NJ-Tg(YAC353G6)W7Hay)
|
decreased susceptibility to neuronal excitotoxicity
|
J:120991
|
Tgfb1tm1Doe/Tgfb1+
(involves: 129S2/SvPas * CF-1)
|
abnormal physiological response to xenobiotic
|
J:137529
|
Tgfbitm1Zhao/Tgfbitm1Zhao
(involves: 129 * C57BL/6J)
|
increased incidence of tumors by chemical induction
|
J:143036
|
Tgfbr2tm1Sjkm/Tgfbr2+
(Not Specified)
|
increased incidence of tumors by chemical induction
|
J:71591
|
Tgm2tm1Gml/Tgm2tm1Gml
(involves: 129X1/SvJ * C57BL/6)
|
increased physiological sensitivity to xenobiotic
|
J:82489
|
Thbs2tm1Bst/Thbs2tm1Bst
(either: (involves: 129S4/SvJae * 129X1/SvJ) or (involves: 129X1/SvJ))
|
increased incidence of tumors by chemical induction
|
J:69756
|
Thpotm1.1(KOMP)Vlcg/Thpotm1.1(KOMP)Vlcg
(C57BL/6N-Thpotm1.1(KOMP)Vlcg/MbpMmucd)
|
decreased bronchoconstrictive response
|
J:211773
|
Thratm1Ven/Thratm1Ven Thrbtm1Df/Thrbtm1Df
(involves: 129P2/OlaHsd * 129S1/Sv * BALB/c * C57BL/6J)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:73382
|
Tiam1tm1Jgc/Tiam1+
(involves: 129P2/OlaHsd * FVB)
|
decreased incidence of tumors by chemical induction
|
J:77148
|
Tiam1tm1Jgc/Tiam1tm1Jgc
(involves: 129P2/OlaHsd * FVB)
|
decreased incidence of tumors by chemical induction
|
J:77148
|
TigarGt(EUCE0047g05)Hmgu/TigarGt(EUCE0047g05)Hmgu
(involves: 129P2/OlaHsd)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:198650
|
TiparpGt(ROSA)79Sor/TiparpGt(ROSA)79Sor
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6J)
|
increased physiological sensitivity to xenobiotic
|
J:250417
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:250417
|
Tlr2tm1Aki/Tlr2tm1Aki Tlr4tm1Aki/Tlr4tm1Aki
(B6.129P2-Tlr2tm1Aki Tlr4tm1Aki)
|
increased physiological sensitivity to xenobiotic
|
J:102879
|
Tlr4tm1Aki/Tlr4tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:162097
|
Tlr4tm1Aki/Tlr4tm1Aki
(B6.129P2-Tlr4tm1Aki)
|
decreased incidence of tumors by chemical induction
|
J:135620
|
Tlr5tm1Flv/Tlr5tm1Flv
(involves: 129S1/Sv * C57BL/6)
|
abnormal physiological response to xenobiotic
|
J:158055
|
Tmbim6Gt1Jcre/Tmbim6Gt1Jcre
(Not Specified)
|
increased physiological sensitivity to xenobiotic
|
J:91831
|
Tmem175em1Dren/Tmem175em1Dren
(B6.Cg-Tmem175em1Dren)
|
increased susceptibility to neuronal excitotoxicity
|
J:304120
|
Tmem175em2Dren/Tmem175em2Dren
(C57BL/6J-Tmem175em2Dren)
|
decreased susceptibility to neuronal excitotoxicity
|
J:304120
|
Tmem175em3Dren/Tmem175+
(C57BL/6J-Tmem175em3Dren)
|
increased susceptibility to neuronal excitotoxicity
|
J:304120
|
Tmem175em3Dren/Tmem175em3Dren
(C57BL/6J-Tmem175em3Dren)
|
increased susceptibility to neuronal excitotoxicity
|
J:304120
|
Tnftm1Gkl/Tnftm1Gkl
(involves: 129S/SvEv * C57BL/6)
|
decreased incidence of tumors by chemical induction
|
J:56068
|
Tnftm1Gkl/Tnftm1Gkl
(C.129S-Tnftm1Gkl)
|
decreased incidence of tumors by chemical induction
|
J:56068
|
Tnfaip3tm1.1Gvl/Tnfaip3tm1.1Gvl Tg(Vil1-cre)997Gum/0
(B6.Cg-Tnfaip3tm1.1Gvl Tg(Vil1-cre)997Gum)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:163410
|
Tnfaip8l3tm1a(KOMP)Mbp/Tnfaip8l3tm1a(KOMP)Mbp
(C57BL/6N-Atm1Brd Tnfaip8l3tm1a(KOMP)Mbp/MbpMmucd)
|
decreased incidence of tumors by chemical induction
|
J:217197
|
Tnfrsf1atm1Blt/Tnfrsf1atm1Blt
(C.129P2-Tnfrsf1atm1Blt)
|
decreased physiological sensitivity to xenobiotic
|
J:87476
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:87476
|
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
(C57BL/6-Tnfrsf1atm1Imx)
|
decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:78637
|
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx Tnfrsf1btm1Imx/Tnfrsf1btm1Imx
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:51349
|
decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:78637
|
increased susceptibility to neuronal excitotoxicity
|
J:33864
|
Tnfrsf1btm1Imx/Tnfrsf1btm1Imx
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:78637
|
Tnfrsf10btm1Wsed/Tnfrsf10btm1Wsed
(involves: 129P2/OlaHsd)
|
decreased physiological sensitivity to xenobiotic
|
J:96816
|
Tnfrsf14tm1Csj/Tnfrsf14tm1Csj
(B6.Cg-Tnfrsf14tm1Csj)
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:169369
|
Tnfsf10tm1Mjs/Tnfsf10tm1Mjs
(C.129-Tnfsf10tm1Mjs)
|
increased incidence of tumors by chemical induction
|
J:73948
|
Tniktm1Teya/Tniktm1Teya
(involves: C57BL/6J)
|
decreased incidence of tumors by chemical induction
|
J:241611
|
Tph1tm1c(KOMP)Wtsi/Tph1tm1c(KOMP)Wtsi Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJae * C57BL/6J * CBA/J)
|
decreased physiological sensitivity to xenobiotic
|
J:284574
|
Tpmttm1Rlng/Tpmt+
(involves: 129P2/OlaHsd * C57BL/6 * NMRI)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:121737
|
Tpmttm1Rlng/Tpmttm1Rlng
(involves: 129P2/OlaHsd * C57BL/6 * NMRI)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:121737
|
Traddtm1.1Mpa/Traddtm1.1Mpa
(involves: BALB/cJ * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:139030
|
Traddtm1.1Zgl/Traddtm1.1Zgl
(involves: C57BL/6 * FVB/N)
|
decreased physiological sensitivity to xenobiotic
|
J:139031
|
Traf3tm1Bshp/Traf3tm1Bshp Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * SJL)
|
decreased physiological sensitivity to xenobiotic
|
J:124329
|
Trem1tm1.1Ahoru/Trem1tm1.1Ahoru
(C57BL/6-Trem1tm1.1Ahoru)
|
decreased incidence of tumors by chemical induction
|
J:191035
|
Trex2tm1.2Coso/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1)
|
increased incidence of tumors by chemical induction
|
J:151766
|
Trex2tm1.2Coso/Trex2tm1.2Coso
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1)
|
increased incidence of tumors by chemical induction
|
J:151766
|
Trim16tm1Gmma/Trim16+ Tg(KRT14-cre)1Cgn/0
(involves: C57BL/6 * DBA/2)
|
increased incidence of tumors by chemical induction
|
J:290272
|
Trim27Gt(XP0484)Wtsi/Trim27Gt(XP0484)Wtsi
(B6.129P2-Trim27Gt(XP0484)Wtsi)
|
decreased incidence of tumors by chemical induction
|
J:189317
|
Trim32tm1Hdin/Trim32tm1Hdin
(involves: 129S1/Sv)
|
abnormal physiological response to xenobiotic
|
J:184218
|
Trp53tm1.1Hwan/Trp53+
(involves: C57BL/6 * C57BL/6N)
|
increased incidence of tumors by chemical induction
|
J:265556
|
Trp53tm1.1Hwan/Trp53tm1.1Hwan
(involves: C57BL/6 * C57BL/6N)
|
increased incidence of tumors by chemical induction
|
J:265556
|
Trp53tm1Brd/Trp53tm1Brd
(NIHOla.129S7-Trp53tm1Brd)
|
decreased incidence of tumors by chemical induction
|
J:93298
|
Trp53tm1Ldo/Trp53+
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal physiological response to xenobiotic
|
J:73757
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:73757
|
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas)
|
increased incidence of tumors by chemical induction
|
J:170769
|
Trp53tm1Tyj/Trp53+ Xpatm1Hvs/Xpatm1Hvs
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
increased incidence of tumors by chemical induction
|
J:170769
|
Trp53tm3Tyj/Trp53+ Tg(Wap-cre)11738Mam/0
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
increased incidence of tumors by chemical induction
|
J:101617
|
Trp53inp1tm1Acar/Trp53inp1tm1Acar
(involves: 129/Sv * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:118867
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:118867
|
Trp53inp2tm1Azo/Trp53inp2tm1Azo Myl1tm1(cre)Sjb/Myl1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased physiological sensitivity to xenobiotic
|
J:212763
|
Trp73tm1Mak/Trp73tm1Mak
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased incidence of tumors by chemical induction
|
J:142848
|
Trp73tm2Mak/Trp73tm2Mak
(either: B6.129P2-Trp73tm2Mak or (involves: 129P2/OlaHsd * C57BL/6J))
|
increased physiological sensitivity to xenobiotic
|
J:157905
|
Trpa1tm1.1Bju/Trpa1tm1.1Bju
(involves: C57BL/6J)
|
decreased physiological sensitivity to xenobiotic
|
J:160860
|
Trpc5tm1.1Lbi/Y
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
decreased susceptibility to neuronal excitotoxicity
|
J:194590
|
Trpc5tm1.1Lbi/Trpc5tm1.1Lbi
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
decreased susceptibility to neuronal excitotoxicity
|
J:194590
|
Trpv1tm1Jul/Trpv1tm1Jul
(involves: 129X1/SvJ * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:144978
|
Trpv1tm1Jul/Trpv1tm1Jul
(B6.129X1-Trpv1tm1Jul/J)
|
abnormal physiological response to xenobiotic
|
J:132936,
J:105525,
J:128319,
J:96901
|
Tsc1tm1Hin/Tsc1+
(involves: 129S4/SvJae * C57BL/6J)
|
increased incidence of tumors by chemical induction
|
J:70463
|
Tslptm1.1Pcn/Tslptm1.1Pcn Tg(KRT14-cre)1Ipc/0
(involves: 129 * C57BL/6 * SJL)
|
decreased physiological sensitivity to xenobiotic
|
J:146511
|
Tslptm1.1Pcn/Tslptm1.1Pcn Tg(KRT14-cre/ERT2)1Ipc/0
(involves: 129 * C57BL/6 * SJL)
|
decreased physiological sensitivity to xenobiotic
|
J:146511
|
Tslptm1.2Pcn/Tslptm1.2Pcn
(involves: 129 * C57BL/6 * SJL)
|
decreased physiological sensitivity to xenobiotic
|
J:146511
|
Tslptm1Mak/Tslptm1Mak
(B6.Cg-Tslptm1Mak)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:175844
|
Ttll3tm1a(EUCOMM)Wtsi/Ttll3tm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
increased incidence of tumors by chemical induction
|
J:216383
|
Tusc2tm1Avi/Tusc2tm1Avi
(involves: 129S1/Sv)
|
increased physiological sensitivity to xenobiotic
|
J:309768
|
Txniptm1.1Road/Txniptm1.1Road
(B6.Cg-Txniptm1.1Road)
|
decreased physiological sensitivity to xenobiotic
|
J:132756
|
Tyrobptm1.1Viv/Tyrobptm1.1Viv
(B6.129P2-Tyrobptm1.1Viv)
|
increased physiological sensitivity to xenobiotic
|
J:96801
|
Uacatm1Kiy/Uacatm1Kiy
(B6.129P2-Uacatm1Kiy)
|
increased incidence of tumors by chemical induction
|
J:157049
|
Ucp1em1Yqiu/Ucp1em1Yqiu
(Not Specified)
|
decreased physiological sensitivity to xenobiotic
|
J:299971
|
Ucp1tm1Kz/Ucp1tm1Kz
(involves: 129S2/SvPas)
|
abnormal physiological response to xenobiotic
|
J:40053
|
Ucp2tm1Lowl/Ucp2tm1Lowl
(involves: 129S4/SvJae * C57BL/6)
|
increased susceptibility to dopaminergic neuron neurotoxicity
|
J:96713
|
Uimc1tm1.2Amj/Uimc1tm1.2Amj
(involves: BALB/cJ * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:191827
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:191827
|
Upp1tm1Gp/Upp1tm1Gp
(involves: 129)
|
decreased physiological sensitivity to xenobiotic
|
J:99912
|
Urahplt2/Urahplt2
(C57BL/6-Urahplt2)
|
decreased physiological sensitivity to xenobiotic
|
J:267227
|
Uri1tm1.1Ndj/Uri1+ Albtm1(cre/ERT2)Mtz/Alb+
(B6.Cg-Albtm1(cre/ERT2)Mtz Uri1tm1.1Ndj)
|
decreased incidence of tumors by chemical induction
|
J:217463
|
Usp4em1Pwa/Usp4em1Pwa
(Not Specified)
|
decreased incidence of tumors by chemical induction
|
J:298778
|
Usp24Gt(XB614)Byg/Usp24+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:303991
|
Usp38em1Cya/Usp38em1Cya
(C57BL/6-Usp38em1Cya)
|
increased physiological sensitivity to xenobiotic
|
J:321973
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:321973
|
Utrntm1Jrs/Utrntm1Jrs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:89397
|
Vasntm1Zgl/Vasntm1Zgl
(B6.Cg-Vasntm1Zgl)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:173568
|
Vav2tm1Kdf/Vav2tm1Kdf Vav3tm1Swat/Vav3tm1Swat
(B6.129S-Vav2tm1Kdf Vav3tm1Swat)
|
decreased physiological sensitivity to xenobiotic
|
J:158008
|
increased physiological sensitivity to xenobiotic
|
J:158008
|
Vav2tm1Tnr/Vav2tm1Tnr
(involves: 129P2/OlaHsd)
|
abnormal physiological response to xenobiotic
|
J:124056
|
Vdrtm1Mbd/Vdrtm1Mbd
(involves: 129S4/SvJae * C57BL/6)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:130511
|
Vhltm1.1Wkr/Vhl+
(involves: 129S4/SvJae * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:157369
|
Vhltm1Wml/Vhl+
(involves: 129S4/SvJae * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:88492
|
War/War Tyrc-e/Tyrc-e
(PBI)
|
abnormal physiological response to xenobiotic
|
J:5635
|
decreased physiological sensitivity to xenobiotic
|
J:5635
|
Wnk1tm1.1Juha/Wnk1tm1.1Juha
(involves: 129S2/SvPas * C57BL/6 * C57BL/6N * SJL)
|
decreased physiological sensitivity to xenobiotic
|
J:165537
|
Wnk4tm1Pfi/Wnk4tm1Pfi
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased physiological sensitivity to xenobiotic
|
J:184790
|
Wwoxtm1Ria/Wwox+
(involves: 129X1/SvJ * C57BL/6)
|
increased incidence of tumors by chemical induction
|
J:120064
|
Wwp2tm1.1Yyiw/Wwp2tm1.1Yyiw
(involves: 129S/SvEv * C57BL/6 * FVB/N)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:228707
|
Xpatm1Tnka/Xpatm1Tnka
(involves: C57BL/6 * CBA)
|
increased incidence of tumors by chemical induction
|
J:28709
|
Xpo7em1.1Gmkf/Xpo7em1.1Gmkf
(involves: C57BL/6 * FVB/N)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:331429
|
Xpo7tm1d(KOMP)Wtsi/Xpo7tm1d(KOMP)Wtsi
(involves: C57BL/6N * FVB/N)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:331429
|
Yap1tm1.1Dupa/Yap1tm1.1Dupa Tg(Vil1-cre)997Gum/0
(involves: 129P2/OlaHsd * C57BL/6J * SJL)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:165471
|
Yap1tm2.1Dupa/Yap1tm2.1Dupa
(Not Specified)
|
increased incidence of tumors by chemical induction
|
J:223215
|
Yipf6M1Btlr/Y
(C57BL/6J-Yipf6M1Btlr/Mmucd)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:187584
|
Yipf6M1Btlr/Yipf6M1Btlr
(C57BL/6J-Yipf6M1Btlr/Mmucd)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:187584
|
Zdhhc9tm1Lex/Y
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased physiological sensitivity to xenobiotic
|
J:231488
|
decreased susceptibility to xenobiotic induced morbidity/mortality
|
J:231488
|
Zfp148tm1Djl/Zfp148tm1Djl
(involves: 129)
|
increased susceptibility to xenobiotic induced morbidity/mortality
|
J:107441
|
Zfp280cem1Xss/Zfp280cem1Xss
(C57BL/6J-Zfp280cem1Xss)
|
decreased incidence of tumors by chemical induction
|
J:331404
|
Zfp746em1Jhsn/Zfp746em1Jhsn
(C57BL/6-Zfp746em1Jhsn)
|
decreased incidence of tumors by chemical induction
|
J:344819
|
Zit1DBA/2J/Zit1DBA/2J
(involves: BALB/cByJ * DBA/2J)
|
increased physiological sensitivity to xenobiotic
|
J:100364
|